ABBA J. KASTIN, M.D.
Professor and Endowed Chair, Pennington Biomedical Research Center
Editor-in-Chief, Peptides
Editor, Handbook of Biologically Active Peptides
President, International Neuropeptide Society/Society for Biologically Active Peptides
EDUCATION
A.B.
Harvard College, 1956
M.D. Harvard Medical School, 1960
TRAINING
7/60 - 7/62
Residency in Medicine, Vanderbilt University Hospital
7/62 - 9/64
Clinical Associate, Endocrinology Branch, National Cancer Institute,
National Institutes of Health
9/64 - 1/65
Special NIH Postdoctoral Fellow with Dr. Andrew V. Schally
ACADEMIC APPOINTMENTS
7/61 - 7/62
Assistant, Department of Medicine, Vanderbilt University
9/64 - 1/65
Assistant, Department of Medicine, Tulane University
1/65 - 7/66
Instructor, Department of Medicine, Tulane University
7/66 - 7/71
Assistant Professor, Department of Medicine, Tulane University
7/71 - 7/74
Associate Professor, Department of Medicine, Tulane University
7/74 - 7/04
Professor, Department of Medicine, Tulane University
7/86 - 7/04
Professor, Neuroscience Training Program, Tulane University
1
7/86 – 9/06
Consulting Professor, Department of Psychology, University of New
Orleans
8/04 - present Professor and Endowed Chair, Pennington Biomedical Research Center,
Louisiana State University Systems
HOSPITAL APPOINTMENTS
Veterans Administration Hospital:
9/64 - 1/65
Medical Research Fellow
1/65 - 1/68
Clinical Investigator
7/66 - 1/68
Clinical Consultant in Endocrinology
1/68 - 7/04
Chief, Endocrinology Section
Charity Hospital:
7/66 - 7/69
Assistant Visiting Physician
7/69 - 7/79
Visiting Physician
7/79 - 7/89
Senior Visiting Physician
HONORARY DEGREES
1980 Doctorate (Honoris Causa), National University (Federico Villarreal) of Peru
1984 Doctorate of Science (Honoris Causa), University of New Orleans
2008 Doctorate (Honoris Causa), Uppsala University, Sweden
HONORARY SOCIETY MEMBERSHIPS
1966 La Societe de Dermo-Chimie
1970 Chilean Society of Endocrinology
1976 Philippine Society of Endocrinology and Metabolism
2
1980 Peruvian Ob/Gyn Society
1980 Peruvian Endocrine Society
1980 Polish Endocrine Society
1984 Hungarian Endocrine Society
2006 Brazilian Society of Toxinology (SBTx)
2008 Indian Society for Comparative Endocrinology
AWARDS
1975 Federal Business Association "Eagle" Award and Key to the City of New Orleans
1975 Recipient (with Dr. A.V. Schally), Edward T. Tyler Fertility Award
1979 Copernicus Medal of the Medical Faculty of Krakow, Poland
1981 Distinguished Alumni Hall of Fame (First Annual Induction), Cleveland Heights
High School
1982 William S. Middleton Award
2001 Strand Award
2007 Honorary Professor, The Peking University Health Science Center, China
2010 Honorary Professor, Lanzhou University, China
MISCELLANEOUS
1978 Most cited scientist list, Institute for Scientific Information, Current Contents, 7/10/78;
Science 202: 296, 1978-top 300; Current Contents 10/12/81-top 100; The Scientist
3/19/90-top 100
1980 - present
Founding Editor-in-Chief, Peptides, an international journal
1980s – present
Nominator: Japan Prize, Kyoto Prize, International Prize for Biology
3
1993 - present
President, International Neuropeptide Society/Society for Biologically Active Peptides
2006 Editor, Handbook of Biologically Active Peptides. Elsevier, San Diego.
2008 Co-Editor (with Weihong Pan), Henry Stewart Talks: The Blood-Brain Barrier, London,
UK
ADVISORY BOARDS
7/74 - 7/77
National Pituitary Agency
1/78 - 12/81
National Association for Retarded Citizens
2/79 - 12/80
Food and Drug Association
7/84 - 12/95
Pre-reviewer in Endocrinology, Residency Review Committee for Internal
Medicine, Accreditation Council for Graduate Medical Education
10/11/89
Congressional testimony, U.S. House of Representatives, representing American
Federation for Clinical Research.
1/98 – 12/00 Bar-Ilan University-Tel Hashomer Brain Research Center, Israel
1/98 - 12/03
Self-Assessment Committee, AMA Accreditation Program (AMA).
EDITORIAL BOARDS
1/76-1/80
Journal of Clinical Endocrinology and Metabolism.
1/76-4/95
Brain Research Bulletin
1/77-12/95
Neuroscience and Biobehavioral Reviews
7/85- 1/01
New Trends in Experimental and Clinical Psychiatry
3/88-3/90
Progress in NeuroEndocrinImmunology
1/89-1/95
Pharmacology, Biochemistry and Behavior
4
1/90-1/95
Molecular and Cellular Neurosciences
1/93-1/95
Physiology and Behavior
1/94-12/04
Endocrine Practice
7/95-6/00
Neuroimmunomodulation
7/96-12/00
Sulzberger & Graham Publishing, Ltd., Professional Books in Pharmacology,
Neuroscience and Biomedical Sciences
1/99-12/06
Hanwood Academic Publishers, Book Series: Nutrition, Brain, and Behavior
1/03-present
Current Pharmaceutical Design
1/04-1/07
Medicinal Chemistry Reviews – Online
1/05-present
Medicinal Chemistry
8/07-12/09
Clinical Medicine: Endocrinology and Diabetes
1/10-present
Clinical Medical Insights: Endocrinology and Diabetes
TEACHING
1976-77
Distinguished Scientist Lecturer, Department of Anatomy, Tulane University
School of Medicine
1977-1996
Outstanding Teacher Awards, Tulane medical students’ Owl Club
1989-90
Welcome Visiting Professor (FASB), East Tennessee State University
1995
Guest of Honor, Research Day in Medicine, LSU Medical Center
1997
Visiting Senior Scientist, JSPS/NIH, Japan
2004
Jim Flood Memorial Lecture, St. Louis University
2007
Kalra Brain-Body Dialogue Lecture, University of Florida
2008
David Rabin Visiting Professor Lectures, Vanderbilt University
5
SOCIETIES
1964
American Federation for Clinical Research
1965
The Endocrine Society
1965
American Association for Advancement of Science
1966
American Physiological Society
1967
Society for Experimental Biology and Medicine
1969
Society for Neuroscience
1970
International Society of Psychoneuroendocrinology
1972
International Society of Neuroendocrinology (Charter Member)
1978
International Pigment Cell Society (Charter Member)
1990
American Peptide Society (Charter Member)
1990
American Geriatrics Society
1991
American Association of Clinical Endocrinology (Charter Member)
1992
International Behavioral Neuroscience Society (Council, 1992-1994; Fellow)
1993
The International Neuropeptide Society (President, 1993-present)
1994
Council of Biology Editors (Editorial Policy Committee, 1998-2001)
1995
American College of Endocrinology (Fellow)
CIVIC/COMMUNITY
Green Wave Masters Swim Club (President, 1978 – 1984)
Civic Symphony Orchestra of New Orleans
Committee, 1991 – 2005)
(President, 1990; Chairman, Nominating
Jewish Federation of Greater New Orleans (Board of Trustees, 1982 – 1988)
6
Harvard Club of Louisiana (President, 1991-1995; Chairman, Advisory Committee,
1996 – present)
Louisiana Philharmonic Orchestra (Advisory Board, 1997 – present)
Opéra Louisiane (Board of Directors, 2007 – present)
Baton Rouge Symphony Orchestra (Board of Directors, 2007 – present)
Visual Arts Visiting Committee, Loyola University, New Orleans (2004 – present)
7
FULL PAPERS
1.
Kastin, A.J. and G.T. Ross. Melanocyte stimulating hormone (MSH) and ACTH
activities of pituitary homografts in albino rats. Endocrinology 75: 187-191, 1964.
2.
Kastin, A.J. and R.F. Gittes. Skin graft challenge to pituitary transplants in the rat.
Endocrinology 75: 457-460, 1964.
3.
Kastin, A.J. and GT. Ross. Modified in vivo assay for MSH. Experiential 20: 461-464,
1964.
4.
Gittes, R.F., A.J. Kastin, D.B. Geoff and A.F. Ketcham. Deficiency of effective
histocompatibility antigens in pituitary and parathyroid tissue. Surgical Forum 15: 164166, 1964.
5.
Kastin, A.J., M.B. Lipsett, A.K. Ommaya and J.M. Moser. Asymptomatic hypernatremia:
physiological and clinical study. Am. J. Med. 38: 306-315, 1965.
6.
Douglas, G.W., A.J. Kastin and R.W. Huntington. Carcinoma arising in a retroperitoneal
mullerian cyst, with widespread metastasis during pregnancy. Am. J. Ob. Gyn. 91: 210216, 1965.
7.
Paul, W.E., A.J. Kastin and W.D. Odell. The effect of ionizing radiation on melanocytestimulating and steroidogenic activities of corticotropin. Biochem. Biophys. Acta 100:
263-269, 1965.
8.
Kastin, A.J. and G.T. Ross. MSH and ACTH activities in pituitaries of frogs with
hypothalamic lesions. Endocrinology 77: 45-48, 1965.
9.
Schally, A.V., C.Y. Bowers, A. Kuroshima, Y. Ishida, T.W. Redding and A.J. Kastin.
Hormonal activities of beef and pig hypothalamus. Excerp. Med. Int. Cong. Series no. 87,
pp. 275-283, Proc. XXIII International Congress of Physiological Sciences, 1965.
10.
Kastin, A.J., A.V. Schally, H. Yajima and K. Kubo. Melanocyte stimulating hormone
activity of synthetic MSH and ACTH peptides in vivo and in vitro. Nature 207: 978-979,
1965.
11.
Kastin, A.J., A. Arimura and A.V. Schally. Topical absorption of polypeptide hormones
with dimethylsulfoxide. Arch. Dermatol. 93: 471-473, 1966.
12.
Gittes, R.F. and A.J. Kastin. Effects of increasing numbers of pituitary transplants in
hypophysectomized rats. Endocrinology 78: 1023-1031, 1966.
13.
Kastin, A.J. and A.V. Schally. In vivo assay for melanocyte lightening substances.
8
Experientia 22: 389, 1966.
14.
Schally, A.V., A.J. Kastin, J.F. Barrett, W.H. Carter, C.Y. Bowers and W.F. White. On
vasodepressor activity in the hypothalamus. Biochem. Pharmacol. 15: 1805-1811, 1966.
15.
Kastin, A.J. and A.V. Schally. MSH activity in pituitaries of rats treated with
hypothalamic extracts. Gen. Comp. Endocrinol. 7: 452-456, 1966.
16.
Schally, A.V. and A.J. Kastin. Purification of a bovine hypothalamic factor which
elevates pituitary MSH levels in rats. Endocrinology 79: 768-772, 1966.
17.
Kastin, A.J. and A.V. Schally. MSH activity in pituitary glands of rats treated with
tranquilizing drugs. Endocrinology 79: 1018-1020, 1966.
18.
Kastin, A.J., G.T. Ross and A.V. Schally. Controle hypothalamique de la secretion de
MSH. Arch. Biochim. Cosmet. 9: 9, 1966.
19.
Kastin, A.J. and A.V. Schally. Autoregulation of release of melanocyte stimulating
hormone from the rat pituitary. Nature 213: 1238-1240, 1967.
20.
Kastin, A.J. and A.V. Schally. MSH activity in pituitaries of rats treated with
hypothalamic extracts from various animals. Gen. Comp. Endocrinol. 8: 344-347, 1967.
21.
Kastin, A.J., T.W. Redding and A.V. Schally. MSH activity in rat pituitaries after
pinealectomy. Proc. Soc. Exp. Biol. Med. 124: 1275-1277, 1967.
22.
Schally, A.V., A.J. Kastin, T.W. Redding, C.Y. Bowers, H. Yajima and K. Kubo.
Thyroid stimulating and pigmentary effects of synthetic peptides related to α-MSH and
ACTH. Metabolism 16: 824-829, 1967.
23.
Kastin, A.J., L. Barrett, S. Viosca, A. Arimura and A.V. Schally. MSH activity in rat
pituitaries after stress. Neuroendocrinology 2: 200-208, 1967.
24.
Kastin, A.J., A.V. Schally, S. Viosca, L. Barrett and T.W. Redding. MSH activity in the
pituitaries of rats exposed to constant illumination. Neuroendocrinology 2: 257-262,
1967.
25.
Schally, A.V., A.J. Kastin, W. Locke and C.Y. Bowers. Hypothalamic releasing and
inhibiting factors. In: Hormones in Blood. C.H. Gray and A.L. Bacharach, eds.,
Academic Press, New York, 1: 491-525, 1967.
26.
Schally, A.V., W. Locke, A.J. Kastin and C.Y. Bowers. Some aspects of
neuroendocrinology. Yearbook of Endocrinology, pp. 5-29, 1967-68.
9
27.
Schally, A.V., A. Arimura, C.Y. Bowers, S. Sawano, A.J. Kastin, T.W. Redding, T.
Saito, W.F. White and A.I. Cohen. Physiological and biochemical studies on some highly
purified hypothalamic releasing factors. In: Pharmacology of Hormonal Polypeptides and
Proteins. R. Back, R. Paoletti and L. Martini, eds., Plenum Press, pp. 158-166, 1968.
28.
Schally, A.V., A. Arimura, C.Y. Bowers, A.J. Kastin, S. Sawano and T.W. Redding.
Hypothalamic neurohumors regulating anterior pituitary function. Rec. Prog. Horm. Res.
24: 497-581, 1968.
29.
Kastin, A.J., G. Gennser, A. Arimura, M.C. Miller and A.V. Schally. Melanocytestimulating and corticotrophic activities in human foetal pituitary glands. Acta
Endocrinologica 58: 6-10, 1968.
30.
Kastin, A.J., M.C. Miller and A.V. Schally. MSH activity in the rat pituitary after
treatment with nembutal and morphine: A new bioassay for MSH-release inhibiting
factor (MIF). Endocrinology 83: 137-140, 1968.
31.
Kastin, A.J., S. Kullander, N.E. Borglin, K. Dyster-Aas, B. Dahlberg, D. Ingvar, C.E.T.
Krakau, M.C. Miller, C.Y. Bowers and A.V. Schally. Extrapigmentary effects of MSH in
amenorrheic women. Lancet 1: 1007-1010, 1968.
32.
Schally, A.V. and A.J. Kastin. The present concept of the nature of hypothalamic
hormones stimulating and inhibiting the release of pituitary hormones. Triangle 9: 19-25,
1969.
33.
Kastin, A.J., A.V. Schally, S. Viosca and M.C. Miller. MSH activity in plasma and
pituitaries of rats after various treatments. Endocrinology 84: 20-27, 1969.
34.
Sandman, C.A., A.J. Kastin and A.V. Schally. Melanocyte-stimulating hormone and
learned appetitive behavior. Experientia 25: 1001-1002, 1969.
35.
Kastin, A.J., M.C. Miller and A.V. Schally. Modified in vitro assay for MSH. Experientia
25: 192-193, 1969.
36.
Kastin, A.J., A.V. Schally, C. Gual, A.R. Midgley, C.Y. Bowers and A. Diaz-Infante.
Stimulation of LH release in men and women by hypothalamic LH-releasing hormone
purified from porcine hypothalami. J. Clin. Endocrinol. Metab. 29: 1046-1050, 1969.
37.
Kastin, A.J. Neuroendocrine research in the Veterans Administration, Special report.
January 29, 1969, part B.
38.
Kastin, A.J., S. Viosca and A.V. Schally. Assay of mammalian MSH-release regulating
factor(s). In: Hypophysiotropic Hormones of the Hypothalamus. J. Meites, ed., Williams
and Wilkins, Baltimore, pp. 171-183, 1970.
10
39.
Dyster-Aas, K., A.J. Kastin, R.P. Vidacovich and A.V. Schally. Melanocyte-stimulating
activity in serum and the aqueous flare response in rabbits. J. Endocrinol. 46: 285-286,
1970.
40.
Kastin, A.J., A.V. Schally, C. Gual, A.R. Midgley, C.Y. Bowers and F. Gomez-Perez.
Administration of LH-releasing hormone to selected subjects. Am. J. Ob. Gyn. 108: 177182, 1970.
41.
Gosbee, J.L., J. Kraicer, A.J. Kastin and A.V. Schally. A functional relationship between
the pars intermedia and ACTH secretion in the Rat. Endocrinology 86: 560-567, 1970.
42.
Schally, A.V. and A.J. Kastin. The role of sex steroids and hypothalamic LH-releasing
hormone and FSH-releasing hormone in the regulation of gonadotropin secretion from
the anterior pituitary gland. In: Advances in Steroid Biochemistry. M.H. Briggs, ed.
Academic Press, New York, pp. 41-69, 1970.
43.
Schally, A.V., A. Arimura, A.J. Kastin, J. Reeves, C.Y. Bowers, Y. Baba and W.F.
White. Hypothalamic LH-releasing hormone: Chemistry, physiology and effect in
humans. In: Mammalian Reproduction. H. Gibian and E.J. Plotz, eds., Springer-Verlag,
Berlin, pp. 45-83, 1970.
44.
Schally, A.V., A. Arimura, C.Y. Bowers, I. Wakabayashi, A.J. Kastin, T.W. Redding,
J.C. Mittler, R.M.G. Nair, P. Pizzolato and A.J. Segal. Purification of hypothalamic
releasing hormones of human origin. J. Clin. Endocrinol Metab. 31: 291-300, 1970.
45.
Bowers, C.Y., A.V. Schally, D.S. Schalch, C. Gual, A.J. Kastin and K. Folkers. Activity
and specificity of synthetic thyrotropin-releasing hormone in man. Biochem. Biophys.
Res. Comm. 39: 352-355, 1970.
46.
Kastin, A.J., A.V. Schally, C. Gual, A.R. Midgley, M.C. Miller and F. Flores. Increased
release of LH after administration of LH-RH to men pretreated with clomiphene. J. Clin.
Endocrinol. Metab. 31: 689-692, 1970.
47.
Kastin, A.J., A.V. Schally, C. Gual and A.R. Midgley. Clinical studies with LH-releasing
hormone. Acta Endocrinol Panam. 1: 147-153, 1970.
48.
Gual, C., F. Flores, A.J. Kastin, A.V. Schally and A.R. Midgley. Valoracion de la funcion
hipofisiaria en el humano mediante el empleo de hormonas liberadoras hipotalamicas
(LH-RH). Reunion A.. Soc. Mex. Nutr. Endocrinol. 10: 331-340, 1970.
49.
Sandman, C.A., A.J. Kastin and A.V. Schally. Behavioral inhibition as modified by
melanocyte-stimulating hormone (MSH) and light-dark condition. Physiol. Behav. 6: 4548, 1971.
11
50.
Schally, A.V., A. Arimura, A.J. Kastin, C.Y. Bowers, T.W. Redding, I. Wakabayashi, Y.
Baba, R.M.G. Nair, J.F. Barrett and J.J. Reeves. Recent advances in hypothalamic
hormones regulating pituitary function. In: Recent Advances in Endocrinology. E.
Mattar, G. Mattar and V.H.T. James, eds., Excerp. Med. Int. Congr. Series no. 238, pp.
293-310, 1971.
51.
Kastin, A.J. and A.V. Schally. Control of MSH release in mammals. In: Recent Advances
in Endocrinology. E. Mattar, G. Mattar and V.H.T. James, eds., Excerp. Med. Int. Congr.
Series no. 238, pp. 311-317, 1971.
52.
Bowers, C.Y., A.V. Schally, A.J. Kastin, A. Arimura, D.S. Schalch, C. Gual, E.
Castineda and K. Folkers. Synthetic thyrotropin-releasing hormone. Activity in men and
women, specificity of action, inhibition by triiodothyronine, and activity orally. J. Med.
Chem. 14: 477-481, 1971.
53.
Kastin, A.J., A.V. Schally, C. Gual, A.R. Midgley, A. Arimura, M.C. Miller and A.
Cabeza. Administration of LH-releasing hormone of human origin to man. J. Clin.
Endocrinol. Metab. 32: 287-289, 1971.
54.
Kastin, A.J., A. Arimura, A.V. Schally and M.C. Miller. Mass-action type, direct
feedback control of pituitary MSH release. Nature 231: 29-30, 1971.
55.
Sandman, C.A., P.M. Denman, L.H. Miller, J.R. Knott, A.V. Schally and A.J. Kastin.
Electroencephalographic measures of melanocyte stimulating hormone activity. J. Comp.
Physiol. Psychol. 76: 103-109, 1971.
56.
Schally, A.V. and A.J. Kastin. Hypothalamic neuroendocrine mediators. Acta. Physiol.
Polonica 22 (Suppl. 3): 5-19, 1971.
57.
Kastin, A.J., A.V. Schally, C. Gual, A.R. Midgley, M.C. Miller and A. Cabeza. Dose
response relationship of LH to LH-releasing hormone in man. J. Clin. Invest. 50: 15511553, 1971.
58.
Kastin, A.J., A. Zarate, A.R. Midgley, E. Canales and A.V. Schally. Ovulation confirmed
by pregnancy after infusion of porcine LH-RH. J. Clin Endocrinol. Metab. 33: 980-982,
1971.
59.
Nair, R.M.G., A.J. Kastin and A.V. Schally. Isolation and structure of hypothalamic
MSH release-inhibiting hormone. Biochem. Biophys. Res. Comm. 43: 1376-1425, 1971.
60.
Kastin, A.J., A.V. Schally and S. Viosca. Inhibition of MSH release in frogs by direct
application of L-prolyl-L-leucylglycinamide to the pituitary. Proc. Soc. Exp. Biol. Med.
137: 1437-1439, 1971.
12
61.
Kastin, A.J., L.H. Miller, D. Gonzalez-Barcena, W.D. Hawley, K. Dyster-Aas, A.V.
Schally, M.L. Velasco-Parra and M. Velasco. Psycho-physiologic correlates of MSH
activity in man. Physiol. Behav. 7: 893-896, 1971.
62.
Schally, A.V., A. Arimura, A.J. Kastin, H. Matsuo, Y. Baba, T.W. Redding, R.M.G.
Nair, L. Debeljuk and W.F. White. Gonadotropin-releasing hormone: one polypeptide
regulates the secretion of LH and FSH. Science 173: 1036-1038, 1971.
63.
Schally, A.V., A.J. Kastin and A. Arimura. Hypothalamic FSH and LH-regulating
hormone: structure, physiology, and clinical studies. Fertil. Steril. 22: 703-721, 1971.
64.
Anderson, M.S., C.Y. Bowers, A.J. Kastin, D.S. Schalch, A.V. Schally, P.S. Snyder, R.D.
Utiger, J.F. Wilbur and A.J. Wise. Synthetic thyrotropin releasing hormone (TRH): a
potent stimulator of thyrotropin secretion in man. N. Engl. J. Med. 285: 1279-1283, 1971.
65.
Schally, A.V. and A.J. Kastin. Stimulation and inhibition of fertility through
hypothalamic agents. Drug Therapy 1: 29-32, 1971.
66.
Plotnikoff, N.P., A.J. Kastin, M.S. Anderson and A.V. Schally. DOPA potentiation by a
hypothalamic factor, MSH release-inhibiting hormone (MIF). Life Sci. 10: 1279-1283,
1971.
67.
Hollander, C.S., T. Mitsuma, A.J. Kastin, L. Shenkman, M. Blum and D.A. Anderson.
Hypertriiodothyroninaemia as a premonitory manifestation of thyrotoxicosis. Lancet 2:
731-733, 1971.
68.
Kastin, A.J. and A.V. Schally. MSH release in mammals. In: Pigmentation: Its genesis
and biologic control. V. Riley, ed. Appleton-Century-Crofts, New York, pp. 215-223,
1972.
69.
Kastin, A.J., A. Zarate, M.C. Miller, A. Hernandez-Ayup, K. Dyster-Aas, C. Gual and
A.V. Schally. Anovulatory uterine bleeding after administration of MSH to women with
secondary amenorrhea. J. Reprod. Fertil. 28: 185-189, 1972.
70.
Kastin, A.J., A.V. Schally, D. Gonzalez-Barcena, D.S. Schalch and L. Lee. Different
responses to two hypothalamic hormones in acromegalics. Arch. Int. Med. 130: 923-927,
1972.
71.
Sandman, C.A., L.H. Miller, A.J. Kastin and A.V. Schally. A neuroendocrine influence
on attention and memory. J. Comp. Physiol. Psychol. 80: 54-58, 1972.
72.
Arimura, A., A.J. Kastin and A.V. Schally. Recent progress in physiological and clinical
studies with LH- and FSH-releasing hormone. In: Gonadotropins. B. Saxena, C. Beling
13
and H. Gandy, eds. John Wiley and Sons, Inc., New York, pp. 32-48, 1972.
73.
Kastin, A.J., A.V. Schally, D.S. Schalch, S.G. Korenman, M.C. Miller, C. Gual and E.
Perez-Pasten. Characterization of the hormonal responses to luteininzing hormonereleasing hormone (LH-RH) in prepubertal and adult subjects. Pediat. Res. 6: 481-486,
1972.
74.
Denman, P.M., L.H. Miller, C.A. Sandman, A.V. Schally and A.J. Kastin.
Electrophysiological correlates of melanocyte-stimulating hormone activity in the frog. J.
Comp. Physiol. Psychol. 80: 59-65, 1972.
75.
Gual, C., A.J. Kastin and A.V. Schally. Clinical experience with hypothalamic releasing
hormones. Thyrotropin releasing hormone (TRH). Rec. Prog. Horm. Res. 28: 173-200,
1972.
76.
Kastin, A.J., C. Gual and A.V. Schally. Clinical experience with hypothalamic releasing
hormones. Luteinizing hormone-releasing hormone and other hypophysiotropic
hormones. Rec. Prog. Horm. Res. 28: 201-227, 1972.
77.
Schally, A.V. and A.J. Kastin. Hypothalamic releasing and inhibiting hormones. Gen.
Comp. Endocrinol. Supplement 3: 76-85, 1972.
78.
Schally, A.V., A. Arimura, A.J. Kastin, L. Debeljuk, H. Matsuo, Y. Baba, R.M.G. Nair
and T.W. Redding. The hypothalamic hormone regulating LH and FSH secretion. In:
Biology of Reproduction: Basic and Clinical Studies. J.T. Velardo and B.A. Kasprow,
eds., Oxford Univ. Press, pp. 61-68, 1972.
79.
Kastin, A.J., A.V. Schally, C. Gual and A. Arimura. Release of LH and FSH after
administration of synthetic LH-releasing hormone. J. Clin. Endocrinol. Metab. 34: 753756, 1972.
80.
Schally, A.V., A.J. Kastin and A. Arimura. FSH-releasing hormone and LH-releasing
hormone. In: Vitamins and Hormones. R.S. Harris, P. Munson, E. Diczfalusy and J.
Glover, eds., Academic Press, New York, vol. 30, pp. 83-164, 1972.
81.
Kastin, A.J. and A.V. Schally. The hypothalamus influences the menstrual cycle. Ob.
Gyn. Suppl. to Medical World News, January, pp. 79-80, 1972.
82.
Schally, A.V., A.J. Kastin and A. Arimura. The hypothalamus and reproduction. Am. J.
Ob. Gyn. 114: 423-442, 1972.
83.
Kastin, A.J., A.V. Schally, C. Gual, S. Glick and A. Arimura. Clinical evaluation in men
of a substance with growth-hormone releasing activity in rats. J. Clin. Endocrinol. Metab.
35: 326-329, 1972.
14
84.
Plotnikoff, N.P., A.J. Kastin, M.S. Anderson and A.V. Schally. Oxotremorine antagonism
by a hypothalamic hormone, melanocyte-stimulating hormone release-inhibiting factor,
MIF. Proc. Soc. Exp. Biol. Med. 140: 811-814, 1972.
85.
Kastin, A.J., S. Viosca, R.M.G. Nair, A.V. Schally and M.C. Miller. Interactions between
pineal, hypothalamus, and pituitary involving melatonin, MSH-release inhibiting factor,
and MSH. Endocrinology 91: 1323-1328, 1972.
86.
Zarate, A., E. Canales, A.V. Schally, L. Ayala-Valdes and A.J. Kastin. Successful
induction of ovulation with synthetic luteinizing hormone-releasing hormone in
anovulatory infertility. Fertil. Steril. 23: 672-674, 1972.
87.
Schalch, D.S., D. Gonzalez-Barcena, A.J. Kastin, A.V. Schally and L.A. Lee.
Abnormalities in the release of TSH in response to thyrotropin-releasing hormone (TRH)
in patients with disorders of the pituitary, hypothalamus, and basal ganglia. J. Clin.
Endocrinol. Metab. 35: 609-615, 1972.
88.
Nair, R.M.G., A.J. Kastin and A.V. Schally. Isolation and structure of another
hypothalamic peptide possessing MSH-release inhibiting activity. Biochem. Biophys.
Res. Comm. 47: 1420-1425, 1972.
89.
Schally, A.V., A. Arimura and A.J. Kastin. The LH and FSH-releasing hormone. Proc.
Symp. 4th International Congress of Endocrinology 273: 93-97, 1972.
90.
Kastin, A.J., N.P. Plotnikoff, R.M.G. Nair, T.W. Redding and M.S. Anderson. MIF: Its
pituitary and extra-pituitary effects. In: Hypothalamic Hypophysiotropic Hormones:
Clinical and Physiological Studies. Excerp. Med. Int. Congr. Series no. 263., Amsterdam,
C. Gual and E. Rosemberg, eds., pp. 159-166, 1972.
91.
Zarate, A., E.S. Canales, A.V. Schally, A.J. Kastin and J. Soria. Induction of ovulation
with synthetic luteinizing hormone-releasing hormone in suspected hypothalamic
infertility. In: Hypothalamic Hypophysiotropic Hormones: Clinical and Physiological
Studies. Excerp. Med. Int. Congr. Series no. 263., Amsterdam, C. Gual and E.
Rosemberg, eds., pp. 251-253, 1972.
92.
Gonzalez-Barcena, D., A.J. Kastin, A. Arimura, J.A. Bermudez, D. Lee, J. Ruelas and
A.V. Schally. Effects of synthetic LH-RH administered by different routes. In:
Hypothalamic Hypophysiotropic Hormones: Clinical and Physiological Studies. Excerp.
Med. Int. Congr. Series no. 263., Amsterdam, C. Gual and E. Rosemberg, eds., pp. 291298, 1972.
93.
Bergada, G., R.E. Mancini. O. Vilar, M.A. Rivarola, J.C. Calamera, C. Bianculli, A.V.
Schally and A.J. Kastin. Effect of chronic administration of synthetic LH-RH/FSH-RH
15
on prepubertal boys and in hypogonadotropic hypogonadism. In: Hypothalamic
Hypophysiotropic Hormones: Clinical and Physiological Studies. Excerp. Med. Int.
Congr. Series no. 263., Amsterdam, C. Gual and E. Rosemberg, eds., pp. 299-301, 1972.
94.
Dunn, J.D., A.J. Kastin, A.J. Carrillo and A.V. Schally. Additional evidence for
dissociation of MSH and ACTH release. J. Endocrinol. 55: 463-464, 1972.
95.
Kastin, A.J., R.H. Ehrensing, D.S. Schalch and M.S. Anderson. Improvement in mental
depression with decreased thyrotropin response after administration of thyrotropinreleasing hormone. Lancet 2: 740-742, 1972.
96.
Dempsey, G.L., A.J. Kastin and A.V. Schally. The effects of MSH on a restricted passive
avoidance response. Horm. Behav. 3: 333-337, 1972.
97.
Nockton, R., A.J. Kastin, S.T. Elder and A.V. Schally. Passive and active avoidance
responses at two levels of shock after administration of melanocyte-stimulating hormone.
Horm. Behav. 3: 339-344, 1972.
98.
Kastin, A.J. and A. Barbeau. Preliminary clinical studies with L-prolyl-L-leucyl-glycine
amide in Parkinson's disease. Can. Med. Assoc. J. 107: 1079-1081, 1972.
99.
Schally, A.V., A. Arimura and A.J. Kastin. Hypothalamic hormones and fertility. Proc.
3rd European Congress of Sterility, Athens, Greece, pp. 843-848, 1972.
100.
Velasco, M., A.J. Kastin and D. Gonzalez-Barcena. Effects of melanocyte-stimulating
hormone on the cortical somatic evoked responses in man. Neuropharmacology 11: 395407, 1972.
101.
Kastin, A.J. and A.V. Schally. Assay of MSH-releasing inhibiting factor (MIF). In:
Peptide Hormones. S.A. Berson and R.S. Yalow, eds., North Holland Pub. Co.,
Amsterdam, pp. 422-427, 1973.
102.
Schally, A.V., A. Arimura and A.J. Kastin. Hypothalamic releasing and inhibiting
hormones. In: Biology Data Book. P.L. Altman and D.S. Dittmer, eds., Vol. 2, pp. 660661, 1973.
103.
Kastin, A.J., D. Gonzalez-Barcena, H. Friesen, L.S. Jacobs, D.S. Schalch, A. Arimura,
W.H. Daughaday and A.V. Schally. Unaltered plasma prolactin levels in men after
administration of synthetic LH-releasing hormone. J. Clin. Endocrinol. Metab. 36: 375377, 1973.
104.
Redding, T.W., A.J. Kastin, R.M.G. Nair and A.V. Schally. The distribution, half-life,
and excretion of 14C and 3H-labeled L-prolyl-L-leucyl-glycinamide in the rat.
Neuroendocrinology 11: 92-100, 1973.
16
105.
Arimura, A., M. Saito, Y. Yaoi, T. Kumasaka, H. Kato, T. Koyama, N. Nishi, A.J. Kastin
and A.V. Schally. Comparison of the effects of subcutaneous and intravenous injection of
synthetic LH-RH on serum LH and FSH levels in men. J. Clin. Endocrinol. Metab. 36:
385-388, 1973.
106.
Kastin, A.J., L.H. Miller, R. Nockton, C.A. Sandman, A.V. Schally and L.O. Stratton.
Behavioral aspects of MSH. Prog. Brain Res. 39: 461-470, 1973.
107.
Plotnikoff, N.P., A.J. Kastin, M.S. Anderson and A.V. Schally. Deserpidine antagonism
by a tripeptide, L-prolyl-L-leucylglycinamide. Neuroendocrinology 11: 67-71, 1973.
108.
Schally, A.V., A. Arimura and A.J. Kastin. Hypothalamic regulating hormones. Science
179: 341-350, 1973.
109.
Gonzalez-Barcena, D., A.J. Kastin, D.S. Schalch, M. Torres-Zamora, E. Perez-Pasten, A.
Kato and A.V. Schally. Responses to thyrotropin-releasing hormone in patients with renal
failure and after infusion in normal men. J. Clin. Endocrinol. Metab. 36: 117-120, 1973.
110.
Schally, A.V., A.J. Kastin, A. Arimura, D. Coy, E. Coy, L. Debeljuk and T.W. Redding.
Recent basic and clinical studies with luteinizing hormone-releasing hormone (LH-RH)
and its analogues. J. Reprod. Fertil. Suppl. 20: 119-136, 1973.
111.
Sandman, C.A., A.J. Kastin, A.V. Schally, J.W. Kendall and L.H. Miller. Neuroendocrine
responses to physical and psychological stress. J. Comp. Physiol. Psychol. 84: 386-390,
1973.
112.
Zarate, A., A.J. Kastin, J. Soria, E.S. Canales and A.V. Schally. Effect of synthetic
luteinizing hormone-releasing hormone (LH-RH) in two brothers with hypogonadotropic
hypogonadism and anosmia. J. Clin. Endocrinol. Metab. 36: 612-614, 1973.
113.
Medeiros-Neto, G.A., S.P.A. Toledo, A.M. Pupo, M. Sucupira, F. Fraige-Filho, E.
Mattar, A.J. Kastin and A.V. Schally. Characterization of the LH response to luteinizing
hormone-releasing hormone (LH-RH) in isolated and multiple tropic hormonal
deficiencies. J. Clin. Endocrinol. Metab. 37: 972-976, 1973.
114.
Aldinger, E.E., W.D. Hawley, A.V. Schally and A.J. Kastin. Cardiovascular actions of
melanocyte-stimulating hormone (MSH) in the dog. J. Endocrinol. 56: 613-614, 1973.
115.
Kastin, A.J., G.D. Beach, W.D. Hawley, J.W. Kendall, M.S. Edwards and A.V. Schally.
Dissociation of MSH and ACTH release in man. J. Clin. Endocrinol. Metab. 36: 770-772,
1973.
116.
Carillo, A.J., A.J. Kastin, J.D. Dunn and A.V. Schally. MSH activity in plasma and
17
pituitaries of rats with large hypothalamic lesions. Neuroendocrinology 12: 120-128,
1973.
117.
Kastin, A.J., M.C. Miller, L. Ferrell and A.V. Schally. General activity in intact and
hypophysectomized rats after administration of melanocyte-stimulating hormone (MSH),
melatonin, and Pro-Leu-Gly-NH2. Physiol. Behav. 10: 399-401, 1973.
118.
Stratton, L.O. and A.J. Kastin. Melanocyte-stimulating hormone in learning and
extinction of two problems. Physiol. Behav. 10: 689-692, 1973.
119.
Kastin, A.J., N.P. Plotnikoff, S. Viosca, M.S. Anderson and A.V. Schally. MSH-Release
inhibiting factors: recent studies. Yale J. Biol. Med. 46: 617-622, 1973.
120.
Nair, R.M.G., T.W. Redding, A.J. Kastin and A.V. Schally. Site of inactivation of MSH
release-inhibiting hormone by human plasma. Biochem. Pharmacol. 22: 1915-1919,
1973.
121.
Gonzalez-Barcena, D., A.J. Kastin, D.S. Schalch, J.A. Bermudez, D. Lee, A. Arimura, J.
Ruelas, I. Zepeda and A.V. Schally. Synthetic LH-releasing hormone (LH-RH)
administered to normal men by different routes. J. Clin. Endocrinol. Metab. 37: 481-484,
1973.
122.
Kastin, A.J., A. Barbeau, R.H. Ehrensing, N.P. Plotnikoff and A.V. Schally. Melanocytestimulating hormone and the hypothalamic hormone which inhibits its release. In:
Advances in Neurology. F.W. McDowell and A. Barbeau, eds., Raven Press, New York,
Vol. 5, pp. 225-229, 1973.
123.
Redding, T.W., A.J. Kastin, D. Gonzalez-Barcena, D.H. Coy, E.J. Coy, D.S. Schalch and
A.V. Schally. The half-life, metabolism, and excretion of tritiated luteinizing hormonereleasing hormone (LH-RH) in man. J. Clin. Endocrinol. Metab. 37: 626-631, 1973.
124.
Schally, A.V., A. Arimura, A.J. Kastin, T. Uehara, J. Takahara, D.H. Coy and E.J. Coy.
Inhibition of the release of growth hormone In vitro by α-melanocyte-stimulating
hormone. Biochem. Biophys. Res. Comm. 52: 1314-1319, 1973.
125.
Sandman, C.A., W.D. Alexander and A.J. Kastin. Neuroendocrine influences on visual
discrimination and reversal learning in the albino and hooded rat. Physiol. Behav. 11:
613-617, 1973.
126.
Stratton, L.O., A.J. Kastin and W.P. Coleman. Activity and dark-preference responses of
albino and hooded rats receiving MSH. Physiol. Behav. 11: 907-909, 1973.
127.
Schally, A.V., A.J. Kastin, A. Arimura, D.H. Coy and J. Vilchez-Martinez. Potential role
of hypothalamic hormones in fertility control. In: Regulation of Human Fertility. K.S.
18
Moghissi and T.N. Evans, eds., Wayne State Univ. Press, pp. 115-131, 1973.
128.
Zarate, A., J. Soria, E.S. Canales, A.J. Kastin and A.V. Schally. Pituitary FSH and LH
reserve in women with isolated gonadotropin deficiency. Ob. Gyn. 42: 507-510, 1973.
129.
Hall, R., G.M. Besser, A.V. Schally, D.H. Coy, D. Evered, D.J. Goldie, A.J. Kastin, A.S.
McNeilly, C.H. Mortimer, C. Phenekos, W.M.G. Tunbridge and D. Weightman. Action
of growth hormone-release inhibitory hormone in healthy men and acromegalics. Lancet
2: 581-584, 1973.
130.
Woolf, P.D., D. Gonzalez-Barcena, D.S. Schalch, L.A. Lee, J.P. Arzac, A.V. Schally and
A.J. Kastin. Lack of effect of steroids on thyrotropin-releasing hormone (TRH) mediated
thyrotropin (TSH) release. Neuroendocrinology 13: 56-62, 1973-74.
131.
Zarate, A., J. Soria, E.S. Canales, A.J. Kastin, A.V. Schally and R. Guzman Toledano.
Pituitary response to synthetic luteinizing hormone-releasing hormone in Prader-Willi
syndrome, prepubertal and pubertal children. Neuroendocrinology 13: 321-326, 1973-74.
132.
Kastin, A.J., S. Viosca and A.V. Schally. Regulation of melanocyte- stimulating hormone
release. In: Handbook of Physiology. E. Knobil and W.H. Sawyer, eds., Vol. 4, pp. 551562, 1974.
133.
Kastin, A.J., A.V. Schally, A. Zarate, A. Arimura, D. Gonzalez-Barcena, G. MedeirosNeto and D.S. Schalch. Analysis of clinical studies with natural and synthetic LH-RH in
man. Israel J. Med. Sci. 10: 1305-1310, 1974. Also In: Heterogeneity of Polypeptide
Hormones. D. Rabinowitz and J. Roth, eds., Academic Press, New York, p. 123, 1974.
134.
Kastin, A.J., A.V. Schally, A. Barbeau and R.H. Ehrensing. Endocrine and extraendocrine studies of hypothalamic hormones in man. In: Recent Studies of Hypothalamic
Function. K. Lederis and K.E. Cooper, eds., Karger, Basel, pp. 196-206, 1974.
135.
Brown, G.M., I.V. Uhlir, J. Seggie, A.V. Schally and A.J. Kastin. Effect of septal lesions
on plasma levels of MSH, corticosterone, GH, and prolactin before and after exposure to
novel environment: role of MSH in the septal syndrome. Endocrinology 94: 583-587,
1974.
136.
Schally, A.V., A. Arimura, A.J. Kastin, D.H. Coy, E.J. Coy, J. Vilchez-Martinez, R.
Geiger, W. Konig and H. Wissman. Physiological, veterinary, and clinical effects of
hypothalamic releasing hormones (RH), especially LH-RH. Pure Appl. Chem. 37: 315328, 1974.
137.
Kastin, A.J., W.D. Hawley, M.C. Miller, A.V. Schally and C. Lancaster. Plasma MSH
and cortisol levels in 567 patients with special reference to brain trauma. Endocrinol.
Exper. 8: 97-105, 1974.
19
138.
Zarate, A., E.S. Canales, J. Soria, L.S. Jacobs, W.H. Daughaday, A.J. Kastin and A.V.
Schally. Gonadotropin and prolactin secretion in human pseudocyesis: effect of synthetic
luteinizing hormone-releasing hormone (LH-RH) and thyrotropin releasing hormone
(TRH). Ann. Endocrinol. 35: 445-450, 1974.
139.
Zarate, A., E.S. Canales, J. Soria, A.J. Kastin, A.V. Schally and A. Gonzalez. Further
observations on the therapy of anovulatory sterility with synthetic luteinizing hormonereleasing hormone. Fertil. Steril. 25: 3-10, 1974.
140.
Zanartu, J., A. Dabancens, A.J. Kastin and A.V. Schally. Effect of synthetic
hypothalamic gonadotropin releasing hormone in anovulatory sterility. Fertil. Steril. 25:
160-169, 1974.
141.
Plotnikoff, N.P., F.N. Minard and A.J. Kastin. DOPA potentiation in ablated animals and
brain levels of biogenic amines in intact animals after prolyl-leucylglycinamide.
Neuroendocrinology 14: 271-279, 1974.
142.
Ehrensing, R.H. and A.J. Kastin. Melanocyte-stimulating hormone-release inhibiting
hormone as an anti-depressant: a pilot study. Arch. Gen. Psychiat. 30: 63-65, 1974.
143.
Gonzalez-Barcena, D., A.J. Kastin, D.S. Schalch and A.V. Schally. Differential effect of
various doses of mestranol on the release of LH and FSH in response to LH-releasing
hormone. Fertil. Steril. 25: 439-442, 1974.
144.
Kastin, A.J., A.V. Schally, D. Gonzalez-Barcena, D.H. Coy and D.S. Schalch. Clinical
comparison of natural LH-RH, synthetic LH-RH and two analogues of LH-RH. J. Clin.
Endocrinol. Metab. 38: 801-804, 1974.
145.
Kastin, A.J., G.L. Dempsey, B. LeBlanc, K. Dyster-Aas and A.V. Schally. Extinction of
an appetitive operant response after administration of MSH. Horm. Behav. 5: 135-139,
1974.
146.
Stratton, L.O. and A.J. Kastin. Avoidance learning at two levels of motivation in rats
receiving MSH. Horm. Behav. 5: 149-155, 1974.
147.
Arimura, A., A.J. Kastin, A.V. Schally, M. Saito, T. Kumasaka, T. Yaoi, N. Nishi and K.
Ohkura. Immunoreactive LH-releasing hormone in plasma: midcycle elevation in
women. J. Clin. Endocrinol. Metab. 38: 510-513, 1974.
148.
Arimura, A., A.J. Kastin, D. Gonzalez-Barcena, G. Siller, R.E. Weaver and A.V. Schally.
Disappearance of LH-releasing hormone in man as determined by radioimmunoassay.
Clin. Endocrinol. 3: 421-425, 1974.
20
149.
Schally, A.V., A.J. Kastin and A. Arimura. The role of the hypothalamus in reproduction.
Ciba Review, pp. 1-2, 1974.
150.
Ehrensing, R.H., A.J. Kastin, D.S. Schalch, H. Friesen, R. Vargas and A.V. Schally.
Affective state and thyrotropin and prolactin responses after repeated injections of
thyrotropin-releasing hormone in depressed patients. Am. J. Psychiat. 131: 714-718,
1974.
151.
Besser, G.M., C.H. Mortimer, D. Carr, A.V. Schally, D.H. Coy, D. Evered, A.J. Kastin,
W.M.G. Tunbridge, M.O. Thorner and R. Hall. Growth hormone release inhibiting
hormone in acromegaly. Brit. Med. J. 1: 352-355, 1974.
152.
Gonzalez-Barcena, D., A.J. Kastin, D.H. Coy, S. Glick, D.S. Schalch, L.A. Lee, J.P.
Arzac and A.V. Schally. Unaltered plasma GH levels in acromegalics and normal men
and women after administration of (pyro)Glu-Ser-Gly-NH2, a proposed GH-releasing
hormone. J. Clin. Endocrinol. Metab. 38: 1134-1136, 1974.
153.
Kastin, A.J., C. Nissen, T.W. Redding, R.M.G. Nair and A.V. Schally. Delayed
disappearance of 14C-labeled-Pro-Leu-Gly-NH2 from the blood of hypophysectomized
rats. Neuroendocrinology 16: 36-42, 1974.
154.
Mortimer, C.H., D. Carr, T. Lind, S.R. Bloom, C.N. Mallinson, A.V. Schally, W.M.G.
Tunbridge, L. Yeomans, D.H. Coy, A.J. Kastin, G.M. Besser and R. Hall. Effects of
growth hormone release inhibiting hormone on circulating glucagon, insulin, and growth
hormone in normal, diabetic, acromegalic, and hypopituitary patients. Lancet 1: 697-701,
1974.
155.
Gonzalez-Barcena, D., A.J. Kastin, D.S. Schalch, M.C. Miller, L. Lee, R. Rivas-Llamas
and A.V. Schally. Response to LH-RH in women before and after treatment with
prednisone. Int. J. Fertil. 19: 107-110, 1974.
156.
Plotnikoff, N.P. and A.J. Kastin. Oxotremorine antagonism by prolyl-leucyl-glycine
amide administered by different routes and with several anticholinergics. Pharmacol.
Biochem. Behav. 2: 417-419, 1974.
157.
Sandman, C.A., W. Beckwith, M.M. Gittis and A.J. Kastin. Melanocyte-stimulating
hormone (MSH) and overtraining effects on extradimensional shift (EDS) learning.
Physiol. Behav. 13: 163-166, 1974.
158.
Redding, T.W., A.J. Kastin, D. Gonzalez-Barcena, D.H. Coy, Y. Hirotsu, J. Ruelas and
A.V. Schally. The disappearance, excretion, and metabolism of tritiated prolyl-leucylglycinamide in man. Neuroendocrinology 16: 119-126, 1974.
159.
Kastin, A.J., A. Arimura, D. Gonzalez-Barcena, D.H. Coy, M.C. Miller, N. Nishi, L. Lee,
21
H. Duron-Huerta, D.S. Schalch and A.V. Schally. Increased potency of four analogues of
LH-releasing hormone in man. Int. J. Fertil. 19: 202-206, 1974.
160.
Gonzalez-Barcena, D., A.J. Kastin, D.S. Schalch, M.C. Miller, R. Henriquez-Espinoza
and A.V. Schally. Response to LH-RH in men infused with theophylline. Int. J. Fertil. 19:
207-209, 1974.
161.
Stone, S.C., F. Jaramillo, A.J. Kastin, A. Arimura, J.R. Vargas, A.V. Schally and R.P.
Dickey. Effect of LH-RH on antibody formation, sperm count and plasma levels of
gonadotropins and testosterone in normal men. Int. J. Fertil. 19: 192-196, 1974.
162.
Plotnikoff, N.P. and A.J. Kastin. Pharmacological studies with a tripeptide, prolyl-leucylglycinamide. Arch. Int. Pharm. Therap. 211: 211-224, 1974.
163.
Kastin, A.J., A.C. Paulsen, J. Zanartu and S.S.C. Yen. Hypothalamic control of
reproduction. Contemp. Ob./Gyn. 3: 143-170, 1974.
164.
Plotnikoff, N.P., A.J. Kastin and A.V. Schally. Growth hormone release inhibiting
hormone: neuropharmacological studies. Pharmacol. Biochem. Behav. 2: 693-696, 1974.
165.
Miller, L.H., A.J. Kastin, C.A. Sandman, M. Fink and W.J. Van Veen. Polypeptide
influence on attention, memory, and anxiety in man. Pharmacol. Biochem. Behav. 2: 663668, 1974.
166.
Alford, F.O., S.R. Bloom, J.D.N. Nabarro, R. Hall, G.M. Besser, D.H. Coy, A.J. Kastin
and A.V. Schally. Glucagon control of fasting glucose in man. Lancet 2: 974-976, 1974.
167.
Besser, G.M., C.H. Mortimer, A.S. McNeilly, M.O. Thorner, G.A. Batistoni, S.R. Bloom,
K.W. Kastrup, K.F. Hanssen, R. Hall, D.H. Coy, A.J. Kastin and A.V. Schally. Long
term infusion of growth hormone releasing inhibiting hormone in acromegaly: effects on
pituitary and pancreatic hormones. Brit. Med. J. 4: 622-627, 1974.
168.
Bloom, S.R., C.H. Mortimer, M.O. Thorner, G.M. Besser, R. Hall, A. Gomez-Pan, V.M.
Roy, R.C.G. Russell, D.H. Coy, A.J. Kastin and A.V. Schally. Inhibition of gastrin and
gastric-acid secretion by growth-hormone release-inhibiting hormone. Lancet 2: 11061109, 1974.
169.
Bermudez, J.A., A.J. Kastin, D.S. Schalch, D. Lee-Benitez, E. Perez-Pasten, D.
Gonzalez-Barcena and A.V. Schally. Hormone response to synthetic LH-releasing
hormone (LH-RH) in prepubertal, pubertal, and adult human males. Endocr. Res. Comm.
1: 477-493, 1974.
170.
Zarate, A., E.S. Canales, J. Soria, A.J. Kastin, A.V. Schally and A. Gonzales. Induction
of ovulation with synthetic luteinizing hormone-releasing hormone. In: Recent Progress
22
in Reproductive Endocrinology. P.G. Crosignani and V.H.T. James, eds., Academic
Press, London, pp. 811-826, 1974.
171.
Zarate, A., E.S. Canales, A.V. Schally and A.J. Kastin. Clinical applications of synthetic
releasing hormones: Utilization for diagnostic purposes. In: Biological and Clinical
Aspects of Reproduction. VIII World cong. Fertil. Steril., Buenos Aires, Nov. 3-9,
Excerp. Med. Int. Cong. Ser. No. 394, pp. 332-334, 1974.
172.
Schally, A.V., A. Arimura, A.J. Kastin, D.H. Coy, E.J. Coy, L. Debeljuk, J. VilchezMartinez, T.W. Redding, T. Uehara, J. Takahara and W.H. Carter. Recent advances in the
chemistry and physiology of hypothalamic hormones, especially the LH-releasing
hormone. In: Some Aspects of Hypothalamic Regulation of Endocrine Functions. P.
Franchimont, ed., F.K. Schattauer Verlag, Stuttgart, pp. 5-14, 1975.
173.
Kastin, A.J., A. Arimura and A.V. Schally. Contributions of clinical studies with natural
LH-RH to subsequent studies with the synthetic hormone. In: Some Aspects of
Hypothalamic Regulation of Endocrine Functions. P. Franchimont, ed., F.K. Schattauer
Verlag, Stuttgart, pp. 99-103, 1975.
174.
Kastin, A.J., N.P. Plotnikoff, C.A. Sandman, M.A. Spirtes, R.M. Kostrzewa, S.M. Paul,
L.O. Stratton, L.H. Miller, F. Labrie, A.V. Schally and H. Goldman. The effects of MSH
and MIF on the brain. In: Anatomical Neuroendocrinology. W.E. Stumpf and L.D. Grant,
eds. Karger, Basel, pp. 290-297, 1975.
175.
Dupont, A., A.J. Kastin, F. Labrie, G. Pelletier, R. Puviani and A.V. Schally. Distribution
of radioactivity in the organs of the rat and mouse after injection of 125I-α-melanocyte
stimulating hormone. J. Endocrinol. 64:237-241, 1975.
176.
Dupont, A., F. Labrie, G. Pelletier, R. Puviani, D.H. Coy, A.V. Schally and A.J. Kastin.
Distribution of radioactivity in the organs of the rat and mouse after injection of L[3H]prolyl-leucylglycinamide. J. Endocrinol. 64: 243-248, 1975.
177.
Kastin, A.J., C.A. Sandman, L.O. Stratton, A.V. Schally and L.H. Miller. Behavioral and
electrographic changes in rat and man after MSH. Prog. Brain Res. 42: 143-150, 1975.
178.
Kastin, A.J., N.P. Plotnikoff, R. Hall and A.V. Schally. Hypothalamic hormones and the
central nervous system. In: Hypothalamic Hormones, M. Motta, P.G. Crosignani and L.
Martini, eds., Academic Press, New York, pp. 261-268, 1975.
179.
Soria, J., A. Zarate, E.S. Canales, A. Ayala, A.V. Schally, D.H. Coy, E.J. Coy and A.J.
Kastin. Increased and prolonged LH-RH/FSH-RH activity of synthetic [D-Ala-6, desGly-NH2]-LH-RH-ethylamide in normal women. Am. J. Ob. Gyn. 123: 145-146, 1975.
180.
Gonzalez-Barcena, D., A.J. Kastin, D.H. Coy, D.S. Schalch, M.L. Vasconcelos, A.
23
Gonzalez-Sanchez and A.V. Schally. Respuesta a la administracion aguda de la hormona
hipotalamic inhibidora de la hormona de crecimiento y de un analogo en acromegalia.
Arch Invest. Med. 6: 505-512, 1975.
181.
Goldman, H., C.A. Sandman, A.J. Kastin and S. Murphy. MSH affects regional perfusion
of the brain. Pharmacol. Biochem. Behav. 3: 661-664, 1975.
182.
Spirtes, M.A., R.M. Kostrezewa and A.J. Kastin. MSH and MIF-1 effects on serotonin
levels and synthesis in various rat brain areas. Pharmacol. Biochem. Behav. 3: 10111015, 1975.
183.
Stratton, L.O. and A.J. Kastin. Increased acquisition of a complex appetitive task after
MSH and MIF. Pharmacol. Biochem. Behav. 3: 901-904, 1975.
184.
Sandman, C.A., J.M. George, J.D. Nolan, H. Van Riezen and A.J. Kastin. Enhancement
of attention in man with ACTH/MSH 4-10. Physiol. Behav. 15: 427-431, 1975.
185.
Kastin, A.J., T.W. Redding, R. Hall, G.M. Besser and A.V. Schally. Lipid mobilizing
hormones of the hypothalamus and pituitary. Pharmacol. Biochem. Behav. 3, Suppl. 1:
121-126, 1975.
186.
Zarate, A., E.S. Canales, H. Villalobos, J. Soria, L.S. Jacobs, A.J. Kastin and A.V.
Schally. Pituitary hormonal reserve in patients presenting hyperprolactinemia, intrasellar
masses, and amenorrhea without galactorrhea. J. Clin. Endocrinol. Metab. 40: 1034-1037,
1975.
187.
Plotnikoff, N.P. and A.J. Kastin. GH-RIF, LH-RH, TRH, MIF-I, substance P, and
angiotensin - central nervous system studies. In: Peptides: Chemistry, Structure and
Biology. R. Walter and J. Meienhofer, eds., Ann Arbor Sci. Pub., pp 645-649, 1975.
188.
Pelletier, G., F. Labrie, A.J. Kastin, D.H. Coy and A.V. Schally. Radioautographic
localization of radioactivity in rat brain after intraventricular or intracarotid injection of
[3H]L-prolyl-leucylglycinamide. Pharmacol. Biochem. Behav. 3: 675-679, 1975.
189.
Pelletier, G., F. Labrie, A.J. Kastin and A.V. Schally. Radioautographic localization of
radioactivity in rat brain after intracarotid injection of 125I-α-melanocyte-stimulating
hormone. Pharmacol. Biochem. Behav. 3: 671-674, 1975.
190.
Plotnikoff, N.P. and A.J. Kastin. Neuropharmacology of hypothalamic releasing factors.
Biochem. Pharmacol. 25: 363-365, 1976.
191.
Besser, G.M., A.M. Paxton, S.A.N. Johnson, E.J. Moody, C.H. Mortimer, R. Hall, A.
Gomez-Pan, A.V. Schally, A.J. Kastin and D.H. Coy. Impairment of platelet function by
growth hormone release inhibiting hormone. Lancet 1: 1166, 1975.
24
192.
Gomez-Pan, A., W.M.G. Tunbridge, A. Duns, R. Hall, G.M. Besser, D.H. Coy, A.V.
Schally and A.J. Kastin. Hypothalamic hormone interaction in acromegaly. Clin.
Endocrin. 4: 455-460, 1975.
193.
Kostrzewa, R.M., A.J. Kastin and M.A. Spirtes. α-MSH and MIF-I effects on
catecholamine levels and synthesis in various rat brain areas. Pharmacol. Biochem.
Behav. 3: 1017-1023, 1975.
194.
Carr, D., A. Gomez-Pan, D.R. Weightman, V.C.M. Roy, R. Hall, G.M. Besser, M.O.
Thorner, A.S. McNeilly, A.V. Schally, A.J. Kastin and D.H. Coy. Growth hormonerelease inhibiting hormone: actions on thyrotropin and prolactin secretion after
thyrotropin releasing hormone. Brit. Med. J. 3: 67-69, 1975.
195.
Schalch, D.S., D. Gonzalez-Barcena, A.J. Kastin, L. Landa, L.A. Lee, M.T. Zamora and
A.V. Schally. Plasma gonadotropins after administration of LH-releasing hormone in
patients with renal or hepatic failure. J. Clin. Endocrinol. Metab. 41: 921-925, 1975.
196.
Spirtes, M.A., N.P. Plotnikoff and A.J. Kastin. Effects of hypothalamic peptides on the
brain. In: CNS and Behavioural Pharmacology. A. Airaksinen, ed., pp. 121-129, 1975.
197.
Schally, A.V., A.J. Kastin and A. Arimura. The hypothalamus and reproduction. Am. J.
Ob. Gyn. 122: 857-862, 1975.
198.
Gonzalez-Barcena, D., A.J. Kastin, M.C. Miller, D.S. Schalch, D.H. Coy, A.V. Schally
and A. Escalante-Herrera. Stimulation of LH release after oral administration of an
analogue of LH-releasing hormone (LH-RH). Lancet 2: 1126-1128, 1975.
199.
Plotnikoff, N.P., W.F. White, A.J. Kastin and A.V. Schally. Gonadotropin releasing
hormone (GnRH): neuropharmacological studies. Life Sci. 17: 1685-1692, 1975.
200.
Gomez-Pan, A., J.D. Reed, M. Albinus, B. Shaw, R. Hall, G.M. Besser, D.H. Coy, A.J.
Kastin and A.V. Schally. Direct inhibition of gastric acid and pepsin secretion by growthhormone release-inhibiting hormone in cats. Lancet 1: 888-890, 1975.
201.
Kastin, A.J., C.A. Sandman and A.V. Schally. Effects of MSH on the brain. In: Unique
Properties of Melanocytes, V. Riley, ed., S. Karger, Basel, Vol. 3, pp. 228-236, 1976.
202.
Medeiros-Comaru, A.M., J. Rodrigues, L.C. Povoa, S. Franco, T. Dimetz, D.H. Coy, A.J.
Kastin and A.V. Schally. Clinical studies with long acting superactive analogs of LH-RH
in women with secondary amenorrhea. Int. J. Fertil. 21: 239-245, 1976.
203.
Kastin, A.J., A.V. Schally, D. Gonzalez-Barcena, A. Zarate, M. Besser and R. Hall.
Clinical studies with hypothalamic peptides. In: Basic Applications and Clinical Uses of
25
Hypothalamic Hormones. A.L. Charro-Salgado, R. Fernandez-Duranzo and J.G. Lopez
del Campo, eds., Excerp. Med. Int. Cong. Ser. no. 374: 235-243, 1976.
204.
Gonzalez-Barcena, D., A.J. Kastin, A. Escalente-Herrera, A. Gonzalez-Martinez, D.H.
Coy and A.V. Schally. Long acting analogues of LH-RH. In: Basic Applications and
Clinical Uses of Hypothalamic Hormones. A.L. Charro-Salgado, R. Fernandez-Duranzo
and J.G. Lopez del Campo, eds., Excerp. Med. Int. Cong. Ser. No. 374: 300-306, 1976.
205.
Gomez-Pan, A., R. Hall, G.M. Besser, C.H. Mortimer, A.V. Schally, A.J. Kastin and
D.H. Coy. Thyrotropin-releasing hormone: clinical studies. In: Basic Applications and
Clinical Uses of Hypothalamic Hormones. A.L. Charro-Salgado, R. Fernandez-Duranzo
and J.G. Lopez del Campo, eds., Excerp. Med. Int. Cong. Series no. 374: 313-318, 1976.
206.
Besser, G.M., R. Hall, C.H. Mortimer, A. Gomez-Pan, A.V. Schally, A.J. Kastin and
D.H. Coy. Growth hormone release inhibiting hormone: actions on the pituitary. In: Basic
Applications and Clinical Uses of Hypothalamic Hormones. A.L. Charro-Salgado, R.
Fernandez-Duranzo and J.G. Lopes del Campo, eds., Excerp. Med. Int. Cong. Series no.
374: 343-346, 1976.
207.
Hall, R., A. Gomez-Pan, G.M. Besser, C.H. Mortimer, A.V. Schally, A.J. Kastin and
D.H. Coy. The extra-pituitary actions of growth hormone-release inhibiting hormone. In:
Basic Application and Clinical Uses of Hypothalamic Hormones. A.L. Charro-Salgado,
R. Fernandez-Duranzo and J.G. Lopes del Campo, eds. Excerp. Med. Int. Cong. Series
no. 374: 347-350, 1976.
208.
Kastin, A.J., N.P. Plotnikoff, A.V. Schally and C.A. Sandman. Endocrine and CNS
effects of hypothalamic peptides and MSH. In: Reviews of Neuroscience. S. Ehrenpreis
and I.J. Kopin, eds., Raven Press, New York, pp. 111-148, 1976.
209.
Kastin, A.J., C. Nissen, K. Nikolics, K. Medzihradszky, D.H. Coy, I. Teplan and A.V.
Schally. Distribution of [3H]α-MSH in rat brain. Brain Res. Bull. 1: 19-26, 1976.
210.
Barbeau, A., M. Roy and A.J. Kastin. Double-blind evaluation of oral L-prolyl- L-leucylglycine amide in Parkinson's disease. Can. Med. Assoc. J. 114: 120-122, 1976.
211.
Barbeau, A. and A.J. Kastin. Polypeptide therapy in Parkinson's disease - A new
approach. In: Advances in Parkinsonism, W. Birkmayer and O. Hornykiewicz, eds.,
Editiones Roche, Basel, pp. 483-487, 1976.
212.
Stratton, L.O. and A.J. Kastin. Melanocyte-stimulating hormone and MSH/ACTH 4-10
reduce tonic immobility in the lizard. Physiol. Behav. 16: 771-774, 1976.
213.
Schally, A.V., A.J. Kastin and D.H. Coy. LH-releasing hormone and its analogues: recent
basic and clinical investigations. Int. J. Fertil. 21: 1-30, 1976.
26
214.
Cox, B., A.J. Kastin and H. Schnieden. A comparison between a melanocyte-stimulating
hormone inhibitory factor (MIF-I) and substances known to activate central dopamine
receptors. Eur. J. Pharm. 36:141-147, 1976.
215.
Stone, S.C., R.P. Dickey, A.J. Kastin and A.V. Schally. LH-RH and steroid levels in
normal ovulatory women. Ob. Gyn. 48: 146-149, 1976.
216.
Schally, A.V., D.H. Coy and A.J. Kastin. Physiological and clinical effects of LH
releasing hormone (LH-RH) and its analogs. In: Recent Advances in Human
Reproduction. A. Campos da Paz, V.A. Drill, M. Hayashi, W. Rodrigues and A.V.
Schally, eds. Excerp. Med. Int. Cong. Series no. 107: 73-78, 1976.
217.
Zarate, A., A. Ayala, A.V. Schally, A.J. Kastin, E.S. Canales, D.H. Coy and E.J. Coy.
The use of long-acting LH-RH analogs in the treatment of female infertility. In: Recent
Advances in Human Reproduction. A. Campos da Paz, V.D. Drill, M. Hayashi, W.
Rodrigues and A.V. Schally, eds., Excerp. Med. Int. Cong. Ser. No. 370: 106-109, 1976.
218.
Forsbach, G., A. Ayala, A. Zarate, E.S. Canales, J. Soria, A.V. Schally, A.J. Kastin, D.H.
Coy and E.J. Coy. Long-acting luteinizing hormone-releasing hormone (LH-RH) analogs
in the treatment of female infertility. Arch. Invest. Med. 7: 43-48, 1976.
219.
Plotnikoff, N.P. and A.J. Kastin. Neuropharmacological tests with α-melanocyte
stimulating hormone. Life Sci. 18: 1217-1222, 1976.
220.
Schally, A.V., D.H. Coy, A. Arimura, T.W. Redding, C.A. Meyers, J. Vilchez, E.
Pedroza, A. Gordin, J. Molnar, A.J. Kastin, F. Labrie, R. Hall, A. Gomez-Pan and G.M.
Besser. Structure-activity relationship of hypophysiotropic hormones. Proc. 5th Int.
Cong. Endocrin., Excerp. Med. Int. Cong Ser. Vol. 1: 163-167, 1976.
221.
Kastin, A.J., C.A. Sandman, L.H. Miller and A.V. Schally. Some questions related to
MSH. Mayo Clin. Proc. 51: 632-636, 1976.
222.
Kadowitz, P.J., B.M. Chapnick and A.J. Kastin. Comparison of α-MSH and several
vasoactive substances on vascular resistance in the feline mesenteric vascular bed.
Pharmacol. Biochem. Behav. 5: 219-221, 1976.
223.
Beckwith, B.E., C.A. Sandman and A.J. Kastin. Influence of 3 short chain peptides (αMSH, MSH/ACTH 4-10, MIF-I) on dimensional attention. Pharmacol. Biochem. Behav.
5, Suppl. 1: 11-16, 1976.
224.
Miller, L.H., L.C. Harris, H. van Riezen and A.J. Kastin. Neuroheptapeptide influence on
attention and memory in man. Pharmacol. Biochem. Behav. 5, Suppl. 1: 17-21, 1976.
27
225.
Sandman, C.A., J. George, B.B. Walker, J.D. Nolan and A.J. Kastin. Neuropeptide
MSH/ACTH 4-10 enhances attention in the mentally retarded. Pharmacol. Biochem.
Behav. 5, Suppl. 1: 23-28, 1976.
226.
Panksepp, J., P. Reilly, P. Bishop, R.B. Meeker, T.R. Vilberg and A.J. Kastin. Effects of
α-MSH on motivation, vigilance and brain respiration. Pharmacol. Biochem. Behav. 5,
Suppl. 1: 59-64, 1976.
227.
Stratton, L.O., C.A. Gibson, K.G. Kolar and A.J. Kastin. Neonatal treatment with TRH
affects development, learning, and emotionality in the rat. Pharmacol. Biochem. Behav.
5, Suppl. 1: 65-67, 1976.
228.
Ehrensing, R.H. and A.J. Kastin. Clinical investigations for emotional effects of
neuropeptide hormones. Pharmacol. Biochem. Behav. 5, Suppl. 1: 89-93, 1976.
229.
Christensen, C.W., C.T. Harston, A.J. Kastin, R.M. Kostrzewa and M.A. Spirtes.
Investigations on α-MSH and MIF-I effects on cyclic AMP levels in rat brain. Pharmacol.
Biochem. Behav. 5, Suppl. 1: 117-120, 1976.
230.
Spirtes, M.A., N.P. Plotnikoff, R.M. Kostrzewa, C.T. Harston, A.J. Kastin and C.W.
Christensen. Possible association of increased rat behavioral effects and increased striatal
dopamine and norepinephrine levels during the DOPA-potentiation test. Pharmacol.
Biochem. Behav. 5, Suppl. 1: 121-124, 1976.
231.
Kostrzewa, R.M., M.A. Spirtes, J.W. Klara, C.W. Christensen, A.J. Kastin and T.H. Joh.
Effects of L-prolyl-L-leucyl-glycine amide (MIF-I) on dopaminergic neurons. Pharmacol.
Biochem. Behav. 5, Suppl. 1: 125-127, 1976.
232.
Greenberg, R., C.E. Whalley, F. Jourdikian, I.S. Mendelson, K. Nikolics, D.H. Coy, A.V.
Schally and A.J. Kastin. Peptides readily penetrate the blood-brain barrier: uptake of
peptides by synaptosomes is passive. Pharmacol. Biochem. Behav. 5, Suppl. 1: 151-158,
1976.
233.
Barbeau, A., M. Gonce and A.J. Kastin. Neurologically active peptides. Pharmacol.
Biochem. Behav. 5, Suppl. 1: 159-163, 1976.
234.
Goldman, H., E.B. Skelley, C.A. Sandman, A.J. Kastin and S. Murphy. Hormones and
regional brain blood flow. Pharmacol. Biochem. Behav. 5, Suppl. 1: 165-169, 1976.
235.
Gonzalez-Barcena, D., A.J. Kastin, D.S. Schalch, D.H. Coy and A.V. Schally. Prolonged
elevation of luteinizing hormone (LH) after intranasal administration of an analogue of
LH releasing hormone. Fertil. Steril. 27: 1246-1249, 1976.
236.
Gomez-Pan, A., M.H. Snow, D.A. Piercy, V. Robson, R. Wilkinson, R. Hall, D.C.
28
Evered, G.M. Besser, A.V. Schally, A.J. Kastin and D.H. Coy. Actions of growth
hormone-release inhibiting hormone (somatostatin) on the renin aldosterone system. J.
Clin. Endocrinol. Metab. 43: 240-243, 1976.
237.
Kastin, A.J., B. Kuzemchak, R.G. Thompkins, A.V. Schally and M.C. Miller. Melanin in
the rat brain. Brain Res. Bull. 1: 567-572, 1976.
238.
Kastin, A.J., C. Nissen, A.V. Schally and D.H. Coy. Blood-brain barrier, half-time
disappearance, and brain distribution for labeled enkephalin and a potent analog. Brain
Res. Bull. 1: 583-589, 1976.
239.
Marks, N., F. Stern and A.J. Kastin. Biodegradation of α-MSH and derived peptides by
rat brain extracts, and by rat and human serum. Brain Res. Bull 1: 591-593, 1976.
240.
Plotnikoff, N.P., A.J. Kastin, D.H. Coy, C.W. Christensen, A.V. Schally and M.A.
Spirtes. Neuropharmacological actions of enkephalin after systemic administration. Life
Sci. 19: 1283-1288, 1976.
241.
Coy, D.H., A.J. Kastin, A.V. Schally, O. Morin, N.G. Caron, F. Labrie, J.M. Walker, R.
Fertel, G.G. Berntson and C.A. Sandman. Synthesis and opioid activities of stereoisomers
and other D-amino acid analogs of methionine-enkephalin. Biochem. Biophys. Res.
Commun. 73: 632-638, 1976.
242.
Dunn, J.D., A.J. Kastin and A.J. Carrillo. Circadian variation in plasma melanocyte
stimulating hormone activity in the rat. Int. J. Chronobiol. 4: 163-169, 1976.
243.
Kastin, A.J., E.L. Scollan, M.G. King, A.V. Schally and D.H. Coy. Enkephalin and a
potent analog facilitate maze performance after intraperitoneal administration in rats.
Pharmacol. Biochem. Behav. 5: 691-695, 1976.
244.
Schally, A.V. and A.J. Kastin. Hormones of the hypothalamus. La Recherche 7: 36-45,
1976.
245.
Zarate, A., E.S. Canales, J. Soria, G. Forsbach, A.J. Kastin and A.V. Schally. Therapeutic
use of gonadoliberin (FSH/LH-RH) in women. Fertil. Steril. 27: 1233-1239, 1976. Also
In: Modern Trends in Infertility and Conception Control. E.E. Wallach and R.D.
Kempers, eds., Williams and Williams Co., Baltimore, p. 203, 1979.
246.
Sandman, C.A. and A.J. Kastin. Pituitary peptide influences on attention and memory. In:
Neurobiology of Sleep and Memory. R.R. Drucker-Colin and J.L. McGaugh, eds.,
Academic Press, New York, pp. 347-360, 1977.
247.
Kastin, A.J., L.H. Miller, C.A. Sandman, A.V. Schally and N.P. Plotnikoff. CNS and
pituitary effects of hypothalamic peptides and MSH. In: Essays in Neurochemistry and
29
Neuropharmacology. M.B.H. Youdim, W. Lovenberg, O.F. Sharman, J.R. Lagnado, eds.,
J. Wiley and Sons, New York, pp. 139-176, 1977.
248.
Ehrensing, R.H. and A.J. Kastin. TRH: Clinical investigations for nonendocrine actions
in man. In: Clinical Neuroendocrinology. L. Martini and G.M. Besser, eds., Academic
Press, New York, pp. 133-142, 1977.
249.
Kastin, A.J., A. Barbeau, N.P. Plotnikoff, A.V. Schally and R.H. Ehrensing. MIF-I:
Actions in man. In: Clinical Neuroendocrinology. L. Martini and G.M. Besser, eds.,
Academic Press, New York, pp. 393-400, 1977.
250.
Sandman, C.A., A.J. Kastin and L.H. Miller. Central nervous system actions of MSH and
related pituitary peptides. In: Clinical Neuroendocrinology. L. Martini and G.M. Besser,
eds., Academic Press, New York, pp. 443-469, 1977.
251.
Sandman, C.A. and A.J. Kastin. Neuropeptide influences on behavior: a possible
treatment for disorders of attention. In: Neuroregulation: Hypotheses about Psychiatric
Disorders. J. Barchas, D.H. Hamburg and E. Usdin, eds., Oxford Univ. Press, New York,
pp. 287-295, 1977.
252.
Ehrensing, R.H., A.J. Kastin, P.F. Larson and G.A. Bishop. Melanocyte-stimulating
hormone release-inhibiting factor-I and tardive dyskinesia. Dis. Nerv. Sys. 38: 303-307,
1977.
253.
Ashton, H., J.E. Millman, R. Telford, J.W. Thompson, T.F. Davies, R. Hall, S. Shuster,
A.J. Thody, D.H. Coy and A.J. Kastin. Psychopharmacological and endocrinological
effects of melanocyte stimulating hormones in normal man. Psychopharmacology 55:
165-172, 1977.
254.
Beckwith, B.E., C.A. Sandman, D. Hothersall and A.J. Kastin. Influence of neonatal
injections of α-MSH on learning, memory and attention in rats. Physiol. Behav. 18: 6371, 1977.
255.
Sandman, C.A., J. George, T.R. McCanne, J.D. Nolan, J. Kaswan and A.J. Kastin.
MSH/ACTH 4-10 influences behavioral and physiological measures of attention. J. Clin.
Endocrinol. Metab. 44: 884-891, 1977.
256.
Walker, M.J., G. Berntson, C.A. Sandman, D.H. Coy, A.V. Schally and A.J. Kastin. An
analogue of enkephalin having a prolonged opiate-like effect in vivo. Science 196: 85-87,
1977.
257.
Schally, A.V., D.H. Coy, A. Arimura, T.W. Redding, A.J. Kastin, J. Vilchez-Martinez, E.
Pedroza, A. Gordin, J. Molnar, C.A. Meyers, F. Labrie, R. Hall, D. Reed, A. Gomez-Pan
and G.M. Besser. Hypothalamic regulatory hormones and their synthetic analogs. In:
30
Proceedings of the Vth International Symposium on Medicinal Chemistry, Paris, July 1922, 1976. J. Mathieu, ed., Elsevier Scientific Pub. Corp., Amsterdam, pp. 1-9, 1977.
258.
Beckwith, B.W., R.K. O'Quin, M.S. Petro, A.J. Kastin and C.A. Sandman. The effects of
neonatal injections of α-MSH on the open field behavior of juvenile and adult rats.
Physiol. Psychol. 5: 295-299, 1977.
259.
Coy, D.H., P. Gill, A.J. Kastin, A. Dupont, L. Cusan, F. Labrie, D. Britton and R. Fertel.
Synthetic and biological studies on unmodified and modified fragments of human ßlipotropin with opioid activities. In: Peptides, M. Goodman and J. Meienhoffer, eds.,
Wiley and Sons, New York, pp. 107-110, 1977.
260.
Schally, A.V., A.J. Kastin and A. Arimura. Hypothalamic hormones: the link between
brain and body. Am. Sci. 65: 712-719, 1977.
261.
Miller, L.H., A.J. Kastin and C.A. Sandman. Psychobiological actions of MSH in man.
In: Melanocyte Stimulating Hormone: Control, Chemistry and Effects. Frontiers of
Hormone Research, Vol. 4. F.J.H. Tilders, D.F. Swaab and T.B. Greidanus, eds., Karger,
Basel, pp. 153-161, 1977.
262.
Geiger, R., J. Sandow and A.J. Kastin. Synthesis and properties of (11-serine) αmelanotropin. Hoppe-Seyler's Z. Physiol. Chem. 358: 1475-1481, 1977.
263.
Plotnikoff, P.J. and A.J. Kastin. Neuropharmacological review of hypothalamic releasing
factors. In: Neuropeptide Influences on the Brain and Behavior. L.H. Miller, C.A.
Sandman and A.J. Kastin, eds., Raven Press, New York, pp. 81-107, 1977.
264.
Sandman, C.A., L.H. Miller and A.J. Kastin. Introduction: Perspectives on the behavioral
effects of the neuropeptides. In: Neuropeptide Influences on the Brain and Behavior. L.H.
Miller, C.A. Sandman and A.J. Kastin, eds., Raven Press, New York, pp. 1-9, 1977.
265.
Miller, L.H., S.C. Fischer, G.A. Groves, M.E. Rudrauff and A.J. Kastin. MSH/ACTH 410 influences on the CAR in human subjects: a negative finding. Pharmacol. Biochem.
Behav. 7: 417-419, 1977.
266.
Walker, J.M., C.A. Sandman, G.G. Berntson, R.F. McGivern, D.H. Coy and A.J. Kastin.
Endorphin analogs with potent and long-lasting analgesic effects. Pharmacol. Biochem.
Behav. 7: 543-548, 1977.
267.
Gonzalez-Barcena, D., A.J. Kastin, D.H. Coy, K. Nikolics and A.V. Schally. Suppression
of gonadotropin release in man by an inhibitory analogue of LH-releasing hormone.
Lancet 2: 997-998, 1977.
268.
Porter, J.R., A.J. Kastin, G. Pelle-Day and R.G. Tompkins. Regional in vitro uptake of a
31
synthetic [3H]-labeled-melanin into rat brain. Brain Res. Bull. 2: 401-404, 1977.
269.
Grynbaum, A., A.J. Kastin, D.H. Coy and N. Marks. Breakdown of enkephalin and
endorphin analogs by brain extracts. Brain Res. Bull. 2: 479-484, 1977.
270.
Marks, N., F. Stern, A.J. Kastin and D.H. Coy. Degradation of delta sleep inducing
peptide (DSIP) and its analogs by brain extracts. Brain Res. Bull. 2: 491-493, 1977.
271.
Schally, A.V., D.H. Coy, A. Arimura, J. Vilchez, T.W. Redding and A.J. Kastin. Survey
of the structure synthesis and biological activity of hypothalamic releasing and inhibiting
hormones. In: Hypothalamic Hormones - Chemistry, Physiology and Clinical
Applications. D. Gupta and W. Voelter, eds., Verlag Chemie, pp. 1-12, 1978.
272.
Ehrensing, R.H. and A.J. Kastin. Dose-related biphasic effect of prolyl-leucylglycinamide (MIF-I) in depression. Am. J. Psychiat. 135: 562-566, 1978.
273.
Kastin, A.J., C.A. Sandman, A.V. Schally and R.H. Ehrensing. Clinical effects of
hypothalamic-pituitary peptides upon the central nervous system. In: Clinical
Neuropharmacology. H.L. Klawans, ed., Raven Press, New York. 3: 133-152, 1978.
274.
Christensen, C.W., M.A. Spirtes, R.M. Kostrzewa and A.J. Kastin.
Neuropharmacological aspects of hypothalamic peptides and alpha-MSH. In: Current
Studies of Hypothalamic Factors. Vol. 1 - Hormones. K. Lederis and W.L. Veale, eds., S.
Karger, Basel, pp. 182-191, 1978.
275.
Sandman, C.A. and A.J. Kastin. A behavioral strategy for the CNS actions of the
neuropeptides. In: Current Studies of Hypothalamic Factors. Vol. 2 - Metabolism and
Behaviour. W.L. Veale and K. Lederis, eds., S. Karger, Basel, pp. 163-174, 1978.
276.
Schally, A.V., D.H. Coy, A. Arimura, T.W. Redding, A.J. Kastin, C. Meyers, J. Seprodi,
R. Chang, W.-Y. Huang, K. Chihara, E. Pedroza, J. Vilchez and R. Millar. Hypothalamic
peptide hormones and their analogues. In: Pharmacology of the Hypothalamus, B. Cox,
I.D. Morris and A.H. Weston, eds., McMillan Press, London, pp. 161-206, 1978.
277.
Spirtes, M.A., C.W. Christensen, C.T. Harston and A.J. Kastin. α-MSH and MIF-I effects
on cGMP levels in various rat brain regions. Brain Res. 144: 189-193, 1978.
278.
Britton, D.R., R. Fertel, D.H. Coy and A.J. Kastin. The effect of enkephalin and
endorphin analogs on receptors in the mouse vas deferens. Biochem. Pharm. 27: 22752277, 1978.
279.
Veith, J.L., C.A. Sandman, J.M. Walker, D.H. Coy and A.J. Kastin. Systemic
administration of endorphins selectively alters open field behavior of rats. Physiol.
Behav. 20: 539-542, 1978.
32
280.
Kastin, A.J., D.H. Coy, A.V. Schally and L.H. Miller. Peripheral administration of
hypothalamic peptides results in CNS changes. Pharmacol. Res. Commun. 10: 293-312,
1978.
281.
Kastin, A.J., D.H. Coy, Y. Jacquet, A.V. Schally and N.P. Plotnikoff. CNS effects of
somatostatin. Metabolism 27 (Suppl. 1): 1247-1252, 1978.
282.
Coy, D.H., A.J. Kastin, M.J. Walker, R.F. McGivern and C.A. Sandman. Increased
analgesic activities of a fluorinated and a dimeric analogue of [D-Ala-2]-methionine
enkephalinamide. Biochem. Biophys. Res. Commun. 83: 977-983, 1978.
283.
Kanade, A., A.E. Ruiz, K. Tornyos, I. Wakabayashi and A.J. Kastin. Panhypopituitarism
and anemia secondary to traumatic fracture of the sella turcica. J. Endocrin. Invest. 1:
263-268, 1978.
284.
Olson, R.D., A.J. Kastin, G.F. Michell, G.A. Olson, D.H. Coy and D.M. Montalbano.
Effects of endorphin and enkephalin analogs on fear habituation in goldfish. Pharmacol.
Biochem. Behav. 9: 111-114, 1978.
285.
Kostrzewa, R.M., A.J. Kastin and S.K. Sobrian. Potentiation of apomorphine action in
rats by L-prolyl-L-leucyl-glycine amide. Pharmacol. Biochem. Behav. 9: 375-378, 1978.
286.
Redding, T.W., A.J. Kastin, K. Nikolics, A.V. Schally and D.H. Coy. Disappearance and
excretion of labeled α-MSH in man. Pharmacol. Biochem. Behav. 9: 207-212, 1978.
287.
Kastin, A.J., E.L. Scollan, R.H. Ehrensing, A.V. Schally and D.H. Coy. Enkephalin and
other peptides reduce passiveness. Pharmacol. Biochem. Behav. 9: 515-519, 1978.
288.
Olson, R.D., A.J. Kastin, D. Montalbano-Smith, G.A. Olson, D.H. Coy and G.F. Michell.
Neuropeptides and the blood-brain barrier in goldfish. Pharmacol. Biochem. Behav. 9:
521-524, 1978.
289.
Olson, G.A., R.D. Olson, A.J. Kastin, F.X. Castellanos, M.T. Kneale, D.H. Coy and R.H.
Wolf. Behavioral effects of D-Ala2-ß-endorphin in squirrel monkeys. Pharmacol.
Biochem. Behav. 9: 687-692, 1978.
290.
Kastin, A.J., D.H. Coy, A.V. Schally and C.A. Meyers. Activity of VIP, somatostatin and
other peptides in the mouse vas deferens assay. Pharmacol. Biochem. Behav. 9: 673-676,
1978.
291.
Sandman, C.A. and A.J. Kastin. Interaction of α-MSH and MIF-I with D-amphetamine on
open-field behavior of rats. Pharmacol. Biochem. Behav. 9: 759-762, 1978.
33
292.
Kastin, A.J. CNS actions of various hypothalamic-pituitary peptides in animals and man.
Neurosci. Res. Prog. Bull. 16: 328-332, 1978.
293.
Kastin, A.J., C.A. Sandman, N.P. Plotnikoff, D.H. Coy, R.D. Olson, A.V. Schally and
L.H. Miller. Central nervous system effects of MSH and hypothalamic peptides. In:
Clinical Psychoneuroendocrinology in Reproduction. L. Carenza, P. Pancheri and L.
Zichella, eds., Academic Press, New York, pp. 47-56, 1978.
294.
Panksepp, J., T. Vilberg, N.J. Bean, D.H. Coy and A.J. Kastin. Reduction of distress
vocalization in chicks by opiate-like peptides. Brain Res. Bull 3: 663-667, 1978.
295.
Marks, N., A.J. Kastin, F. Stern and D.H. Coy. Metabolism of potent enkephalin analogs
(FK 33-823, D-Ala2, pentafluorophenylalanine-4-enkephalinamide and a dimer of D-Ala2enkephalin) and D-amino acid substituted derivatives of human ß-endorphin. Brain Res.
Bull. 3: 687-690, 1978.
296.
Kastin, A.J., C. Nissen, A.V. Schally and D.H. Coy. Radioimmunoassay of DSIP-like
material in rat brain. Brain Res. Bull 3: 691-695, 1978.
297.
Coy, D.H., A.J. Kastin and N.P. Plotnikoff. Etudes biologiques faites avec les
encephalines, les endorphins et leurs analogues. Ann. Anesth. Franc. 19: 373-378, 1978.
298.
Schally, A.V., A. Arimura, D.H. Coy, A.J. Kastin, C.A. Meyers, T.W. Redding, K.
Chihara, W.Y. Huang, R.C.C. Chang, E. Pedroza and J. Vilchez-Martinez. Hypothalamic
hormones regulating pituitary (and other) functions: their physiology and biochemistry as
well as recent studies with their synthetic analogues. In: Central Regulation of the
Endocrine System. K. Fuxe, T. Hokfelt and R. Luft, eds., Plenum Press, New York, pp.
9-29, 1978.
299.
Kastin, A.J., D.H. Coy, R.D. Olson, J. Panksepp, A.V. Schally and C.A. Sandman.
Behavioral effects of the brain opiates enkephalin and endorphin. In: Central Nervous
System Effects of Hypothalamic Hormones and Other Peptides. R. Collu, A. Barbeau,
J.R. Ducharme, J.-G. Rochefort, eds., Raven Press, New York, pp. 273-281, 1979.
300.
Schally, A.V., A.M. Medeiros-Comaru and A.J. Kastin. Hormonas hipothalamicas y su
aplicacion en la pratica medica. Tribuna Medica 16: 2, 1979.
301.
Kastin, A.J., R.D. Olson, A.V. Schally and D.H. Coy. CNS effects of peripherally
administered brain peptides. Life Sci. 25: 401-414, 1979.
302.
Schally, A.V., D.H. Coy, C.A. Meyers and A.J. Kastin. Hypothalamic peptide hormones:
Basic and clinical studies. In: Hormonal Proteins and Peptides. C.H. Li, ed., Academic
Press, New York, pp. 1-54, 1979.
34
303.
Wass, J.A.H., G.M. Besser, A. Gomez-Pan, M.F. Scanlon, R. Hall, A.J. Kastin, D.H. Coy
and A.V. Schally. Comparison of long-acting analogues of luteinizing hormone releasing
hormone in man. Clin. Endocrinol. 10: 419-430, 1979.
304.
Kostrzewa, R.M., J.C. Hardin, R.L. Snell, A.J. Kastin, D.H. Coy and F. Bymaster. MIF-I
and postsynaptic receptor sites for dopamine. Brain Res. Bull. 4: 657-662, 1979.
305.
Olson, G.A., R.D. Olson, A.J. Kastin, M.T. Green, R. Roig-Smith, C.W. Hill and D.H.
Coy. Effects of an enkephalin analog on complex learning in the rhesus monkey.
Pharmacol. Biochem. Behav. 11: 341-345, 1979.
306.
King, M.G., A.J. Kastin, R.D. Olson and D.H. Coy. Systemic administration of Metenkephalin, [D-Ala2]-Met-enkephalin, ß-endorphin, and [D-Ala2]-ß-endorphin: effects on
eating, drinking, and activity measures in rats. Pharmacol. Biochem. Behav. 11: 407-411,
1979.
307.
Sandman, C.A., R.F. McGivern, C. Berka, M. Walker, D.H. Coy and A.J. Kastin.
Neonatal administration of ß-endorphin produces “chronic” insensitivity to thermal
stimuli. Life Sci. 25: 1755-1760, 1979.
308.
Kastin, A.J., B. Kuzemchak, A.V. Schally and M.W. Eggert. Rat brain melanin at
different ages and after various treatments. Brain Res. Bull. 4: 793-797, 1979.
309.
Olson, R.D., A.J. Kastin, G.J. LaHoste, G.A. Olson and D.H. Coy. Possible non-narcotic
component to action of opiate peptides on tonic immobility. Pharmacol. Biochem. Behav.
11: 705-708, 1979.
310.
Kastin, A.J., M.T. Jemison and D.H. Coy. Analgesia after peripheral administration of
enkephalin and endorphin analogues. Pharmacol. Biochem. Behav. 11: 713-716, 1979.
311.
Kastin, A.J., C. Nissen, A.V. Schally and D.H. Coy. Additional evidence that small
amounts of a peptide can cross the blood-brain barrier. Pharmacol. Biochem. Behav. 11:
717-719, 1979.
312.
Kastin, A.J., R.D. Olson, R.H. Ehrensing, M.C. Berzas, A.V. Schally and D.H. Coy.
MIF-I's differential actions as an opiate antagonist. Pharmacol. Biochem. Behav. 11: 721723, 1979.
313.
King, B.M., F.X. Castellanos, A.J. Kastin, M.C. Berzas, M.D. Mauk, G.A. Olson and
R.D. Olson. Naloxone-induced supression of food intake in normal and hypothalamic
obese rats. Pharmacol. Biochem. Behav. 11: 729-732, 1979.
314.
Nance, D.W., D.H. Coy and A.J. Kastin. Experiments with a proposed anorexigenic
tripeptide: pyro-Glu-His-Gly-OH. Pharmacol. Biochem. Behav. 11: 733-735, 1979.
35
315.
Kostrzewa, R.M., Fukushima, H., C.T. Hartson, K.W. Perry, R.W. Fuller and A.J. Kastin.
Striatal dopamine turnover and MIF-I. Brain Res. Bull. 4: 799-802, 1979.
316.
Huang, W.Y., R.C.C. Chang, A.J. Kastin, D.H. Coy and A.V. Schally. Isolation and
structure of pro-methionine-enkephalin, a new potential enkephalin precursor from
porcine hypothalami. Proc. Natl. Acad. Sci. 76: 6177-6180, 1979.
317.
Olson, G.A., R.D. Olson, A.J. Kastin and D.H. Coy. Endogenous opiates: through 1978.
Neurosci. Biobehav. Rev. 3: 285-299, 1979.
318.
Schally, A.V., A.M. Comaru-Schally, J. Zadina and A.J. Kastin. LH-RH and its
stimulatory and inhibitory analogues: clinical studies. In: Psychoneuroendocrinology in
Reproduction. L. Zichella and P. Pancheri, eds., Elsevier Press, Amsterdam, pp. 9-18,
1979.
319.
Kastin, A.J., R.H. Ehrensing, D.H. Coy, A.V. Schally and R.M. Kostrzewa. Behavioral
effects of brain peptides, including LH-RH.
In: Psychoneuroendocrinology in
Reproduction. L. Zichella and P. Pancheri, eds., Elsevier Press, Amsterdam, pp. 69-80,
1979.
320.
Olson, G.A., R.D. Olson, A.J. Kastin and D.H. Coy. The opioid neuropeptides enkephalin
and endorphin and their hypothesized relation to pain. In: Pain: Meaning and
Management. W.L. Smith, S.C. Gross and H. Merskey, eds., Spectrum Pub., New York,
p. 21, 1980.
321.
Schally, A.V., T.W. Redding, R.C.C. Chang, A. Arimura, W.Y. Huang, D.H. Coy, C.A.
Meyers, E. Pedroza, A.J. Kastin and C. Turkelson. Chemistry and physiology of
hypothalamic hormones. In: Polypeptide Hormones. R.F. Beers, Jr. and E.G. Bassett,
eds., Raven Press, New York, pp. 169-184, 1980.
322.
Kastin, A.J., J.E. Zadina, D.H. Coy, A.V. Schally and C.A. Sandman. Hypothalamic
peptides affect behavior after systemic injection. In: Polypeptide Hormones. R.F. Beers,
Jr. and E.G. Bassett, eds., Raven Press, New York, pp. 223-234, 1980.
323.
Olson, R.D., A.J. Kastin, G.A. Olson and D.H. Coy. Behavioral effects after systemic
injection of opiate peptides. Psychoneuroendocrinology 5: 47-52, 1980.
324.
Kastin, A.J., R.H. Ehrensing, R.D. Olson, A.V. Schally and D.H. Coy. Neurological
effects of MIF-I, MSH, and opiate peptides in clinical studies. Int. J. Neurol. 14: 205-209,
1980.
325.
Kastin, A.J., A.V. Schally and R.M. Kostrzewa. Possible aminergic mediation of MSH
release and of the CNS effects of MSH and MIF-I. Fed. Proc. 39: 2931-2936, 1980.
36
326.
Kastin, A.J., L.A. Wade, D.H. Coy, A.V. Schally and R.D. Olson. Peptides and the
blood-brain barrier. In: Brain and Pituitary Peptides. W. Wuttke, A. Weindl, K.H. Voigt
and R.R. Dries, eds., Munich, Karger, pp. 71-78, 1980.
327.
Kastin, A.J., G.A. Olson, C.A. Sandman, D.H. Coy, A.V. Schally and R.D. Olson. Brain
opiates affect behavior after systemic injection. In: Growth Hormone and Other
Biologically Active Peptides. A. Pecile and E.E. Muller, eds., Excerpta Med.,
Amsterdam, pp. 201-206, 1980.
328.
Miller, L.H., G.A. Groves, M.J. Bopp and A.J. Kastin. A neuroheptapeptide influence on
cognitive functioning in the elderly. Peptides 1: 55-57, 1980.
329.
O'Steen, W.K. and A.J. Kastin. Relationship of melanocyte-stimulating hormone to
photoreceptor damage. Peptides 1: 19-22, 1980.
330.
Yehuda, S., J. Zadina, A.J. Kastin and D.H. Coy. D-amphetamine-induced hypothermia
and hypermotility in rats: changes after systemic administration of ß-endorphin. Peptides
1: 179-185, 1980.
331.
Mauk, M.D., G.A. Olson, A.J. Kastin and R.D. Olson. Behavioral effects of LH-RH.
Neurosci. Biobehav. Rev. 4: 1-8, 1980.
332.
LaHoste, G.J., G.A. Olson, A.J. Kastin and R.D. Olson. Behavioral effects of melanocyte
stimulating hormone. Neurosci. Biobehav. Rev. 4: 9-16, 1980.
333.
Yehuda, S., A.J. Kastin and D.H. Coy. Antagonistic actions of MIF-I on the hypothermia
and hypomotility induced by ß-endorphin or morphine. Int. J. Neurosci. 11: 317-320,
1980.
334.
Ehrensing, R.H. and A.J. Kastin. Effects of MIF-I and TRH on the brain. In: Hormones
and the Brain. D. de Wied and P.A. van Keep, eds., MIP Press, Lancaster, pp. 155-165,
1980.
335.
Kastin, A.J., G.A. Olson, A.V. Schally and D.H. Coy. DSIP-More than a sleep peptide?
Trends Neurosci. 3: 163-165, 1980.
336.
Hanker, J.P., J. Knippenberg, A.J. Kastin, E.J. Wickings, A.V. Schally, D.H. Coy and
H.P.G. Schneider. Gonadotropin release during repeated administration of D-Leu6 des
Gly10- LH-RH-EA at different stages of the menstrual cycle and in functional
amenorrhea. Int. J. Fertil. 25: 7-17, 1980.
337.
Davis, K.L., A.J. Kastin, B.A. Beilstein and A.L. Vento. MSH and MIF-I in animal
models of tardive dyskinesia. Pharmacol. Biochem. Behav. 13: 37-40, 1980.
37
338.
Coy, D.H. and A.J. Kastin. Tyrosine-modified analogs of methionine-enkephalin and
their effects on the mouse vas deferens. Peptides 1: 175-177, 1980.
339.
Schally, A.V., R.C.C. Chang, W.-Y. Huang, D.H. Coy, A.J. Kastin and T.W. Redding.
Isolation, structure, biological characterization, and synthesis of ß-[Tyr9] melanotropin(9-18) decapeptide from pig hypothalami. Proc. Natl. Acad. Sci.USA 77: 3947-3951,
1980.
340.
Schally, A.V., A.M. Comaru-Schally and A.J. Kastin. Present status of the use of LH-RH
and its analogs in the diagnosis and therapy of infertility. In: The LH Releasing Hormone.
C. Beling and A. Wentz, eds., Masson Pub. Co., New York, pp. 1-13, 1980.
341.
Kastin, A.J. and A.V. Schally. Early clinical studies with LH-RH. In: The LH Releasing
Hormone. C. Beling and A. Wentz, eds., Masson Pub. Co., New York, pp.15-20, 1980.
342.
Yehuda, S. and A.J. Kastin. Interaction of MIF-I or α-MSH with D-amphetamine or
chlorpromazine on thermoregulation and motor activity of rats maintained at different
ambient temperatures. Peptides 1: 243-248, 1980.
343.
Yehuda, S., A.J. Kastin and D.H. Coy. Thermoregulatory and locomotor effects of DSIP:
paradoxical interaction with D-amphetamine. Pharmacol. Biochem. Behav. 13: 895-900,
1980.
344.
Yehuda, S. and A.J. Kastin. Peptides and thermoregulation. Neurosci. Biobehav. Rev. 4:
459-471, 1980.
345.
Sandman, C.A., B.E. Beckwith and A.J. Kastin. Are learning and attention related to the
sequence of amino acids in ACTH/MSH peptides? Peptides 1: 277-280, 1980.
346.
Kastin, A.J., R.M. Kostrzewa, A.V. Schally and D.H. Coy. Neonatal administration of
Met-enkephalin facilitates maze performance of adult rats. Pharmacol. Biochem. Behav.
13: 883-886, 1980.
347.
Coy, D.H. and A.J. Kastin. Structure-CNS activity studies with the enkephalins.
Pharmacol. Ther. 10: 657-668, 1980.
348.
Kastin, A.J., M.D. Mauk, A.V. Schally and D.H. Coy. Unusual dose-related effect of an
endorphin analog in a complex maze. Physiol. Behav. 25: 959-962, 1980.
349.
Kastin, A.J., D.H. Coy, A.V. Schally and J.E. Zadina. Dissociation of effects of LH-RH
analogs on pituitary regulation and reproductive behavior. Pharmacol. Biochem. Behav.
13: 913-914, 1980.
38
350.
Kastin, A.J., S.P. Lawrence and D.H. Coy. Radioimmunoassay of MIF-1/Tyr-MIF-1-like
material in rat pineal. Pharmacol. Biochem. Behav. 13: 901-905, 1980.
351.
Kastin, A.J., C. Nissen, J.E. Zadina, A.V. Schally and R.H. Ehrensing. Naloxone-like
actions of MIF-1 do not require the presence of the pituitary. Pharmacol. Biochem.
Behav. 13: 907-912, 1980.
352.
Kastin, A.J., A. Arimura, D. Gonzalez-Barcena, J. Fishback, A.V. Schally and D.H. Coy.
Dynamics of injected somatostatin in blood of patients with hepatic failure and
acromegaly. Peptides 1: 257-259, 1980.
353.
McGivern, R.F., J.M. Harris, N. Yessaian, A.J. Kastin, D.H. Coy, C.A. Sandman and E.P.
Noble. Antagonism of ethanol induced sleep-time by α-MSH, MSH/ACTH 4-10 and
naloxone. Substance and Alcohol Actions/Misuse 1: 335-342, 1980.
354.
LaHoste, G.J., R.D. Olson, G.A. Olson and A.J. Kastin. Effects of pavlovian conditioning
and MIF-1 on the development of morphine tolerance in rats. Pharmacol. Biochem.
Behav. 13: 799-804, 1980.
355.
Olson, R.D., A.J. Kastin, T.K. von Almen, D.H. Coy and G.A. Olson. Systemic injections
of gastro-intestinal peptides alter behavior in rats. Peptides 1: 383-385, 1980.
356.
Olson, G.A., R.D. Olson, A.J. Kastin and D.H. Coy. Endogenous opiates: 1979. Peptides
1: 365-379, 1980.
357.
Olson, R.D., A.J. Kastin, G.A. Olson, B.M. King, T.K. von Almen, M.C. Berzas, M.L.
Ibanez and D.H. Coy. MIF-1 suppresses deprivation-induced fluid consumption in rats.
Peptides 1: 353-357, 1980.
358.
Gonzalez-Barcena, D., H. Trevino Ortiz, F. Gordon, A.J. Kastin, D.H. Coy and A.V.
Schally. Influence of LH-RH agonists and antagonists on gonadotropin release in
humans. Int. J. Fertil. 25: 185-189, 1980.
359.
Canales, E.S., H. Montvelinsky, A. Zarate, A.J. Kastin, D.H. Coy and A.V. Schally.
Suppressive effect of an inhibitory LHRH analog on the gonadotropin release to LHRH
in normal women. Int. J. Fertil. 25: 190-192, 1980.
360.
Canales, E.S., H. Montvelinsky, MA. E. Fonseca, A. Zarate, A.J. Kastin, D.H. Coy and
A.V. Schally. The use of a potent stimulatory LHRH analog (D-Trp-6, LHRH) in the
induction of ovulation. Int. J. Fertil. 25: 193-197, 1980.
361.
Kastin, A.J., J.E. Zadina and A.V. Schally. Foundations of the clinical use of LHRH:
early studies with the porcine hypothalamic Hormone. Materia Medical Polona 12: 33,
1980.
39
362.
Hudson, R., A. King, G. Singer, A. Tucker, D.H. Coy and A.J. Kastin. Schedule-induced
self-injection of enkephalin and heroin by the rat. In: Problems in Pain. C. Peck and M.
Wallace, eds., Pergamon Press, pp. 73-77, 1980.
363.
Meyers, C.A., A.J. Kastin, A.V. Schally and D.H. Coy. Use of the mouse vas deferens
assay to evaluate the action of somatostatin peptides on gastric acid secretion. Digestion
21: 21-24, 1981.
364.
Kastin, A.J., R.D. Olson, E. Fritschka and D.H. Coy. Neuropeptides and the blood-brain
barrier. In: Cerebral Microcirculation and Metabolism. J. Cervos-Navarro and E.
Fritschka, eds., Raven Press, New York, pp. 139-145, 1981.
365.
Walker, J.M., G.G. Berntson, C.A. Sandman and A.J. Kastin. Induction of analgesia by
central administration of Org 2766, an analog of ACTH 4-9. Eur. J. Pharm. 69: 71-79,
1981.
366.
Sandman, C.A. and A.J. Kastin. Intraventricular administration of MSH induces
hyperalgesia in rats. Peptides 2: 231-233, 1981.
367.
Ehrensing, R.H., A.J. Kastin and A.V. Schally. Behavioral and hormonal effects of
prolonged high doses of LHRH in male impotency. Peptides 2, Suppl. 1: 115-121, 1981.
368.
Kastin, A.J., W.A. Banks, N. Marks and R.D. Olson. Dissociative effects of CNS
peptides with some unusual applications of RIA. In: Physiological Peptides and New
Trends in Radioimmunology. Ch. A. Bixollon, ed., Elsevier, Amsterdam, pp. 89-99,
1981.
369.
Sandman, C.A., A.J. Kastin and A.V. Schally. Neuropeptide influences on the central
nervous system: A psychobiological perspective. In: Neuroendocrine Regulation and
Altered Behaviour. P.D. Hrdina and R.L. Singhal, eds., Croom Helm Ltd., pp. 4-27,
1981.
370.
Olson, R.D., A.J. Kastin, G.A. Olson and D.H. Coy. Behavioural modulation by systemic
administration of enkephalins and endorphins. In: Neuroendocrine Regulation and
Altered Behaviour. P.D. Hrdina and R.L. Singhal, eds., Croom Helm Ltd., pp. 142-150,
1981.
371.
Kastin, A.J., G.A. Olson, C.A. Sandman and R.E. Ehrensing. Possible role of peptides in
senile dementia. In: Strategies for the Development of an Effective Treatment for Senile
Dementia. T. Crook and S. Gershon, eds., Mark Powley Associates, pp. 139, 1981.
372.
Kastin, A.J., R.D. Olson, C.A. Sandman, A.V. Schally and D.H. Coy. Multiple
independent actions of neuropeptides on behavior. In: Endogenous Peptides and Learning
40
and Memory Processes. J.L. Martinez, R.A. Jensen, R.B. Messing, H. Rigter and J.L.
McGaugh, eds., Academic Press, New York, pp. 563-577, 1981.
373.
Sandman, C.A. and A.J. Kastin. The influence of fragments of the LPH chains on
learning, memory and attention in animals and man. Pharmacol. Ther. 13: 39-60, 1981.
374.
Sankar, R., F.R. Domer and A.J. Kastin. Selective effects of α-MSH and MIF-1 on the
blood-brain barrier. Peptides 2: 345-347, 1981.
375.
Miller, L.H., A.J. Kastin, M. Hayes, A. Sterste, J. Garcia and D.H. Coy. Inverse
relationship between onset and duration of EEG effects of six peripherally administered
peptides. Pharmacol. Biochem. Behav. 15: 845-848, 1981.
376.
Olson, R.D., R.C. Fernandez, A.J. Kastin, G.A. Olson, S.W. Delatte, T.K. von Almen,
D.G. Erickson, D.C. Hastings and D.H. Coy. Low doses of naloxone and MIF-1 peptides
increase fluid consumption in rats. Pharmacol. Biochem. Behav. 15: 921-924, 1981.
377.
Olson, G.A., R.D. Olson, A.J. Kastin and D.H. Coy. Endogenous opiates: 1980. Peptides
2: 349-369, 1981.
378.
Kastin, A.J., L.C. Honour and D.H. Coy. Kyotorphins affect aversive pecking in chicks.
Physiol. Behav. 27: 1073-1076, 1981.
379.
Kastin, A.J., C. Nissen and D.H. Coy. DSIP-like immunoreactivity in the developing rat
brain. Brain Res. Bull. 7: 687-690, 1981.
380.
Kastin, A.J., P.F. Castellanos, W.A. Banks and D.H. Coy. Radioimmunoassay of DSIPlike material in human blood: possible protein binding. Pharmacol. Biochem. Behav. 15:
969-974, 1981.
381.
Kastin, A.J., C. Nissen and D.H. Coy. Permeability of the blood-brain barrier to DSIP
peptides. Pharmacol. Biochem. Behav. 15: 955-959, 1981.
382.
Kastin, A.J., S.P. Lawrence and D.H. Coy. Radioimmunoassayable N-Tyr-MIF-1-like
activity in rat brain is increased by pinealectomy. Brain Res. Bull. 7: 697-702, 1981.
383.
Kastin, A.J., L.C. Honour and D.H. Coy. Effects of MIF-1 and three related peptides on
reserpine-induced hypothermia in mice. Pharmacol. Biochem. Behav. 15: 983-985, 1981.
384.
Moldow, R.L., A.J. Kastin, C.S. Hollander, D.H. Coy and C.A. Sandman. Brain ßendorphin-like immunoreactivity in adult rats given ß-endorphin neonatally. Brain Res.
Bull. 7: 683-686, 1981.
385.
Luciano, M.G., J.E. Zadina, A.J. Kastin and D.H. Coy. Mu and delta opiate receptors in
41
rat brain are affected by GTP but not by MIF-1. Brain Res. Bull. 7: 677-682, 1981.
386.
Zadina, J.E., A.J. Kastin, L.A. Fabre and D.H. Coy. Facilitation of sexual receptivity in
the rat by an ovulation-inhibiting analog of LHRH. Pharmacol. Biochem. Behav. 15: 961964, 1981.
387.
Sander, G.E., T.D. Giles, A.J. Kastin, A.C. Quiroz, A. Kaneish and D.H. Coy.
Cardiopulmonary pharmacology of enkephalins in the conscious dog. Peptides 2: 403407, 1981.
388.
Davis, B.M., G.M. Brown, M. Miller, H.G. Friesen, A.J. Kastin and D.L. Davis. Effects
of cholinergic stimulation on pituitary hormone release. Psychoneuroendocrinology 7:
347-354, 1982.
389.
Kastin, A.J., R.D. Olson, C.A. Sandman, D.H. Coy, J.E. Zadina and R.H. Ehrensing.
CNS actions of peripherally administered peptides: some unresolved issues. In: Changing
Concepts of the Nervous System. A.R. Morrison and P.L. Strick, eds., Academic Press,
New York, pp. 757-768, 1982.
390.
Olson, R.D., A.J. Kastin, G.A. Olson and D.H. Coy. Central nervous system effects after
systemic injection of opiate peptides. In: Endorphins and Opiate Antagonists in
Psychiatric Research: Clinical Implications. N.S. Shah and A.G. Donald, eds., Plenum
Press, pp. 6l-74, l982.
391.
Olson, G.A., A.J. Kastin, D.H. Coy and R.D. Olson. Systemic injections of enkephalins
and endorphins alter behavior. In: Analgesia by Peridural and Spinal Opiates. A.L. Cools
and G.M.M. Nijhuis, eds., pp. 63-73, 1982.
392.
Kastin, A.J., D.H. Coy, A.V. Schally and R.D. Olson. Dissociative actions of peptides on
the brain. In: Functional Regulation at the Cellular and Molecular Levels. R.A.
Corradino, ed., Elsevier, pp. 91-103, 1982.
393.
Sander, G., T. Giles, A. Kastin, A. Kaneish and D. Coy. Leucine-enkephalin: reversal of
intrinsic cardiovascular stimulation by pentobarbital. Eur. J. Pharmacal. 78: 467, 1982.
394.
Ehrensing, R.H. and A.J. Kastin. MIF-1 and regulation of the hypothalamic-pituitaryadrenocortical system in depression. In: Biological Markers in Psychiatry and Neurology.
E. Usdin and I. Handin, eds., Pergamon Press, New York, pp. 299-305, 1982.
395.
Clarkson, D.B., B.M. King, R.C. Hemmer, G.A. Olson, A.J. Kastin and R.D. Olson.
Naloxone decreases consumption of liquid and solid sucrose in vagotomized rats.
Physiol. Behav. 29: 927-930, 1982.
396.
Ehrensing, R.H., G.F. Michell and A.J. Kastin. Similar antagonism of morphine analgesia
42
by MIF-1 and naloxone in Carassius auratus. Pharmacol. Biochem. Behav. 17: 757-761,
1982.
397.
Banks, W.A., A.J. Kastin and D.H. Coy. Delta sleep-inducing peptide crosses the bloodbrain-barrier in dogs: some correlations with protein binding. Pharmacol. Biochem.
Behav. 17: 1009-1014, 1982.
398.
Kastin, A.J., C. Nissen and R.D. Olson. Failure of MIF-1 or naloxone to reverse
ischemic- induced neurologic deficits in gerbils. Pharmacol. Biochem. Behav. 17: 10831085, 1982.
399.
Kastin, A.J., W.A. Banks, P.F. Castellanos, C. Nissen and D.H. Coy. Differential
penetration of DSIP peptides into rat brain. Pharmacol. Biochem. Behav. l7: 1187-l191,
l982.
400.
Zadina, J.E., A.J. Kastin, E.F. Krieg and D.H. Coy. Characterization of binding sites for
N-Tyr-MIF-1 (Tyr-Pro-Leu-Gly-NH2) in rat brain. Pharmacol. Biochem. Behav. l7:
1193-1198, l982.
401.
Kastin, A.J. and L.A. Fabre. Limitations to effect of α-MSH on permeability of bloodbrain barrier to IV 99mTc-pertechnetate. Pharmacol. Biochem. Behav. l7:1199-1201, l982.
402.
Kastin, A.J., L.C. Honour, J. Sueiras-Diaz and D.H. Coy. Opposite effects of CRF and
ACTH on reserpine-induced hypothermia. Pharmacol. Biochem. Behav. l7: l203-l206,
l982.
403.
Hemmer, R.C., G.A. Olson, A.J. Kastin, J.H. McLean and R.D. Olson. Effects of
naloxone and its quaternary form on fluid consumption in rats. Pharmacol. Biochem.
Behav. l7: l287-l290, l982.
404.
Sander, G.E., A.J. Kastin and T.D. Giles. MIF-1 does not act like naloxone in
antagonizing the cardiovascular activity of leucine-enkephalin in the conscious dog.
Pharmacol. Biochem. Behav. 17: l301-l303, l982.
405.
Olson, G.A., R.D. Olson, A.J. Kastin and D.H. Coy. Endogenous opiates: l981. Peptides
3: l039-l072, l982.
406.
Kastin, A.J., A.V. Schally, G.A. Olson and D.H. Coy. Early questions involving
hypothalamic peptides. In: The Anterior Pituitary Gland. A.S. Bhatnagar, ed., Raven
Press, pp. 55-59, l983.
407.
Kastin, A.J., W.A. Banks, J.E. Zadina and M. Graf. Brain peptides: the dangers of
constricted nomenclatures. Life Sci. 32: 295-30l, l983.
43
408.
Kastin, A.J. and C.A. Sandman. Possible role of peptides in mental retardation. In:
Curative Aspects of Mental Retardation: Biomedical and Behavioral Advances. F.J.
Menolascino, R. Neman, J.A. Stark, eds. Paul H. Brookes Publishing Co., Inc. pp. l47l64, l983.
409.
Banks, W.A., A.J. Kastin and D.H. Coy. Delta sleep-inducing peptide (DSIP)-like
material is absorbed by the gastrointestinal tract of the neonatal rat. Life Sci 33: l587l597, l983.
410.
Kastin, A.J., H. Vaudry, J.E. Zadina and R.D. Olson. MIF-l, Tyr-MIF-l, and MSH:
control of MSH release and extra-pigmentary effects. Amer. Zool. 25: 55l-558, l983.
411.
Olson, G.A., R.D. Olson and A.J. Kastin. Endogenous opiates: l982. Peptides 4: 563-576,
l983.
412.
Tonon, M.C., P. Leroux, P. Saulot, H. Vaudry, D.H. Coy and A.J. Kastin. Effect of TyrPro-Leu-Gly-NH2 on melanotropin-stimulating hormone release in the frog and rat. Gen.
Comp. Endocrinol. 52: l7-22, l983.
4l3.
Banks, W.A. and A.J. Kastin. Aluminium increases permeability of the blood-brain
barrier to labelled DSIP and ß-endorphin: possible implications for senile and dialysis
demenita. Lancet pp. l227-l229, l983.
4l4.
Banks, W.A. and A.J. Kastin. CSF-plasma relationships for DSIP and some
neuropeptides. Pharmacol. Biochem. Behav. l9: l037-l040, l983.
4l5.
Hayashi, T., A.J. Kastin, D.H. Coy and R.D. Olson. Tyr-MIF-l affects passive avoidance
behavior but not motor activity in rats. Brain Res. Bull. ll: 659-662, l983.
4l6.
Olson, G.A., R.D. Olson, A.J. Kastin and D.H. Coy. Endogenous opiate systems may
modulate learning and memory. In: Psychoneuroendocrine Dysfunction. N.S. Shah and
A.G. Donald, eds., Plenum Press, pp. 279-292, 1984.
4l7.
Kastin, A.J., R.D. Olson, G.A. Olson and D.H. Coy. Effects of hypothalamic peptides on
behavior. In: The Hypothalamus. J.R. Givens, ed. Year Book Medical Publisher, Inc., pp.
29l-301, 1984.
4l8.
Feldman, S.C. and A.J. Kastin. Localization of neurons containing immunoreactive delta
sleep-inducing peptide in the rat brain: an immunocytochemical study. Neuroscience 11:
303-3l8, 1984.
4l9.
Marks, N., M.J. Berg, A.J. Kastin and D.H. Coy. Evidence for conversion of N-Tyr-MIFl into MIF-l by a specific brain aminopeptidase. Neurochem. Int. 6: 347-353, 1984.
44
other
420.
Graf, M.V. and A.J. Kastin. Delta-sleep-inducing peptide (DSIP): a review. Neurosci.
Biobehav. Rev. 8: 83-93, 1984.
421.
Kastin, A.J., J.E. Zadina, W.A. Banks and M.V. Graf. Misleading concepts in the field of
brain peptides. Peptides 5 (Suppl. 1): 249-253, 1984.
422.
Banks, W.A., A.J. Kastin, E.G. Biglieri and A.E. Ruiz. Primary adrenal hyperplasia: a
new subset of primary hyperaldosteronism. J. Clin. Endocrinol. Metab. 58: 783-785,
1984.
423.
Banks, W.A., A.J. Kastin and D.H. Coy. Evidence that [125I]N-Tyr-delta sleep-inducing
peptide crosses the blood-brain barrier by a non-competitive mechanism. Brain Res. 30l:
20l-207, 1984.
424.
Graf, M.V., C.A. Hunter and A.J. Kastin. Presence of delta-sleep-inducing peptide-like
material in human milk. J. Clin. Endocrinol. Metab. 59: l27-l32, 1984.
425.
Graf, M.V., A.J. Kastin., D.H. Coy and J.E. Zadina. DSIP reduces amphetamine-induced
hyperthermia in mice. Physiol. Behav. 33: 29l-295 1984.
426.
Vilberg, T.R., J. Panksepp, A.J. Kastin and D.H. Coy. The pharmacology of endorphin
modulation of chick distress vocalization. Peptides 5:823-827, 1984.
427.
Kastin, A.J., G.A. Olson, J.E. Zadina and R.D. Olson. Disparate effects of peripherally
administrated endorphins and enkephalins in laboratory animals. In: Central and
Peripheral Endorphins. E.E. Muller and A.R. Genazzani, eds., Raven Press, New York,
pp. 99-l08, 1984.
428.
Graf, M.V. and A.J. Kastin. DSIP-like material exists in peripheral organs of rats in large
dissociable forms. Proc. Soc. Exp. Biol. Med. l77: l97-204, 1984.
429.
Olson, G.A., R.D. Olson and A.J. Kastin. Endogenous opiates: l983. Peptides 5: 975-992,
1984.
430.
Fischman, A.J., A.J. Kastin and M.V. Graf. HPLC shadowing: artifacts in peptide
characterization monitored by RIA. Peptides 5: l007-l0l0, 1984.
431.
Graf, M.V., A.J. Kastin and A.J. Fischman. DSIP occurs in free forms in mammalian
plasma, human CSF, and urine. Pharmacol. Biochem. Behav. 21: 76l-766, 1984.
432.
Kastin, A.J., J. Dickson and A.J. Fischman. DSIP-like material in brain parts of rats
running a complex maze. Physiol. Behav. 33: 427-431, 1984.
433.
Fischman, A.J., A.J. Kastin and M.V. Graf. Circadian variation of DSIP-like material in
45
rat plasma. Life Sci. 35: 2079-2084, 1984.
434.
Kastin, A.J., D.A. Abel, R.H. Ehrensing, D.H. Coy and M.V. Graf. Tyr-MIF-l and MIF-l
are active in the water wheel test for antidepressant drugs. Pharmacol. Biochem. Behav.,
21: 767-771, 1984.
435.
Hayashi, T., A.F. Fischman, A.J. Kastin and D.H. Coy. Some analogs of Tyr-MIF-l affect
passive avoidance behavior but not motor activity in rats. Pharmacol. Biochem. Behav.
21: 809-812, 1984.
436.
Kastin, A.J., E. Stephens, R.H. Ehrensing and A.J. Fischman. Tyr-MIF-l acts as an opiate
antagonist in the tail-flick test. Pharmacol. Biochem. Behav. 21: 937-941, 1984.
437.
Banks, W.A. and A.J. Kastin. A brain-to-blood carrier-mediated transport system for
small, N-tyrosinated peptides. Pharmacol. Biochem. Behav. 21: 943-946, 1984.
438.
Kastin, A.J., P.F. Castellanos, A.J. Fischman, J.K. Proffitt and M.V. Graf. Evidence for
peptide aggregation. Pharmacol. Biochem. Behav. 21: 969-973, 1984.
439.
Ehrensing, R.H., A.J. Kastin and G.F. Michell. Antagonism of morphine analgesia by
prolyl-leucyl-glycinamide (MIF-l) in humans. Pharmacol. Biochem. Behav. 21: 975-978,
1984.
440.
Zadina, J.E. and A.J. Kastin. A rapid filtration method for receptor binding:
characterization with mu and delta opiate receptors. Pharmacol. Biochem. Behav. 21:
947-95l, 1984.
441.
Feldman, S.C. and A.J. Kastin. The distribution of neurons containing delta sleepinducing peptide in the hippocampal formation. Brain Res. Bull. l3: 833-837, 1984.
442.
Graf, M.V., A.J. Kastin and G.A. Schoenenberger. Delta-sleep inducing peptide and two
of its analogs reduce nocturnal increase of N-acetyltransferase activity in rat pineal gland.
J. Neurochem. 44: 629-632, 1985.
443.
Banks, W.A. and A.J. Kastin. Aluminum alters the permeability of the blood-barrier to
some non-peptides. Neuropharmacology. 24: 407-412, 1985.
444.
Graf, M.V., A.J. Kastin and A.J. Fischman. Interaction of arginine vasopressin and
corticotropin releasing factor demonstrated with an improved bioassay. Proc. Soc. Exp.
Biol. Med. l79: 303-308, 1985.
445.
Kastin, A.J., J.E. Zadina, C.A. Sandman and R.D. Olson. Perinatal injections of opiate
and other peptides exert long-term effects. In: Endorphins, Neuroregulators and
Behaviour in Human Reproduction. P. Pancheri, L. Zichella and P. Falaschi, eds.,
46
Excerpta Med. (Amsterdam) Cur. Clin. Prac. Ser. 26: 16-22, 1985.
446.
Banks, W.A. and A.J. Kastin. The aluminum-induced increase in blood-brain barrier
permeability to delta-sleep inducing peptide occurs throughout the brain and is
independent of phosphorus and acetylcholinesterase levels. Psychopharmacology 86: 8489, 1985.
447.
Graf, M.V., A.J. Kastin, D.H. Coy, A.J. Fischman. Delta-sleep-inducing peptide reduces
CRF-induced corticosterone release. Neuroendocrinology 4l: 353-356, 1985.
448.
Banks, W.A. and A.J. Kastin. Peptides and the blood-brain barrier: lipophilicity as a
predictor of permeability. Brain Res. Bull. l5: 287-292, 1985.
449.
Olson, G.A., R.D. Olson and A.J. Kastin. Endogenous opiates: 1984. Peptides 6: 769-79l,
1985.
450.
Banks, W.A., A.J. Kastin and J.K. Selznick. Modulation of immunoactive levels of DSIP
and blood-brain barrier permeability by lighting and diurnal rhythm. J. Neurosci. Res. l4:
347-355, 1985.
451.
Banks, W.A., A.J. Kastin and E.A. Michals. Transport of thyroxine across the bloodbrain barrier is directed primarily from brain to blood in the mouse. Life Sci. 37: 24072414, 1985.
452.
Zadina, J.E. and A.J. Kastin. Interactions between the antiopiate Tyr-MIF-l and the mu
opiate morphiceptin at their respective binding sites in brain. Peptides 6: 965-970, 1985.
453.
Kastin, A.J., E. Stephens, J.E. Zadina, D.H. Coy and A.J. Fischman. Tyr-MIF-l,
identified in brain tissue, and its analogs are active in two models of antinociception.
Pharmacol. Biochem. Behav. 23: l045-l049, 1985.
454.
Olson, G.A., S.W. Delatte, A.J. Kastin, J.H. McLean, D.F. Phillpott and R.D. Olson.
Naloxone and fluid consumption in rats: Dose-response relationships for l5 days.
Pharmacol. Biochem. Behav. 23: l065-l068, 1985.
455.
Banks, W.A. and A.J. Kastin. Aging and the blood-brain barrier: changes in the carriermediated transport of peptides in rats. Neurosci. Lett. 6l: l7l-l75, 1985.
456.
Zadina, J.E., A.J. Kastin, D.H. Coy and B.A. Adinoff. Developmental, behavioral, and
opiate receptor changes after prenatal or postnatal β-endorphin, CRF, or Tyr-MIF-l.
Psychoneuroendocrinology l0: 367-383, 1985.
457.
Banks, W.A. and A.J. Kastin. Permeability of the blood-brain barrier to neuropeptides:
the case for penetration. Psychoneuroendocrinology l0: 385-399, 1985.
47
458.
Graf, M.V., A.J. Kastin and A.J. Fischman. The natural occurrence and some extra-sleep
effects of DSIP. In: Endogenous Sleep Substances and Sleep Regulation. S. Inoue and
A.A. Borbely, eds., Japan Scientific Societies Press, Tokyo: VNU Science Press BV
Utrecht, The Netherlands, pp. 155-l65, 1985.
459.
Galina, Z.H. and A.J. Kastin. MIF-l antagonizes warm-, but not cold-water stress-induced
analgesia: dissociation from immobility. Peptides 6: 1109-1112, 1985.
460.
Olson, G.A., M.F. Pignatiello, A.J. Kastin, B.F. Geiger and R.D. Olson. Lesions in
ventromedial hypothalamus or amygdala do not affect naloxone's suppression of water
consumption. Physiol. Behav. 36: 967-970, 1986.
461.
Coy, D.H. and A.J. Kastin. Structure-CNS activity studies with the enkephalins. In:
Neuropeptides and Behavior. D. de Wied, W.H. Gispen and Tj.B. van Wimersma
Greidanus, eds., Pergamon Press, Oxford, pp. 385-396, 1986.
462.
Miller, L.H., B.A. Turnbull, A.J. Kastin and D.H. Coy. Sleep-wave activity of a delta
sleep-inducing peptide analog correlates with its penetrance of the blood-brain barrier.
Sleep 9: 80-84, 1986.
463.
Kastin, A.J., T.D. Giles and J.C. Dickson. Immunoreactive plasma concentrations of an
endogenous antiopiate are higher in spontaneously hypertensive rats than in WistarKyoto rats. Hypertension 8: l98-202, 1986.
464.
Kastin, A.J., R.H. Ehrensing, C. Hara and D.H. Coy. Parallel behavioral and EEG studies
of the CNS effects of MSH in animals and humans. In: Central Actions of ACTH and
Related Peptides. D. de Wied and W. Ferrarri, eds., Liviana Press, Padova, pp. l47-l52,
1986.
465.
Graf, M.V., A.J. Kastin and G.A. Schoenenberger. Delta sleep-inducing peptide in
spontaneously hypertensive rats. Pharmacol. Biochem. Behav. 24: l797-l799, 1986.
466.
Hara, C. and A.J. Kastin. Acute administration of MIF-l or Tyr-MIF-l inhibits
haloperidol- induced catalepsy in rats. Pharmacol. Biochem. Behav. 24: l785-l787, 1986.
467.
Banks, W.A. and A.J. Kastin. Aging, peptides, and the blood-brain barrier: implications
and speculations. In: Treatment Development Strategies for Alzheimer's Disease. T.
Crook, R. Bartus, S. Ferris and S. Gershon, eds., pp. 245-265, 1986.
468.
Zadina, J.E., W.A. Banks and A.J. Kastin. Central nervous system effects of peptides,
l980-1985: a cross-listing of peptides and their central actions from the first six years of
the journal Peptides. Peptides 7: 497-537, 1986.
48
469.
Zadina, J.E. and A.J. Kastin. Neonatal peptides affect developing rats: β-endorphin alters
nociception and opiate receptors, corticotropin-releasing factor alters corticosterone.
Devel. Brain Res. 29: 2l-30, 1986.
470.
Banks, W.A., A.J. Kastin, D.H. Coy and E. Angulo. Entry of DSIP peptides into dog
CSF: Role of physicochemical and pharmacokinetic parameters. Brain Res. Bull. 17:
155-158, 1986.
471.
Hara, C. and A.J. Kastin. Biphasic effects of MIF-1 and Tyr-MIF-1 on apomorphineinduced sterotypy in rats. Pharmacol. Biochem. Behav. 25: 757-761, 1986.
472.
Banks, W.A., A.J. Kastin, A.J. Fischman, D.H. Coy and S.L. Strauss. Carrier-mediated
transport of enkephalins and N-Tyr-MIF-1 across blood-brain barrier. Am. J. Physiol.
251: E477-E482, 1986.
473.
Olson, G.A., R.D. Olson and A.J. Kastin. Endogenous opiates: 1985. Peptides 7: 907933, 1986.
474.
Galina, Z.H. and A.J. Kastin. Minireview: Existence of antiopiate systems as illustrated
by MIF-1/Tyr-MIF-1. Life Sci. 39: 2153-2159, 1986.
475.
Pretorius H.T., A.J. Kastin and W.A. Banks. Binding of Tyr-MIF-1 to isolated brain
capillaries. Brain Res. Bull. 17: 829-831, 1986.
476.
Zadina, J.E. and A. J. Kastin. Interactions of Tyr-MIF-1 at opiate receptor sites.
Pharmacol. Biochem. Behav. 25: 1303-1305, 1986.
477.
Graf, M.V. and A. J. Kastin. Delta sleep-inducing peptide (DSIP): an update. Peptides 7:
1165-1187, 1986.
478.
Banks, W.A. and A. J. Kastin. Modulation of the carrier-mediated transport of the TyrMIF-1 across the blood-brain barrier by essential amino acids. J. Pharmacol Exp. Ther.
239: 668-672, 1986.
479.
Zadina, J.E. and A.J. Kastin. Multi-independent actions of peptides in the brain: LHRH,
MIF-1 and CRF. Amer. Zool. 26: 951-964, 1986.
480.
Kastin, A.J., R.D. Olson, J.E. Zadina and W.A. Banks. Relationship of clinical to basic
research with peptides as illustrated by MSH. In: Neural and Endocrine Peptides and
Receptors. T.W. Moody, ed., Plenum Press, New York, pp. 645-652, 1986.
481.
Moldow, R.L., A.J. Kastin, M. Graf and A. J. Fischman. Stress mediated changes in
hypothalamic corticotropin releasing factor-like immunoreactivity. Life Sci. 40: 413-418,
1987.
49
482.
Sandman, C.A. and A.J. Kastin. Behavioral actions of ACTH and related peptides. In:
Hormonal Proteins and Peptides. C.H. Li, ed., Academic Press, Inc., Orlando, pp. 147171, 1987.
483.
Kastin, A.J., Z.H. Galina, A. Horvath and R.D. Olson. Some principles in the peptide
field. J. Allergy Clin. Immunol. 79: 6-11, 1987.
484.
Kastin, A.J. and J.C. Dickson. Hypophysectomy increases Tyr-MIF-1-like
immunoreactivity in rat plasma. Neuroendocrinology 45: 177-181, 1987.
485.
Galina, Z.H. and A.J. Kastin. Tyr-MIF-1 attenuates antinociceptive responses induced by
three models of stress-analgesia. Br. J. Pharmacol. 90: 669-674, 1987.
486.
Zadina, J.E., A.J. Kastin, P.K. Manasco, M.F. Pignatiello and K.L. Nastiuk. Long-term
hyperalgesia by neonatal ß-endorphin and morphiceptin is blocked by neonatal Tyr-MIF1. Brain Res. 409: 10-18, 1987.
487.
Kastin, A.J., R.H. Ehrensing, W.A. Banks and J.E. Zadina. Possible therapeutic
implications of the effects of some peptides in the brain. Prog. Brain Res. 72: 223-234,
1987.
488.
Kastin, A.J., J.E. Zadina, R.H. Ehrensing and D. Schwartzenburg. MIF-1 and Tyr-MIF-1
can act differently from amitriptyline in an animal modelof depression. New Trends Exp.
Clin. Psychiat. 3: 49-58, 1987.
489.
Banks, W.A. and A.J. Kastin. Saturable transport of peptides across the blood-brain
barrier. Life Sci. 41: 1319-1338, 1987.
490.
Kastin, A.J. and R.D. Olson. Melanocyte-stimulating hormone (MSH). In: Encyclopedia
of Neuroscience. G. Adelman, ed., Birkhauser Inc., Boston, pp. 622-623, 1987.
491.
Kastin, A.J. and R.H. Ehrensing. Neuropeptides, MIF-1/Tyr-MIF-1. In: Encyclopedia of
Neuroscience. G. Adelman, ed., Birkhauser Inc., Boston, pp. 838-839, 1987.
492.
Kastin, A.J. and J.E. Zadina. Peptides, multiple independent actions. In: Encyclopedia of
Neuroscience. G. Adelman, ed., Birkhauser Inc., Boston, pp. 936-937, 1987.
493.
Kastin, A.J. and W.A. Banks. Peptides and the blood-brain barrier. In: Encyclopedia of
Neuroscience. G. Adelman, ed., Birkhauser, Inc., Boston, pp. 937-938, 1987.
494.
Kastin, A.J. and M.V. Graf. Delta sleep-inducing peptide (DSIP). In: Encyclopedia of
Neuroscience. G. Adelman, ed., Birkhauser, Inc., Boston, pp. 1106-1107, 1987.
50
495.
Miller, L.G. and A.J. Kastin. MIF-1 and Tyr-MIF-1 augment GABA-stimulated
benzodiazepine receptor binding. Peptides 8: 751-755, 1987.
496.
Banks, W.A., A.J. Kastin and E.A. Michals. Tyr-MIF-1 and met-enkephalin share a
saturable blood-brain barrier transport system. Peptides 8: 899-903, 1987.
497.
Miller, L.G., A.J. Kastin and D.J. Greenblatt. Tyr-MIF-1 augments benzodiazepine
receptor binding in vivo. Pharmacol. Biochem. Behav. 28: 521-524, 1987.
498.
Banks, W.A., A.J. Kastin, A. Horvath and E.A. Michals. Carrier-mediated transport of
vasopressin across the blood-brain barrier of the mouse. J. Neurosci. Res. 18: 326-332,
1987.
499.
Barrera, C.M., A.J. Kastin and W.A. Banks. D-[Ala1]-peptide T-amide is transported from
blood to brain by a saturable system. Brain Res. Bull. 19: 629-633, 1987.
500.
Miller, L.G., A.J. Kastin and R.B. Roy. Effects of Tyr-MIF-1 and MIF-1 at the GABAA
receptor chloride channel site. Brain Res. Bull. 19: 743-745, 1987.
501.
Strimas, J.H., D.S. Chi and A.J. Kastin. Brain peptide reverses effect of morphine on
human lymphocytes. Peptides 8: 1165-1167, 1987.
502.
Olson, G.A., R.D. Olson and A.J. Kastin. Endogenous opiates: 1986. Peptides 8: 11351164, 1987.
503.
Galina, Z.H. and A.J. Kastin. Differential activity of the endogenous antiopiate Tyr-MIF1 after various intensities of stress. Neurosci. Lett. 84: 312-316, 1988.
504.
Banks, W.A., A.J. Kastin and B.J. Nager. Analgesia and the blood-brain barrier transport
system for Tyr-MIF-1/enkephalins: evidence for a dissociation. Neuropharmacology 27:
175-179, 1988.
505.
Banks, W.A., A.J. Kastin and M.B. Fasold. Differential effect of aluminum on the bloodbrain barrier transport of peptides, technetium, and albumin. J. Pharmacol. Exp. Ther.
244: 579-585, 1988.
506.
Banks, W.A. and A.J. Kastin. Peptides and the senescent blood-brain barrier. Neurobiol.
Aging 9: 48-49, 1988.
507.
Fischman, A.J., A.J. Kastin, M.V. Graf and R.L. Moldow. Constant light and dark affect
the circadian rhythm of the hypothalamic-pituitary-adrenal axis. Neuroendocrinology 47:
309-316, 1988.
508.
Banks, W.A. and A.J. Kastin. Twenty-one hormones fail to inhibit the brain to blood
51
transport system for Tyr-MIF-1 and the enkephalins in mice. J. Pharm. Pharmacol. 40:
289-291, 1988.
509.
Iyer, K.S., G.A. Marks, A.J. Kastin and S.M. McCann. Evidence for a role of delta sleepinducing peptide in slow-wave sleep and sleep-related growth hormone release in the rat.
Proc. Nat. Acad. Sci. USA 85: 3653-3656, 1988.
510.
Banks, W.A. and A.J. Kastin. Interactions between the blood-brain barrier and
endogenous peptides: Emerging clinical implications. Am. J. Med. Sci. 31: 459-465,
1988.
511.
Kastin, A.J., J.E. Zadina, G.A. Olson and W.A. Banks. Considerations regarding some
peptides involved in biorhythms, reproduction, stress, and pineal function. In:
Biorhythms and Stress in the Physiopathology of Reproduction. P. Pancheri and L.
Zichella, eds., Hemisphere Publishing Corporation, New York, pp. 11-19, 1988.
512.
Zadina, J.E. and A.J. Kastin. Developmental and long-term effects of perinatal stress and
peptides released during stress. In: Biorhythms and Stress in the Physiopathology of
Reproduction. P. Pancheri and L. Zichella, eds., Hemisphere Publishing Corporation,
New York, pp. 485-491, 1988.
513.
Pulvirenti, L. and A.J. Kastin. Blockade of brain dopamine receptors antagonizes the
anti- immobility effect of MIF-1 and Tyr-MIF-1 in rats. Eur. J. Pharmacol. 151: 289-292,
1988.
514.
Graf, M., A.J. Fischman, A.J. Kastin and R.L. Moldow. Circadian variation in response
to CRF-41 and AVP. Am. J. Physiol. 255: E265-E271, 1988.
515.
Banks, W.A., A.J. Kastin, C.M. Barrera and D.A. Durham. Movement of peptides
between the blood and the central nervous system: a brief perspective. European
Conference Biotechnology; Scientific, Technical and Challenges: Verona, Italy, pp. 135140, 1988.
516.
Banks, W.A. and A.J. Kastin. Peptides and the blood brain barrier: penetration and
modulating influences. In: Peptide and Amino Acid Transport Mechanisms in the Central
Nervous System. L. Rakic, D.J. Begley, H. Davson and B.V. Zlokovic, eds.,
Stockton/MacMillan Press, New York, pp. 21-32, 1988.
517.
Pulvirenti, L. and A.J. Kastin. Naloxone, but not Tyr-MIF-1, reduces volitional ethanol
drinking in rats: correlation with degree of spontaneous preference. Pharmacol. Biochem.
Behav. 31: 129-134, 1988.
518.
Miller, L.G., A.J. Kastin, R.B. Roy, A. Gaver, A.J. Fischman and A. Horvath. Structural
specificity of MIF-1 and Tyr-MIF-1 in augmenting GABA-stimulated benzodiazepine
52
receptor binding. Res. Commun. Chem. Pathol. Pharmacol. 62: 365-368, 1988.
519.
Banks, W.A., T.L. Trentman, A.J. Kastin and Z.H. Galina. The general anesthesia
induced by various drugs differentially affects analgesia and its variability. Pharmacol.
Biochem. Behav. 31: 397-403, 1988.
520.
Banks. W.A., A.J. Kastin, M.B. Fasold, C.M. Barrera and G. Augereau. Studies of the
slow bidirectional transport of iron and transferrin across the blood-brain barrier. Brain
Res. Bull. 21: 881-885, 1988.
521.
Pulvirenti, L. and A.J. Kastin. MIF-1 reduces stress-induced eating in rats. New Trends
Exp. Clin. Psychiat. 4: 229-233, 1988.
522.
Banks, W.A., A.J. Kastin, T.L. Trentman, H.S. Haynes, B.G. Johnson and Z.H. Galina.
Mediation of serotonin-induced analgesia by the 5HT2 receptor in the pentobarbital
anesthetized mouse model. Brain Res. Bull. 21: 887-891, 1988.
523.
Horvath, A. and A.J. Kastin. Isolation of tyrosine-melanocyte-stimulating hormone
release-inhibiting factor 1 from bovine brain tissue. J. Biol. Chem. 264: 2175-2179, 1989.
524.
Beckwith, B.E. and A.J. Kastin. Central actions of melanocyte- stimulating hormone
(MSH). In: Peptide Hormones: Effects and Mechanisms of Action. A.N. Vilar and P.M.
Conn, eds., CRC Press, 1: 195-218, 1989.
525.
Zadina, J.E., A.J. Kastin, L.J. Ge, H. Gulden and K.J. Bungart. Chronic, but not acute,
administration of morphine alters antiopiate (Tyr-MIF-1) binding sites in rat brain. Life
Sci. 44: 555-561, 1989.
526.
Banks, W.A. and A.J. Kastin. Inhibition of the brain to blood transport system for
enkephalins and Tyr-MIF-1 in mice addicted or genetically predisposed to drinking
ethanol. Alcohol. 6: 53-57, 1989.
527.
Olson, G.A., R.D. Olson and A.J. Kastin. Endogenous opiates: 1987. Peptides 10: 205236, 1989.
528.
Kostrzewa, R.M., T.G. White, J.E. Zadina and A.J. Kastin. MIF-1 attenuates
apomorphine stereotypies in adult rats after neonatal 6-hydroxydopamine. Eur. J.
Pharmacol. 163: 33-42, 1989.
529.
Pignatiello, M.F., G.A. Olson, A.J. Kastin, R.H. Ehrensing, J.H. McLean and R.D. Olson.
MIF-1 is active in a chronic stress animal model of depression. Pharmacol. Biochem.
Behav. 32: 737-742, 1989.
530.
Banks, W.A. and A.J. Kastin. Effect of neurotransmitters on the system that transports
53
Tyr-MIF-1 and the enkephalins across the blood-brain barrier: a dominant role for
serotonin. Psychopharmacology. 98: 380-385, 1989.
531.
Kastin, A.J., L.G. Miller and D.S. Schwartzenburg. MIF-1 and Tyr-MIF-1 fail to alter
benzodiazepine-induced hypothermia. Pharmacol. Biochem. Behav. 33: 261-263, 1989.
532.
Banks, W.A. and A.J. Kastin. Aluminum-induced neurotoxicity: alterations in membrane
function at the blood-brain barrier. Neurosci. Biobehav. Rev. 13: 47-53, 1989.
533.
Olson, G.A., R.D. Olson and A.J. Kastin. Endogenous opiates: 1988. Peptides 10: 12531280, 1989.
534.
Banks, W.A., A.J. Kastin and D.A. Durham. Bidirectional transport of interleukin-1 alpha
across the blood-brain barrier. Brain Res. Bull. 23: 433-437, 1989.
535.
Barrera, C.M., W.A. Banks and A.J. Kastin. Passage of Tyr-MIF-1 from blood to brain.
Brain Res. Bull. 23: 439-442, 1989.
536.
Kastin, A.J., D. Schwartzenburg, L. Tsui, L.G. Miller, G.A. Olson and R.D. Olson.
Differential effects of Tyr-MIF-1 and naloxone in two animal models involving
benzodiazepine. Brain Res. Bull. 23: 443-446, 1989.
537.
Chi, D.S., J.H. Strimas and A.J. Kastin. In vitro studies of Tyr-MIF-1 with human
lymphocytes. Brain Res. Bull. 23: 549-552, 1989.
538.
Banks, W.A. and A.J. Kastin. Quantifying carrier-mediated transport of peptide from the
brain to the blood. Methods Enzymol. P. M. Conn, ed., Academic Press, San Diego, 168:
652-660, 1989.
539.
Miller, L.G., A.J. Kastin and R.B. Roy. MIF-1 and Tyr-MIF-1 augment muscimolstimulated chloride uptake in cerebral cortex. Brain Res. Bull. 23: 413-415, 1989.
540.
Zadina, J.E., A.J. Kastin and L.-J. Ge. Tyr-MIF-1 binding in brain is not altered by
ligands selective for the GABAA/benzodiazepine receptor. Neurosci. Lett. 110: 143-147,
1990.
541.
Kastin, A.J., W.A. Banks and J.E. Zadina. Hormones and messenger peptides in normal
brain function. In: Principles and Practice of Endocrinology and Metabolism. K.L.
Becker, ed., J.B. Lippincott Co., Philadelphia, pp. 1474-1479, 1990.
542.
Kastin, A.J., W.A. Banks and J.E. Zadina. A decade of changing perceptions about
neuropeptides. Ann. NY Acad. Sci. 579: 1-7, 1990.
543.
Banks, W.A. and A.J. Kastin.Editorial Review: Peptide transport systems for opiates
54
across the blood-brain barrier. Am. J. Physiol. 259: E1-E10, 1990.
544.
Sandman, C.A. and A.J. Kastin. Neuropeptide modulation of development and behavior:
implications for psychopathology. In: Application of Basic Neuroscience to Child
Psychiatry. S.I. Deutsch, A. Weizman and R.Weizman, ed., Plenum Press, New York, pp.
101-124, 1990.
545.
Zadina, J.E., S.L. Chang, L.-J. Ge, A.J. Kastin and R.E. Harlan. Downregulation of mu
opiate receptors by morphine and presence of Tyr-MIF-1 binding sites in SH-SY5Y
human neuroblastoma cells. In: New Leads in Opioid Research. J.M. van Ree, A.H.
Mulder, V.M. Weigant and T.B. van Wimersma Greidanus eds., Excerpta Medica,
Amsterdam, pp.151-153, 1990.
546.
Banks, W.A. and A.J. Kastin. Uptake of peptides containing Tyr-Pro by human and
mouse erythrocytes. Biochem. Pharmacol. 40: 607-614, 1990.
547.
Zadina, J.E., A.J. Kastin, L.-J. Ge and V. Brantl. Hemorphins, cytochrophins, and human
ß-casomorphins bind to antiopiate (Tyr-MIF-1) as well as opiate binding sites in rat brain.
Life Sci. 47: PL25-PL30, 1990.
548.
Banks, W.A. and A.J. Kastin. Exchange of peptides between the circulation and the
nervous system: role of the blood-brain barrier. In: Circulating Regulatory Factors and
Neuroendocrine Function. J.C. Porter and D. Jezova, eds., Plenum Press, New York, pp.
59-69, 1990.
549.
Banks, W.A., A.V. Schally, C.M. Barrera, M.B. Fasold, D.A. Durham, V.J. Csernus, K.
Groot and A.J. Kastin. Permeability of the murine blood-brain barrier to some
octapeptide analogs of somatostatin. Proc. Natl. Acad. Sci. USA. 87: 6762-6766, 1990.
550.
Horvath, A. and A.J. Kastin. Evidence for presence of Tyr-MIF-1 (Tyr-Pro-Leu-GlyNH2) in human brain cortex. Int. J. Pept. Protein Res. 36: 281-284, 1990.
551.
Banks, W.A., A.J. Kastin, E.A. Michals and C.M. Barrera. Stereospecific transport of
Tyr-MIF-1 across the blood-brain barrier by peptide transport system-1. Brain Res. Bull.
25: 589-592, 1990.
552.
Olson, G.A., R.D. Olson and A.J. Kastin. Endogenous opiates: 1989. Peptides 11: 12771304, 1990.
553.
Zadina, J.E., A.J. Kastin, L.-J. Ge and V. Brantl. Casomorphin-related peptides bind to
non-opiate (Tyr-MIF-1) sites as well as opiate receptors in brain. In: ß-Casomorphins and
Related Peptides. F. Nyberg and V.Brantl, eds., Uppsala, Sweden, pp 61-63, 1990.
554.
Miller, L.G. and A.J. Kastin. MIF-1 and Tyr-MIF-1 do not alter GABA binding on the
55
GABAA receptor. Brain Res. Bull. 25: 917-918, 1990.
555.
Krowicki, Z.K. and A.J. Kastin. Effects of Tyr-MIF-1 (Tyr-Pro-Leu-Gly-NH2) on GH,
LH, prolactin, FSH, and TSH secretion in rats with and without morphine. Neuropeptides
18: 41-47, 1991.
556.
Britton, J.R. and A.J. Kastin. Biologically active polypeptides in milk. Am. J. Med. Sci.
301: 124-132, 1991.
557.
Banks, W.A. and A.J. Kastin. Leucine modulates peptide transport system-1 across the
blood-brain barrier at a stereospecific site within the central nervous system. J. Pharm.
Pharmacol. 43: 252-254, 1991.
558.
Banks, W.A. and A.J. Kastin. Regulation of the passage of peptides across the bloodbrain barrier. In: Peptides, Peptoids and Proteins. P.D. Garzone, W.A. Colburn and M.
Mokotoff, eds., pp. 148-153, 1991.
559.
Durham, D.A., W.A. Banks and A.J. Kastin. Carrier-mediated transport of labeled
oxytocin from brain to blood. Neuroendocrinology 53: 447-452, 1991.
560.
Banks, W.A. and A.J. Kastin. Blood to brain transport of interleukin links the immune
and central nervous systems. Life Sci. 48: PL117-PL121, 1991.
561.
Barrera, C.M., A.J. Kastin, M.B. Fasold and W.A. Banks. Bidirectional saturable
transport of LHRH across the blood-brain barrier. Am. J. Physiol. 261: E312-E318, 1991.
562.
Kastin, A.J., J. Seligson, J.H. Strimas and D.S. Chi. Failure of Met-enkephalin to enhance
natural killer cell activity. Immunobiology 183: 55-68, 1991.
563.
Banks, W.A., Kastin, A.J. and C.M. Barrera. Delivering peptides to the central nervous
system: dilemnas and strategies. Pharm. Res. 8: 1345-1350, 1991.
564.
Kastin, A.J., M.A. Pearson and W.A. Banks. EEG evidence that morphine and an
enkephalin analog cross the blood-brain barrier. Pharmacol. Biochem. Behav. 40: 771774, 1991.
565.
Olson, G.A., R.D. Olson and A.J. Kastin. Endogenous opiates: 1990. Peptides 12: 14071432, 1991.
566.
Banks, W.A., A.J. Kastin, C.M. Barrera and L.M. Maness. Lack of saturable transport
across the blood-brain barrier in either direction for ß-amyloid (Alzheimer's disease
protein). Brain Res. Bull. 27: 819-823, 1991.
567.
Barrera, C.M., W.A. Banks, M.B. Fasold and A.J. Kastin. Effects of various reproductive
56
hormones on the penetration of LHRH across the blood-brain barrier. Pharmacol.
Biochem. Behav. 41: 255-257, 1991.
568.
Banks, W.A., L. Ortiz, S.R. Plotkin and A.J. Kastin. Human interleukin (IL) 1α, murine
IL-1α and murine IL-1ß are transported from blood to brain in the mouse by a shared
saturable mechanism. J. Pharmacol. Exp. Ther. 259: 988-996, 1991.
569.
Banks, W.A. and A.J. Kastin. The interleukins-1α, -1ß, and -2 do not acutely disrupt the
murine blood-brain barrier. Int. J. Immunopharmacol. 14: 629-636, 1992.
570.
Zhang, X.-Y, J.E. Zadina, M. Ehrlich and A.J. Kastin. Tyr-MIF-1, but not MIF-1 or
morphine, decreases cyclic AMP-dependent protein kinase activity extracted from HeLa
cells. Mol. Cell. Neurosci. 3: 348-353, 1992.
571.
Banks, W.A. and A.J. Kastin. Human interleukin-1α crosses the blood-testis barriers of
the mouse. J. Androl. 13: 254-259, 1992.
572.
Banks, W.A. and A.J. Kastin. Bidirectional passage of peptides across the blood-brain
barrier. Prog. Brain Res. 91: 139-148, 1992.
573.
Zadina, J.E., A.J. Kastin, D. Kersh and A. Wyatt. Tyr-MIF-1 and hemorphin can act as
opiate agonists as well as antagonist in the guinea pig ileum. Life Sci. 51: 869-885, 1992.
574.
Banks, W.A. and A.J. Kastin. Exchange of peptides between the central nervous system
and the blood. Chimicaoggi 10: 38-40, 1992.
575.
Erchegyi, J., A.J. Kastin, J.E. Zadina, Qiu, X.-D. Isolation of a heptapeptide Val-Val-TyrPro-Trp-Thr-Gln (valorphin) with some opiate activity. Int. J. Pept. Protein Res. 39: 477484, 1992.
576.
Erchegyi, J., A.J. Kastin and J. Zadina. Isolation of a novel tetrapeptide with opiate and
antiopiate activity from human brain cortex: Tyr-Pro-Trp-Gly-NH2 (Tyr-W-MIF-1).
Peptides 13: 623-632, 1992.
577.
Petersheim, M., R.L. Moldow, H.N. Halladay, A.J. Kastin and A.J. Fischman.
Conformational studies of N-Tyr-MIF-1 in aqueous solution by 1H nuclear magnetic
resonance spectroscopy. Int. J. Pept. Protein Res. 40: 41-48, 1992.
578.
Kostrzewa, R.M., R. Brus, D.H. Coy, H. Criswell. P.S. Coogan and A.J. Kastin. DAla2,F5 Phe4-dynorphin amide, an opiate with analgesic and toxic properties. Pol. J.
Pharmacol. Pharm. 44: 109-120, 1992.
579.
Zlokovic, B.V., W.A. Banks, H. Elkadi, J. Erchegyi, J.B. Mackic, J.G. McComb and A.J.
Kastin. Transport, uptake and metabolism of blood-borne vasopressin by the blood-brain
57
barrier. Brain Res. 590: 213-218, 1992.
580.
Banks, W.A., A.J. Kastin and J.B. Jaspan. Orally administered cyclo(His-Pro) reduces
ethanol-induced narcosis in mice. Pharmacol. Biochem. Behav. 43: 939-941, 1992.
581.
Banks, W.A., A.J. Kastin, S. Radulovic, F.K. Conley, D.L. Johnson and A.V. Schally.
Selective uptake of the somatostatin analog RC-160 across the blood-brain tumor barrier
of mice with KHT sarcomas. Anti-Cancer Drugs 3: 513-518, 1992.
582.
Olson, G.A., R.D. Olson and A.J. Kastin. Endogenous opiates: 1991. Peptides 13: 12471287, 1992.
583.
Kastin, A.J., L. Fabre, M.M. Brown and R.D. Olson. Age- and sex-related changes in
Tyr-MIF-1-like immunoreactivity in rat plasma. Neuroendocrinology 56: 902-906, 1992.
584.
Erchegyi, J., J.E. Zadina, X.-D. Qiu, D.C. Kersh, L.-J. Ge, M.M. Brown and A.J. Kastin.
Structure-activity relationship of analogs of the endogenous brain peptides Tyr-MIF-1
and Tyr-W-MIF-1. Pept. Res. 6: 31-38, 1993.
585.
Zadina, J.E., S.L. Chang, L.-J. Ge and A.J. Kastin. Mu opiate receptor down-regulation
by morphine and up-regulation by naloxone in SH-SY5Y human neuroblastoma cells. J.
Pharmacol. Exp. Ther. 265: 254-265, 1993.
586.
Hackler, L., A.J. Kastin, J. Erchegyi and J.E. Zadina. Isolation of Tyr-W-MIF-1 from
bovine hypothalami. Neuropeptides 24: 159-164, 1993.
587.
Kostrzewa, R.M. and A.J. Kastin. Tyr-MIF-1 attenuates development of tolerance to
spiperone-induced catalepsy in rats. Brain Res. Bull. 31: 707-712, 1993.
588.
Malin, D.R., J.E. Zadina, J.R. Lake, R.B. Rogillio, T.M. Benson, L.S. Corriere, B.P.
Handunge and A.J. Kastin. Tyr-MIF-1 precipitates abstinence syndrome in morphinedependent rats. Brain Res. 610: 169-171, 1993.
589.
Kastin, A.J., L. Fabre, W.A. Banks and J.E. Zadina. Uptake, content, regulation of
plasma concentrations, and binding of Tyr-MIF-1 by the adrenals. Neuroendocrinology.
57: 541-549, 1993.
590.
Banks, W.A., A.J. Kastin, V. Akerstrom and J.B. Jaspan. Radioactively iodinated
cyclo(His-Pro) crosses the blood-brain barrier and reverses ethanol-induced narcosis.
Am. J. Physiol. 26: E723-E729, 1993.
591.
Zadina, J.E., A.J. Kastin, V. Kenigs, C. Bruno and L. Hackler. Prolonged analgesia after
intracerebroventricular Tyr-W-MIF-1 (Tyr-Pro-Trp-Gly-NH2). Neurosci. Lett. 155: 220222, 1993.
58
592.
Banks, W.A. and A.J. Kastin. The potential for alcohol to affect the passage of peptide
and protein hormones across the blood-brain barrier: a hypothesis for a disturbance in
brain-body communication. NIAAA Research Monograph 23: 401-411, 1993.
593.
Banks, W.A., A.J. Kastin and C.A. Ehrensing. Endogenous peptide Tyr-Pro-Trp-GlyNH2 (Tyr-W-MIF-1) is transported from the brain to the blood by peptide transport
system-1. J. Neurosci. Res. 35: 690-695, 1993.
594.
Banks, W.A., A.J. Kastin, G.A. Olson and R.D. Olson. Permeability of the blood-brain
barrier and blood-testis barrier to LH, FSH, and albumin in younger and older mice.
Neuroendocrinol. Lett. 15: 177-181, 1993.
595.
Banks, W.A., A.J. Kastin, G. Komaki and A. Arimura. Pituitary adenylate cyclase
activating polypeptide (PACAP) can cross the vascular component of the blood-testis
barrier in the mouse. J. Andrology 14: 170-173, 1993.
596.
Banks, W.A. and A.J. Kastin. Peptide binding in blood and passage across the bloodbrain barrier. In: Proceedings of the International Symposium on Blood Binding and
Drug Transfer. J.P. Tillement, H. Eckert, E. Albengres, J. Barre, P. Baumann, F. Belpaire
and M. Lemaire, eds., Editions Fort et Clair, Paris pp. 223-241, 1993.
597.
Gutierrez, E.G., W.A. Banks and A.J. Kastin. Murine tumor necrosis factor alpha is
transported from blood to brain in the mouse. J. Neuroimmunol. 47: 169-176, 1993.
598.
Banks, W.A. and A.J. Kastin. Measurement of transport of cytokines across the bloodbrain barrier. In: Neurobiology of Cytokines, Part A., P.M.Conn and E.B. De Souza, eds.,
Academic Press, San Diego, 16: 67-77, 1993.
599.
Harrison, L.M., J.E. Zadina, W.A. Banks and A.J. Kastin. Effects of neonatal treatment
with Tyr-MIF-1, morphiceptin, and morphine on development, tail flick, and blood-brain
barrier transport. Dev. Brain Res. 75: 207-212, 1993.
600.
Banks, W.A., A.J. Kastin and E.G. Gutierrez. Interleukin-1α in blood has direct access to
cortical brain cells. Neurosci. Lett. 163: 41-44, 1993.
601.
Olson, G.A., R.D. Olson and A.J. Kastin. Endogenous opiates: 1992. Peptides 14: 13391378, 1993.
602.
Banks, W.A., A.J. Kastin, G. Komaki and A. Arimura. Passage of pituitary adenylate
cyclase activating polypeptide1-27 and pituitary adenylate cyclase activating polypeptide138 across the blood-brain barrier. J. Pharmacol. Exp. Ther. 267: 690-696, 1993.
603.
Banks, W.A. and A.J. Kastin. Physiological consequences of the passage of peptides
59
across the blood brain barrier. Rev. Neurosci. 4: 365-372, 1993.
604.
Banks, W.A. and A.J. Kastin. Opposite direction of transport across the blood-brain
barrier for Tyr-MIF-1 and MIF-1: comparison with morphine. Peptides 15: 23-29, 1994.
605.
Kastin, A.J., K. Hahn, J. Erchegyi, J.E. Zadina, L. Hackler, M. Palmgren and W.A.
Banks. Differential metabolism of Tyr-MIF-1 and MIF-1 in rat and human plasma.
Biochem. Pharmacol. 47: 699-709, 1994.
606.
Waguespack, P.J., W.A. Banks and A.J. Kastin. Interleukin-2 does not cross the bloodbrain barrier by a saturable transport system. Brain Res. Bull. 34: 103-109, 1994.
607.
Maness, L.M., A.J. Kastin, J.T. Weber, W.A. Banks, B.S. Beckman and J.E. Zadina. The
neurotrophins and their receptors: structure, function, and neuropathology. Neurosci.
Biobehav. Rev. 18: 143-159, 1994.
608.
Hackler, L., A.J. Kastin and J.E. Zadina. Isolation of a novel peptide with a unique
binding profile from human brain cortex: Tyr-K-MIF-1 (Tyr-Pro-Lys-Gly-NH2). Peptides
15: 945-950, 1994.
609.
Kastin, A.J., W.A. Banks, K. Hahn and J.E. Zadina. Extreme stability of Tyr-MIF-1 in
CSF. Neurosci. Lett. 174: 26-28, 1994.
610.
Banks, W.A. and A.J. Kastin. Effects of aluminum on blood-brain barrier structure and
function. Life Chemistry Reports 11: 141-149, 1994.
611.
Banks, W.A., A.J. Kastin, H.M. Sam, V.T. Cao, B. King, L.M. Maness and A.V. Schally.
Saturable efflux of the peptides RC-160 and Tyr-MIF-1 by different parts of the bloodbrain barrier. Brain Res. Bull. 35: 179-182, 1994.
612.
Ahmed, B., A.J. Kastin, W.A. Banks and J.E. Zadina. CNS effects of peptides: a crosslisting of peptides and their central actions published in the journal Peptides, 1986-1993.
Peptides 15: 1105-1155, 1994.
613.
Zadina, J.E., L.M. Harrison, L.-J. Ge, A.J. Kastin and S.L. Chang. Differential regulation
of mu and delta opiate receptors by morphine, selective agonists and antagonists and
differentiating agents in SH-SY5Y human neuroblastoma cells. J. Pharmacol. Exp. Ther.
270: 1086-1096, 1994.
614.
Banks, W.A., A.J. Kastin and C.A. Ehrensing. Blood-borne interleukin-1α is transported
across the endothelial blood-spinal cord barrier of mice. J. Physiol. 479.2: 257-264, 1994.
615.
Ehrensing, R.H., A.J. Kastin, G.F. Wurzlow, G.F. Michell and A.H. Mebane.
Improvement in major depression after low subcutaneous doses of MIF-1. J. Affect.
60
Disord. 31: 227-233, 1994.
616.
Harrison, L.M., A.J. Kastin, J.T. Weber, W.A. Banks, D.L. Hurley and J.E. Zadina. The
opiate system in invertebrates. Peptides 15: 1309-1329, 1994.
617.
Banks, W.A., A.J. Kastin and E.G. Gutierrez. Penetration of interleukin-6 across the
murine blood-brain barrier. Neurosci. Lett. 179: 53-56, 1994.
618.
Maness, L.M., W.A. Banks, M.B. Podlisny, D.J. Selkoe and A.J. Kastin. Passage of
human amyloid ß-protein 1-40 across the murine blood-brain barrier. Life Sci. 55: 16431650, 1994.
619.
Kastin, A.J., W.A. Banks, R.D. Olson and J.E. Zadina. Novel concepts from novel
peptides. Ann. NY Acad. Sci. 739: 1-10, 1994.
620.
Jaspan, J.B., W.A. Banks and A.J. Kastin. Study of passage of peptides across the bloodbrain barrier: biological effects of cyclo(His-Pro) after intravenous and oral
administration. Ann. NY Acad. Sci. 739: 101-107, 1994.
621.
Banks, W.A. and A.J. Kastin. Brain-to-blood transport of peptides and the alcohol
withdrawal syndrome. Ann. NY Acad. Sci. 739: 108-118, 1994.
622.
Gergen, K.A., S.L. Chang, Y.F. Niu, A.J. Kastin and J.E. Zadina. Expression of the FOS
proto-oncogene protein in brain after icv administration of Tyr-W-MIF-1 (Tyr-Pro-TrpGly-NH2). Peptides 15: 1505-1511, 1994.
623.
Olson, G.A., R.D. Olson and A.J. Kastin. Endogenous opiates: 1993. Peptides 15: 15311556, 1994.
624.
Kastin, A.J., K. Hahn, W.A. Banks and J.E. Zadina. Delayed degradation of Tyr-MIF-1
in neonatal rat plasma. Peptides 15: 1561-1563, 1994.
625.
Zadina, J.E., A.J. Kastin, L. Hackler and S.L. Chang. Cyclic analogues of Tyr-W-MIF-1
with prolonged analgesic activity and potency comparable to DAMGO and morphine.
Peptides 15: 1567-1569, 1994.
626.
Zadina, J.E., A.J. Kastin, L.-J. Ge and L. Hackler. Mu, delta, and kappa opiate receptor
binding of Tyr-MIF-1 and of Tyr-W-MIF-1, its active fragments, and two potent analogs.
Life Sci. 55: PL461-PL466, 1994.
627.
Gutierrez, E.G., W.A. Banks and A.J. Kastin. Blood-borne interleukin-1 receptor
antagonist crosses the blood-brain barrier. J. Neuroimmunol. 55: 153-160, 1994.
628.
Hackler, L., M.E. Carey and A.J. Kastin. Enhanced isolation of Tyr-MIF-1 from fresh
61
human brain cortex. Brain Res. Bull. 36: 109-111, 1995.
629.
Kastin, A.J., L. Fabre, W.A. Banks, L. Hackler and J.E. Zadina. Increase in plasma TyrMIF-1-like immunoreactivity after hypophysectomy is robust and reversible by
corticosterone. Neuropeptides 28: 65-71, 1995.
630.
Banks, W.A. and A.J. Kastin. Blood-brain permeability: pharmacological implications
with special emphasis on peptides. In: Pharmacokinetics. P. G. Welling and F. L. Tse,
eds., Marcel Dekker, Inc., New York, 67: 119-138, 1995.
631.
Kastin, A.J., K. Hahn, J.E. Zadina, W.A. Banks and L. Hackler. Melanocyte- stimulating
hormone release-inhibiting factor-1 (MIF-1) can be formed from Tyr-MIF-1 in brain
mitochondria but not in brain homogenate. J. Neurochem. 64: 1855-1859, 1995.
632.
Banks, W.A. and A.J. Kastin. Regional variation in transport of pancreatic polypeptide
across the blood-brain barrier. Pharmacol. Biochem. Behav. 51: 139-147, 1995.
633.
Bollinger, J.E., J.T. Mague, W.A. Banks, A.J. Kastin and D.M. Roundhill. Lipophilic
hexadentate aluminum complexes of new phenolate-derivatized cyclohexanetriamine
ligands and their effect on the peptide transport system (PTS-1). Inorg.Chem. 34: 21432152, 1995.
634.
Zadina, J.E., A.J. Kastin, L.M. Harrison, L.-J. Ge and S.L. Chang. Opiate receptor
changes after chronic exposure to agonists and antagonists. Ann. NY Acad. Sci. 757:
353-361, 1995.
635.
Kastin, A.J., W.A. Banks, B. Ahmed and J.E. Zadina. Influence of hormones and
messenger peptides on normal brain function. In: Principles and Practice of
Endocrinology & Metabolism. K.L. Becker, ed., J.B. Lippincott, Philadelphia, pp. 16821691, 1995.
636.
Banks, W.A. and A.J. Kastin. Permeability of the blood-brain barrier to melanocortins.
Peptides 16: 1157-1161, 1995.
637.
Banks, W.A., D.J. Wustrow, W.L. Cody, M.D. Davis and A.J. Kastin. Permeability of the
blood-brain barrier to the neurotensin8-13 analog NT1. Brain Res. 695: 59-63, 1995.
638.
Banks, W.A., S.R. Plotkin and A.J. Kastin. Permeability of the blood-brain barrier to
soluble cytokine receptors. Neuroimmunomodulation 2: 161-165, 1995.
639.
Olson, G.A., R.D. Olson and A.J. Kastin. Endogenous opiates: 1994. Peptides 16: 15171555, 1995.
640.
Banks, W.A., A.J. Kastin, L.M. Maness, W, Huang and J.B. Jaspan. Permeability of the
62
blood-brain barrier to amylin. Life Sci. 57: 1993-2001, 1995.
641.
Maness, L.M., W.A. Banks, J.E. Zadina and A.J. Kastin. Selective transport of bloodborne interleukin-1α into the posterior division of the septum of the mouse brain. Brain
Res. 700: 83-88, 1995.
642.
Banks, W.A., A.J. Kastin and P. Zatta. The blood-brain barrier in aluminum toxicity and
Alzheimer's disease. In: Non-neuronal Cells in Alzheimer's Disease. P. Zatta and M.
Nicolini, eds., World Scientific Publishing Co. Pte. Ltd., Singapore, pp. 1-12, 1995.
643.
Banks, W.A., A.J. Kastin and R.D. Broadwell. Passage of cytokines across the bloodbrain barrier. Neuroimmunomodulation 2: 241-248, 1995.
644.
Banks, W.A. and A.J. Kastin. Peptide transport system-1. In: New Concepts of a BloodBrain Barrier. J. Greenwood, D. Begley, M.B. Segal and S. Lightman (Eds.) Plenum
Press, p. 111-117, 1995.
645.
Maness, L.M., W.A. Banks, J.E. Zadina and A.J. Kastin. Periventricular penetration and
disappearance of ICV Tyr-MIF-1, DAMGO, tyrosine, and albumin. Peptides 17: 247250, 1996.
646.
Banks, W.A. and A.J. Kastin. Reversible association of the cytokines MIP-1α and MIP1β with the endothelia of the blood-brain barrier. Neurosci. Lett. 205: 202-206, 1996.
647.
Banks, W.A., A.J. Kastin, W. Huang, J.B. Jaspan and L.M. Maness. Leptin enters the
brain by a saturable system independent of insulin. Peptides 17: 305-311, 1996.
648.
Gergen, K., J.E. Zadina, A.J. Kastin and D. Paul. Intrathecal Tyr-W-MIF-1 produces
potent, naloxone-reversible analgesia modulated by α2-adrenoceptors. Eur. J. Pharmacol.
298: 235-239, 1996.
649.
Martins, J.M., A.J. Kastin and W.A. Banks. Unidirectional specific and modulated brain
to blood transport of corticotropin-releasing hormone. Neuroendocrinology 63: 338-348,
1996.
650.
Kastin, A.J., J.E. Zadina, R.D. Olson and W.A. Banks. The history of neuropeptide
research: version 5.a. In: Neuropeptides: Basic and Clinical Advances. J.N. Crawley and
S. McLean, eds., Ann. NY Acad. Sci., New York. 780: 1-18, 1996.
651.
Bollinger, J.E., W.A. Banks, A.J. Kastin and D.M. Roundhill. Iron-59 complexes of
lipophilic hexadentate phenolate-derivatized cyclohexanetriamine ligands. Inorganic
Chimica Acta 242: 201-204, 1996.
652.
Plotkin, S.R., W.A. Banks and A.J. Kastin. Comparison of saturable transport and
63
extracellular pathways in the passage of interleukin-1α across the blood-brain barrier. J.
Neuroimmunol. 67: 41-47, 1996.
653.
Zadina, J.E., D. Paul, K.A. Gergen, L.-J. Ge, L. Hackler and A.J. Kastin. Binding of TyrW-MIF-1 (Tyr-Pro-Trp-Gly-NH2) and related peptides to μ1 and μ2 opiate receptors.
Neurosci. Lett. 215: 65-69, 1996.
654.
Cashion, M.F., W.A. Banks and A.J. Kastin. Sequestration of centrally administered
insulin by the brain: effects of starvation, aluminum, and TNF-α. Horm Behav. 30: 280286, 1996.
655.
Pan, W.H., W.A. Banks, M.K. Kennedy, E.G. Gutierrez and A.J. Kastin. Differential
permeability of the BBB in acute EAE: enhanced transport of TNF-α. Am. J. Physiol. 34:
E636-E642, 1996.
656.
Banks, W.A. and A.J. Kastin. Passage of peptides across the blood-brain barrier:
pathophysiological perspectives. Life Sci. 59: 1923-1943, 1996.
657.
Olson, G.A., R.D. Olson and A.J. Kastin. Endogenous opiates: 1995. Peptides 17: 14211466, 1996.
658.
Bollinger, J.E., W.A. Banks, A.J. Kastin, M.J. Welch and D.M. Roundhill.
Biodistribution of the lipophilic complexes 59Fe(RsalH2)3tach (R=H, NO2 and OMe) and
68
Ga(NO2salH2)3tach. Nucl. Med. Biol. 23: 645-652, 1996.
659.
Banks, W.A., L.M. Maness, M.F. Banks and A.J. Kastin. Aluminum-sensitive
degradation of amyloid β-protein1-40 by murine and human intracellular enzymes.
Neurotoxicol. Teratol. 18: 671-677, 1996.
660.
Banks, W.A., A.J. Kastin, L.M. Harrison and J.E. Zadina. Perinatal treatment of rats with
opiates affects the development of the blood-brain barrier transport system PTS-1.
Neurotoxicol. Teratol. 18: 711-715, 1996.
661.
Banks, W.A., M.B. Fasold and A.J. Kastin. Measurement of efflux rates from brain to
blood. In: Methods in Molecular Biology, Neuropeptide Protocols. G.B. Irvine and C.H.
Williams, eds., Humana Press Inc., Totowa, NJ, Vol. 73, pp. 353-360, 1997.
662.
Banks, W.A., A.J. Kastin and S.I. Rapoport. Permeability of the blood-brain barrier to
circulating free fatty acids. In: Handbook of Essential Fatty Acid Biology: Biochemistry,
Physiology and Behavioral Neurobiology. S. Yehuda, D.I. Mostofsky, eds., Humana
Press, Totowa, NJ, pp. 3-14, 1997.
663.
Shayo, M., R.N. McLay, A.J. Kastin, and W.A. Banks. The putative blood-brain barrier
transporter for the β-amyloid binding protein apolipoprotein J is saturated at
64
physiological concentrations. Life Sci. 60: PL115-PL118, 1997.
664.
Zadina, J.E., L. Hackler, L.-J. Ge and A.J. Kastin. A potent and selective endogenous
agonist for the μ-opiate receptor. Nature 386: 499-502, 1997.
665.
Martins, J.M., W.A. Banks and A.J. Kastin. Acute modulation of the active carriermediated brain-to-blood transport of corticotropin-releasing hormone. Am. J. Physiol.
272: E312-E319, 1997.
666.
Plotkin, S.R., W.A. Banks, P.J. Waguespack and A.J. Kastin. Ethanol alters the
concentration of Met-enkephalin in brain by affecting peptide transport system-1
independent of preproenkephalin mRNA. J. Neurosci. Res. 48: 273-280, 1997.
667.
Banks, W.A and A.J. Kastin. The role of blood-brain barrier transporter PTS-1 in
regulating concentrations of methionine enkephalin in blood and brain. Alcohol 14: 237245, 1997.
668.
Maness, L.M., W.A. Banks and A.J. Kastin. Investigation of blood-brain barrier
penetration and central nervous system distribution of peptides and proteins by in vivo
autoradiography. STP Pharma Sciences 7: 12-16, 1997.
669.
Pan, W., W.A. Banks and A.J. Kastin. Permeability of the blood-brain and blood-spinal
cord barriers to interferons. J. Neuroimmunol. 76: 105-111, 1997.
670.
Kastin, A.J., R.D. Olson, J.M. Martins, G.A. Olson, J.E. Zadina and W.A. Banks.
Chronic fatigue syndrome: possible integration of hormonal and immunological
observations. In: Chronic Fatigue Syndrome. S. Yehuda and D.I. Mostofsky, eds.,
Plenum Press, New York, p. 161-192, 1997.
671.
Champion, H.C., J.E. Zadina, A.J. Kastin, L. Hackler, L.-J. Ge and P.J. Kadowitz . The
endogenous mu-opioid receptor agonists endomorphins 1 and 2 have novel hypotensive
activity in the rabbit. Biochem. Biophys. Res. Commun. 235: 567-570, 1997.
672.
Pan, W., W.A. Banks and A.J. Kastin. Blood-brain permeability to ebiratide and TNF in
acute spinal cord injury. Exp. Neurol. 146: 367-373, 1997.
673.
Banks, W.A., A.J. Kastin and V. Akerstrom. HIV-1 protein GP120 crosses the bloodbrain barrier: role of adsorptive endocytosis. Life Sci. 61: PL119-PL125, 1997.
674.
Banks,W.A., A.J. Kastin, L.M. Maness, M.F.Banks, M. Shayo and R.N.McLay.
Interactions of β-amyloids with the blood-brain barrier. In: Cerebrovascular Pathology in
Alzheimer’s Disease. J.C. de la Torre and V. Hachinski, eds., Ann NY Acad. Sci., New
York, 826: 191-199, 1997.
65
675.
Banks, W.A. and A.J. Kastin. Relative contributions of peripheral and central sources to
levels of IL-1α in the cerebral cortex of mice: assessment with species-specific enzyme
immunoassays. J. Neuroimmunol. 79: 22-28, 1997.
676.
Pan,W., J.E. Zadina, R.E. Harlan, J.T. Weber, W.A. Banks and A.J. Kastin. Tumor
necrosis factor-α: a neuromodulator in the CNS. Neurosci. Biobehav. Rev. 21: 603-613,
1997.
677.
McLay, R.N., S.M. Freeman, R.E. Harlan, C.F. Ide, A.J. Kastin and J.E. Zadina. Aging in
the hippocampus: interrelated actions of neurotrophins and glucocorticoids. Neurosci.
Biobehav. Rev. 21: 615-629, 1997.
678.
Banks, W.A., J.B. Jaspan and A.J. Kastin. Selective, physiological transport of insulin
across the blood-brain barrier: novel demonstration by species-specific
radioimmunoassays. Peptides 18: 1257-1262, 1997.
679.
Champion, H.C., J.E. Zadina, A.J. Kastin, L. Hackler, L.-J. Ge and P.J. Kadowitz.
Endomorphin 1 and 2, endogenous ligands for the μ-opioid receptor, decrease cardiac
output, and total peripheral resistance in the rat. Peptides 18: 1393-1397, 1997.
680.
Banks, W.A., J.B. Jaspan, W. Huang and A.J. Kastin. Transport of insulin across the
blood-brain barrier: saturability at euglycemic doses of insulin. Peptides 18: 1423-1429,
1997.
681.
McLay, R.N., W.A. Banks and A.J. Kastin. Granulocyte macrophage-colony stimulating
factor crosses the blood-testis barrier in mice. Biol. Reprod. 57: 822-826, 1997.
682.
McLay, R.N., M. Kimura, W.A. Banks and A.J. Kastin. Granulocyte macrophagecolony-stimulating factor crosses the blood-brain and blood-spinal cord barriers. Brain
120: 2083-2091, 1997.
683.
Banks, W.A., J.B. Jaspan and A.J. Kastin. Effect of diabetes mellitus on the permeability
of the blood-brain barrier to insulin. Peptides 18: 1577-1584, 1997.
684.
Hackler, L., J.E. Zadina, L.-J. Ge and A.J. Kastin. Isolation of relatively large amounts of
endomorphin-1 and endomorphin-2 from human brain cortex. Peptides 18: 1635-1639,
1997.
685.
Martin-Schild, S., J.E. Zadina, A.A. Gerall, S. Vigh and A.J. Kastin. Localization of
endomorphin-2-like immunoreactivity in the rat medulla and spinal cord. Peptides 18:
1641-1649, 1997.
686.
Olson,G.A., R.D. Olson and A.J. Kastin. Endogenous opiates: 1996. Peptides 18: 16511688, 1997.
66
687.
Martins, J.M., W.A. Banks and A.J. Kastin. Transport of CRH from mouse brain directly
affects peripheral production of β-endorphin by the spleen. Am. J. Physiol. 273:E1083E1089, 1997.
688.
Champion, H..C., J.E. Zadina, A.J. Kastin and P.J. Kadowitz. The endogenous μ-opioid
agonists, endomorphin 1 and 2, have vasodilator activity in the hindquarters vascular bed
of the rat. Life Sci. 61: PL409-PL416, 1997
689.
Plotkin, S.R., W.A. Banks and A.J. Kastin. Enkephalin, PPE mRNA, and PTS-1 in
alcohol withdrawal seizure-prone and -resistant mice. Alcohol 15: 25-31, 1998.
690.
Kastin, A.J., K. Hahn, W.A. Banks and J.E. Zadina. Regional differences in the
metabolism of Tyr-MIF-1 and Tyr-W-MIF-1 by rat brain mitochondria. Biochem.
Pharmacol. 55: 33-36, 1998.
691.
Higashida, H., N. Hoshi, R. Knijnik, J.E. Zadina and A.J. Kastin. Endomorphins inhibit
high-threshold Ca2+channel currents in rodent NG108-15 cells overexpressing μ-opioid
receptors. J. Physiol. 507: 71-75, 1998.
692.
Harrison, L.M., A.J. Kastin and J.E. Zadina. Differential effects of endomorphin-1,
endomorphin-2, and Tyr-W-MIF-1 on activation of G-proteins in SH-SY5Y human
neuroblastoma membranes. Peptides 19: 749-753. 1998.
693.
Harrison, L.M., A.J. Kastin and J.E. Zadina. Tyr-W-MIF-1 attenuates down-regulation of
opiate receptors in SH-SY5Y human neuroblastoma cells. J. Pharmacol. Exp.Ther. 284:
611-617, 1998.
694
Banks, W.A., V. Akerstrom and A.J. Kastin. Adsorptive endocytosis mediates the
passage of HIV-1 across the blood-brain barrier: evidence for a post-internalization
coreceptor. J. Cell Sci. 111: 533-540, 1998.
695.
Pan, W., W.A. Banks and A.J. Kastin. Permeability of blood-brain barrier to
neurotrophins. Brain Res. 788: 87-94, 1998.
696.
Banks, W.A. and A.J. Kastin. Differential permeability of the blood-brain barrier to two
pancreatic peptides: insulin and amylin. Peptides 19: 883-889, 1998.
697.
Champion, H.C., J.E. Zadina, A.J. Kastin and P.J. Kadowitz. Endomorphin 1 and 2 have
vasodepressor activity in the anesthetized mouse. Peptides 19: 925-929, 1998.
698.
Banks, W.A., A.J. Kastin and A. Arimura. Effect of spinal cord injury on the
permeability of the blood-brain and blood-spinal cord barriers to the neurotropin PACAP.
Exp. Neurol. 151: 116-123, 1998.
67
699.
Banks, W.A., A.J. Kastin and C.A Ehrensing. Diurnal uptake of circulating interleukin1α by brain, spinal cord, testis and muscle. Neuroimmunomodulation 5: 36-41, 1998.
700.
Maness, L.M., A.J. Kastin and W.A. Banks. Relative contributions of a CVO and the
microvascular bed to delivery of blood-borne IL-1α to the brain. Am J. Physiol. 275:
E207-E212, 1998.
701.
Czapla, M.A., H.C. Champion, J.E. Zadina, A.J. Kastin, L. Hackler, L.-J. Ge and P.J.
Kadowitz. Endomorphin 1 and 2, endogenous μ-opioid agonists, decrease systemic
arterial pressure in the rat. Life Sci. 62: PL175-PL179, 1998.
702.
Champion, H.C., T.J. Bivalacqua, D.G. Lambert, S.M. McWilliams, J.E. Zadina, A.J.
Kastin and P.J Kadowitz. Endomorphin 1 and 2, the endogenous μ-opioid agonists,
produce biphasic changes in systemic arterial pressure in the cat. Life Sci. 63: PL131PL136, 1998.
703.
Champion, H.C., T.J. Bivalacqua, D.E. Friedman, J.E. Zadina, A.J. Kastin and P.J.
Kadowitz. Nitric oxide release mediates vasodilator responses to endomorphin 1 but not
nociceptin/OFQ in the hindquarters vascular bed of the rat. Peptides 19: 1595-1602,
1998.
704.
Harrison, L.M., A.J. Kastin and J.E. Zadina. Opiate tolerance and dependence: receptors,
G-proteins, and antiopiates. Peptides 19: 1603-1630, 1998.
705.
Maness, L.M., A.J. Kastin, C.L. Farrell and W.A. Banks. Fate of leptin after
intracerebroventricular injection into the mouse brain. Endocrinology 139: 4556-4562,
1998.
706.
Martin-Schild, S., A.A. Gerall, A.J. Kastin and J.E. Zadina. Endomorphin-2 is an
endogenous opioid in primary sensory afferent fibers. Peptides 19: 1783-1789, 1998.
707.
Olson, G.A., R.D. Olson, A.L. Vaccarino and A.J. Kastin. Endogenous opiates: 1997.
Peptides 19: 1791-1843, 1998.
708.
Pan, W., W.A. Banks, M.B. Fasold, J. Bluth and A.J. Kastin. Transport of brain-derived
neurotrophic factor across the blood-brain barrier. Neuropharmacology 37: 1553-1561,
1998.
709.
Martin-Schild, S., A.A. Gerall, A.J. Kastin and J.E. Zadina. Differential distribution of
endomorphin 1- and endomorphin 2-like immunoreactivities in the CNS of the rodent. J.
Comp. Neurol. 405: 450-471, 1999.
710.
Kastin, A.J and V. Akerstrom. Nonsaturable entry of neuropeptide Y into brain. Am. J.
68
Physiol. 276: E479-E482, 1999.
711.
Pan, W. and A.J. Kastin. Penetration of neurotrophins and cytokines across the bloodbrain/blood-spinal cord barrier. Adv. Drug Delivery Rev. 36: 291-298, 1999.
712.
Kastin, A.J. and V. Akerstrom. Orexin A but not orexin B rapidly enters brain from blood
by simple diffusion. J. Pharmacol. Exp. Ther. 289: 219-223, 1999.
713.
Banks, W.A., A.J. Kastin, J.M. Brennan and K.L. Vallance. Adsorptive endocytosis of
HIV-1 gp120 by blood-brain barrier is enhanced by lipopolysaccharide. Exp. Neurol.
156: 165-171, 1999.
714.
Cashion, M.F., W.A. Banks, K.L. Bost and A.J. Kastin. Transmission routes of HIV-1
gp120 from brain to lymphoid tissues. Brain Res. 822: 26-33, 1999.
715.
Pan, W., A.J. Kastin, L.M. Maness and J.M. Brennan. Saturable entry of ciliary
neurotrophic factor into brain. Neurosci. Lett. 263: 69-71, 1999.
716.
Pan, W., A.J. Kastin, R.L. Bell and R.D. Olson. Upregulation of tumor necrosis factor α
transport across the blood-brain barrier after acute compressive spinal cord injury. J.
Neuroscience 19: 3649-3655, 1999.
717.
Kastin, A.J., C.A. Sandman, G.A. Olson and R.D. Olson. Melanocyte-stimulating
hormone (MSH) and its analogs. In: Encyclopedia of Neuroscience, 2nd Ed., G.A.
Adelman and G.H. Smith, eds. Elsevier Science, Amsterdam, pp. 1125-1126, 1999.
718.
Kastin, A.J., W.A. Banks and W. Pan. Peptides and cytokines cross the blood-brain
barrier. In: Encyclopedia of Neuroscience, 2nd Ed., G.A. Adelman and G.H. Smith, eds.
Elsevier Science, Amsterdam, pp. 1607-1608, 1999.
719.
Kastin, A.J., R.H. Ehrensing and J.E. Zadina. The Tyr-MIF-1 family of peptides. In:
Encyclopedia of Neuroscience, 2nd Ed., G.A. Adelman and G.H. Smith, eds. Elsevier
Science, Amsterdam, pp. 2082-2083, 1999.
720.
McLay, R.N., S.M. Freeman, R.E. Harlan, A.J. Kastin and J.E. Zadina. Tests used to
assess the cognitive abilities of aged rats: their relation to each other and to hippocampal
morphology and neurotrophin expression. Gerontology 45: 143-155, 1999.
721.
Sakurada, S., J.E. Zadina, A.J. Kastin, S. Katsuyama, T. Fujimura, K. Murayama, M.
Yuki, H. Ueda and T. Sakurada. Differential involvement of μ-opioid receptor subtypes
in endomorphin-1- and -2-induced antinociception. Eur. J. Pharmacol. 372: 25-30, 1999.
722.
Banks, W.A., R.N. McLay, A.J. Kastin, U. Sarmiento and S. Scully. Passage of leptin
across the blood-testis barrier. Am. J. Physiol. 276: E1099-E1104, 1999.
69
723.
Banks, W.A., A.J. Kastin and W. Pan. Uptake and degradation of blood-borne insulin by
the olfactory bulb. Peptides 20: 373-378, 1999.
724.
Nores, W.L., R.D. Olson, G.A. Olson, A.L. Vaccarino, R.L. Bell, J.E. Zadina and A.J.
Kastin. Tyr-W-MIF-1-induced conditioned place preference. Peptides 20: 479-484, 1999.
725.
Bell, R.L., A.L. Vaccarino, R.D. Olson, G.A. Olson, W.L. Nores, J.G. Cambre, J.E.
Zadina and A.J. Kastin. Tolerance and morphine-induced cross-tolerance are shown to
Tyr-W-MIF-1 analgesia. Peptides 20: 971-978, 1999.
726.
Pan, W. and A.J. Kastin. Entry of EGF into brain is rapid and saturable. Peptides 20:
1091-1098, 1999.
727.
Pan, W., A.J. Kastin, W.A. Banks and J.E. Zadina. Effects of peptides: a cross-listing of
peptides and their central actions published in the journal Peptides from 1994 through
1998. Peptides 20: 1127-1138, 1999.
728.
Maresh, G.A., A.J. Kastin, T.T. Brown, J.E. Zadina and W.A. Banks. Peptide transport
system-1 (PTS-1) for Tyr-MIF-1 and Met-enkephalin differs from the receptors for
either. Brain Res. 839: 336-340, 1999.
729.
Kastin, A.J. and V. Ackerstrom. Entry of CART into brain is rapid but not inhibited by
excess CART or leptin. Am. J. Physiol. 277: E901-E904, 1999.
730.
Pan, W., K. Vallance and A.J. Kastin. TGFα and the blood-brain barrier: accumulation in
cerebral vasculature. Exp. Neurol. 160: 454-459, 1999.
731.
Kastin, A.J., W. Pan, L.M. Maness and W.A. Banks. Peptides crossing the blood-brain
barrier: some unusual observations. Brain Res. 848: 96-100, 1999.
732.
Kastin, A.J. Multiple direct actions of peptides on the CNS. Brain Res. Bull. 50: 361-362,
1999.
733.
Zadina, J.E., S. Martin-Schild, A.A. Gerall, A.J. Kastin, L. Hackler, L.-J. Ge and X.
Zhang. Endomorphins: novel endogenous μ-opiate receptor agonist in regions of high μopiate receptor density. Ann. NY Acad. Sci. 897: 136-144, 1999.
734.
Champion, H.C., T.J. Bivalacqua, J.E. Zadina, A.J Kastin and P.J. Kadowitz. Vasodilator
responses to the endomorphin peptides, but not nociceptin/OFQ, are mediated by nitric
oxide release. Ann. NY Acad. Sci. 897: 165-172, 1999.
735.
Kelly, J.P., G. Nicolau, A. Redmond, B.E. Leonard, J. Noble, L. Sverdlov, R. Molinar,
A.J. Kastin, R.H. Ehrensing and J.P. Feigher. The effect of treatment with a new
70
antidepressant, INN 00835, on platelet serotonin uptake in depressed patients. J. Affect.
Disord. 55: 231-236, 1999.
736.
Kastin, A.J., W. Pan, L.M. Maness, R.J. Koletsky and P. Ernsberger. Decreased transport
of leptin across the blood-brain barrier in rats lacking the short form of the leptin
receptor. Peptides 20: 1449-1453, 1999.
737.
Vaccarino, A.L., G.A. Olson, R.D. Olson and A.J. Kastin. Endogenous opiates: 1998.
Peptides 20: 1527-1574, 1999.
738.
Kastin, A.J., V. Akerstrom, L. Hackler and J.E. Zadina. Phe13,Tyr19-Melaninconcentrating hormone and the blood-brain barrier: role of protein binding. J.
Neurochem. 74: 385-391, 2000.
739.
Pan W., A.J. Kastin and J.M. Brennan. Saturable entry of leukemia inhibitory factor from
blood to the central nervous system. J. Neuroimmunol. 106: 172-180, 2000.
740.
Kastin, A.J. and V. Akerstrom. Fasting, but not adrenalectomy, reduces transport of
leptin into the brain. Peptides 21: 679-682, 2000.
741.
Kastin, A.J. and V. Akerstrom. Mahogany (1377-1428) enters brain by a saturable
transport system. J. Pharmacol. Exp. Ther. 294: 633-634, 2000.
742.
Maness, L.M., W.A. Banks and A.J. Kastin. Persistence of blood-to-brain transport of
leptin in obese leptin-deficient and leptin receptor-deficient mice. Brain Res. 873: 165167, 2000.
743.
Soignier, R.D., A.L. Vaccarino, A.M. Brennan, A.J. Kastin and J.E. Zadina. Analgesic
effects of endomorphin-1 and endomorphin-2 in the formalin test in mice. Life Sci. 67:
907-912, 2000.
744.
Somogyvari-Vigh, A., W. Pan, D. Reglodi, A.J Kastin and A. Arimura. Effect of middle
cerebral artery occlusion on the passage of pituitary adenylate cyclase activating
polypeptide across the blood-brain barrier in the rat. Regul. Pept. 91: 89-95, 2000.
745.
Pan, W. and A.J. Kastin. Interactions of IGF-1 with the blood-brain barrier in vivo and in
situ. Neuroendocrinology 72: 171-185, 2000.
746.
Sakurada, S., T. Hayashi, M. Yuki, T. Fujimura, K. Murayama, A. Yonezawa, C.
Sakurada, M. Takeshita, J.E. Zadina, A.J. Kastin and T. Sakurada. Differential
antagonism of endomorphin-1 and endomorphin-2 spinal antinociception by
naloxonazine and 3-methoxynaltrexone. Brain Res. 881: 1-8, 2000.
747.
Kastin, A.J. and W. Pan. Dynamic regulation of leptin entry into brain by the blood-brain
71
barrier. Reg. Pep. 92: 37-43, 2000.
748.
Kastin, A.J., V. Akerstrom and L. Hackler. Agouti-related protein (83-132) aggregates
and crosses the blood-brain barrier slowly. Metabolism 49: 1444-1448, 2000.
749.
Feighner, J.P., R.H. Ehrensing, A.J. Kastin, B.E. Leonard, L. Sverdlov, G. Nicolau, A.
Patel, J. Hlavka, H. Abajian and J.F. Noble. A double-blind, placebo-controlled, efficacy,
safety, and pharmacokinetic study of INN 00835, a novel antidepressant peptide, in the
treatment of major depression. J. Affect. Disord. 61: 119-126, 2000.
750.
Plotkin, S.R., W.A. Banks, L.M. Maness and A.J. Kastin. Differential transport of rat and
human interleukin-1α across the blood-brain barrier and blood-testis barrier in rats. Brain
Res. 881: 57-61, 2000.
751.
McLay, R.N., A.J. Kastin and J.E. Zadina. Passage of interleukin-1β across the bloodbrain barrier is reduced in aged mice: a possible mechanism for diminished fever in
aging. Neuroimmunomodulation 8: 148-153, 2000.
752.
Kastin, A.J., V.A. Akerstrom and W. Pan. Activation of urocortin transport into brain by
leptin. Peptides 21: 1811-1818, 2000.
753.
Wilson, A.M., R.D. Soignier, J.E. Zadina, A.J. Kastin, W.L. Nores, R.D. Olson and G.A.
Olson. Dissociation of analgesic and rewarding effects of endomorphin-1 in rats. Peptides
21: 1871-1874, 2000.
754.
Vaccarino, A.L. and A.J. Kastin. Endogenous opiates: 1999. Peptides 21: 1975-2034,
2000.
755.
Kastin, A.J., V. Akerstrom, L. Hackler and W. Pan. Adrenomedullin and the blood-brain
barrier. Horm. Metab. Res. 33: 19-25, 2001.
756.
Pan, W. and A.J. Kastin. Changing the chemokine gradient: CINC1 crosses the bloodbrain barrier. J. Neuroimmunol. 115: 64-70, 2001.
757.
Kastin, A.J., W. Pan, J.E. Zadina and W.A. Banks. The endocrine brain. In: Principles
and Practice of Endocrinology and Metabolism, edited by K.L. Becker, Philadelphia:
Lippincott Williams & Wilkins, 2001, pp. 1611-1615.
758.
Kastin, A.J. and V. Akerstrom. Glucose and insulin increase the transport of leptin
through the blood-brain barrier in normal mice but not in streptozotocin-diabetic mice.
Neuroendocrinology 73: 237-242, 2001.
759.
Kastin, A.J. and V. Akerstrom. Pretreatment with glucose increases entry of urocortin
into mouse brain. Peptides 22: 829-834, 2001.
72
760.
Pan, W. and A.J. Kastin. Diurnal variation of leptin entry from blood to brain involving
partial saturation of the transport system. Life Sci. 68: 2705-2714, 2001.
761.
Plotkin, S.R., W.A. Banks, C.S. Cohn and A.J. Kastin. Withdrawal from alcohol in
withdrawal seizure-prone and -resistant mice: evidence for enkephalin resistance.
Pharmacol. Biochem. Behav. 68: 379-387, 2001.
762.
Maresh, G.A., L.M. Maness, J.E. Zadina and A.J. Kastin. In vitro demonstration of a
saturable transport system for leptin across the blood-brain barrier. Life Sci. 69: 67-73,
2001.
763.
Pan, W., A.J. Kastin, L. Gera and J.M Stewart. Bradykinin antagonist decreases early
disruption of the blood-spinal cord barrier after spinal cord injury in mice. Neurosci. Lett.
307: 25-28, 2001.
764.
Smith, R.R., S. Martin-Schild, A.J. Kastin and J.E. Zadina. Decreases in endomorphin-2like immunoreactivity concomitant with chronic pain after nerve injury. Neuroscience
105: 773-778, 2001.
765.
Kastin, A.J., K. Hahn and J.E. Zadina. Regional differences in peptide degradation by rat
cerebral microvessels: A potential novel regulatory mechanism for communication
between blood and brain. Life Sci. 69: 1305-1312, 2001.
766.
Kastin, A.J., M.B. Fasold, R.R. Smith, K.A. Horner and J.E. Zadina. Saturable brain-toblood transport of endomorphins. Exp. Brain Res. 139: 70-75, 2001.
767.
Pan, W. and A.J. Kastin. Increase in TNF transport after SCI is specific for time, region,
and type of lesion. Exp. Neurol. 170: 357-363, 2001.
768.
Kastin, A.J., V. Akerstrom, and L.M. Maness. Chronic loss of ovarian function decreases
transport of leptin into mouse brain. Neurosci. Lett. 310: 69-71, 2001.
769.
Sakurada, S., T. Hayashi, M. Yuhki, T. Orito, J.E. Zadina, A.J.Kastin, T. Fujimura, K.
Murayama, C. Sakurada, T. Sakurada, M. Narita, T. Suzuki, K. Tan-no, and L.F. Tseng.
Differential antinociceptive effects induced by intrathecally administered endomorphin-1
and endomorphin-2 in the mouse. Eur. J. Pharmacol. 427: 203-210, 2001.
770.
Feighner, J.P., R.H. Ehrensing, A.J. Kastin, A. Patel, L. Sverdlov, J. Hlavka, H.B.
Abajian, J.F. Noble and G. Nicolau. Double-blind, placebo-controlled study of INN
00835 (netamiftide) in the treatment of outpatients with major depression. Int. Clin.
Psychopharmacol. 16: 1-8, 2001.
771.
Gozes, I., D.E. Brenneman, P. Geppetti, A.J. Kastin, R.E. Mains, T.W. Moody, K.
73
Seroogy, A.D. Spier, and M. Zimmermann. Neuropeptides: brain messengers of many
faces. Trends in Neurosci. 24: 687-690, 2001.
772.
Banks, W.A., B.M. King, K.N. Rossiter, R.D. Olson, G.A. Olson, and A.J. Kastin.
Obesity-inducing lesions of the central nervous system alter leptin uptake by the bloodbrain barrier. Life Sci. 69: 2765-2773, 2001.
773.
Kastin, A.J., V. Akerstrom, and W. Pan. Validity of multiple-time regression analysis in
measurement of tritiated and iodinated leptin crossing the blood-brain barrier: meaningful
controls. Peptides 22: 2127-2136, 2001.
774.
McLay, R.N., W. Pan, and A.J. Kastin. Effects of peptides on animal and human
behavior: a review of studies published in the first twenty years of the journal Peptides.
Peptides 22: 2181-2255, 2001.
775.
Vaccarino, A.L. and A.J. Kastin. Endogenous opiates: 2000. Peptides 22: 2257-2328,
2001.
776.
Kastin, A.J., V. Akerstrom, and L. Hackler. Food deprivation decreases blood galaninlike peptide and its rapid entry into the brain. Neuroendocrinology 74: 423-432, 2001.
777.
Pan, W. and A.J. Kastin. Upregulation of the transport system for TNFα at the bloodbrain barrier. Arch. Physiol. Biochem. 109: 350-353, 2001.
778.
Pan, W., G. Cornelissen, F. Halberg, and A.J. Kastin. Circadian rhythm of tumor necrosis
factor α uptake into mouse spinal cord (Selected Contribution). J. Appl. Physiol. 92:
1357-1362, 2002.
779.
Kastin, A.J., M.B. Fasold, and J.E. Zadina. Endomorphins, Met-Enkephalin, Tyr-MIF-1,
and the P-glycoprotein efflux system. Drug Metab. Disp. 30: 231-234, 2002.
780.
Pan, W. and A.J. Kastin. TNFα transport across the blood-brain barrier is abolished in
receptor knockout mice. Exp. Neurol. 174: 193-200, 2002.
781.
Kastin, A.J., V. Akerstrom, and W. Pan. Interactions of glucagon-like peptide-1 (GLP-1)
with the blood-brain barrier. J. Molec. Neurosci. 18: 7-14, 2002.
782.
Kastin, A.J. and V. Akerstrom. Differential interactions of urocortin/corticotropinreleasing hormone peptides with the blood-brain barrier. Neuroendocrinology 75: 367374, 2002.
783.
Wang, Q.P., J.E. Zadina, J.-L.Guan, A.J. Kastin, H. Funahashi, and S. Shioda.
Endomorphin-2 immunoreactivity in the cervical dorsal horn of the rat spinal cord at the
electron microscopic level. Neuroscience 113: 593-605, 2002.
74
784.
Sakurada, S., T. Hayashi, M. Yuhki, T. Fujimura, K. Murayama, A. Yonezawa, C.
Sakurada, M. Takeshita, T. Sato, J.E. Zadina, A.J. Kastin, and T. Sakurada. Differential
antagonism of endomorphin-1 and endomorphin-2 supraspinal antinociception by
naloxonazine and 3-methylnaltrexone. Peptides 23: 895-901, 2002.
785.
Pan, W., B. Solomon, L. M. Maness, and A.J. Kastin. Antibodies to β-amyloid decrease
the blood-to-brain transfer of β-amyloid peptide. Exp. Biol. Med. 227: 609-615, 2002.
786.
Kastin, A.J., W. Pan, V. Akerstrom, L. Hackler, C. Wang, and C.M. Kotz. Novel peptidepeptide cooperation may transform feeding behavior. Peptides 23: 2189-2196, 2002.
787.
Pan, W., L. Zhang, J. Liao, B. Csernus, and A.J. Kastin. Selective increase in TNFα
permeation across the blood-spinal cord barrier after SCI. J. Neuroimmunol. 14: 111-117,
2003.
788.
Pan, W., A.J. Kastin, T. Rigai, R. McLay, and C.G. Pick. Increased hippocampal uptake
of tumor necrosis factor α and behavioral changes in mice. Exp. Brain Res. 149: 195-199,
2003.
789.
Kastin, A.J., and V. Akerstrom. Entry of exendin-4 into brain is rapid but may be limited
at high doses. Int. J. Obes. 27: 313-318, 2003.
790.
Wang, Q.-P., J.E. Zadina, J.-L. Guan, A.J. Kastin, and S. Shioda. Electron microscopic
examination of the endomorphin 2-like immunoreactive neurons in the rat hypothalamus.
Brain Res. 969: 126-134, 2003.
791.
Kastin, A.J., V. Akerstrom, and W. Pan. Glial cell line-derived neurotrophic factor does
not enter normal mouse brain. Neurosci. Lett. 340: 239-241, 2003.
792.
Kastin, A.J. and W. Pan. Feeding peptides interact in several ways with the blood-brain
barrier. Curr. Pharm. Des. 9: 789-794, 2003.
793.
Pan, W. and A.J. Kastin. Interactions of cytokines with the blood-brain barrier:
Implications for feeding. Curr. Pharm. Des 9: 827-831, 2003
794.
Kastin, A.J., V. Akerstrom, and W. Pan. Interleukin-10 as a CNS therapeutic: the
obstacle of the blood-brain/blood-spinal cord barrier. Mol. Brain Res. 114: 168-171,
2003.
795.
Kastin, A.J., V. Akerstrom, L. Hackler, and W. Pan. Different mechanisms influencing
permation of PDGF-AA and PDGF-BB across the blood-brain barrier. J. Neurochem 87:
7-12, 2003.
75
796.
Kastin, A.J., V. Akerstrom, and W. Pan. Circulating TGF-β does not cross the intact
blood-brain barrier. J. Molec. Neurosci. 21: 43-48, 2003.
797.
Kastin, A.J., and W. Pan. Peptide transport across the blood-brain barrier. In: Peptide
Transport and Delivery into the Central Nervous System, edited by Laszlo Prokai and
Katalin Prokai-Tatrai, Basel, Switzerland: Birkhäuser Verlag, 2003, pp 79-100.
798.
Pan, W., B. Csernus, and A.J. Kastin. Upregulation of p55 and p75 receptors mediating
TNF α transport across the injured blood-spinal cord barrier. J. Molec. Neurosci. 21: 173184, 2003.
799.
Kastin, A.J., and W. Pan. Brain influx of endogenous peptides affecting food intake. In:
Blood-Spinal Cord and Brain Barriers in Health and Disease, edited by Hari Shanker
Sharma and Jan Westman, San Diego, California: Elsevier, 2004, pp 57-62.
800.
Pan, W., and A.J. Kastin. Transport of cytokines and neurotrophins across the bloodbrain barrier and their regulation after spinal cord injury. In: Blood-Spinal Cord and
Brain Barriers in Health and Disease, edited by Hari Shanker Sharma and Jan Westman,
San Diego, California: Elsevier, 2004, pp 395-407.
801.
Kastin, A.J., Victoria Akerstom, and Weihong Pan. Neuregulin 1-β1 enters brain and
spinal cord by receptor-mediated transport. J. Neurochem. 88: 965-970, 2004.
802.
Pan, W., and A.J. Kastin. Polypeptide delivery across the blood-brain barrier. Current
Drug Targets - CNS & Neurological Disorders. 3: 131-136, 2004.
803.
Somogyvari-Vigh, A., A.J. Kastin, J. Liao, J.E. Zadina, and W. Pan. Endomorphins exit
the brain by a saturable efflux system at the basolateral surface of cerebral endothelial
cells. Exp. Brain. Res. 156: 224-230, 2004.
804.
Kastin. A.J. Editorial: Twenty-five years of peptides. Peptides 25: 315-317, 2004.
805.
Pejovic V, V.Soskic, W. Pan, A.J.Kastin. Brain proteome of mice lacking the receptors
for tumor necrosis factor α. Proteomics, 4: 1461 - 1464, 2004
806.
Pan W, V. Akerstrom, J. Zhang, V. Pejovic, A.J. Kastin. Modulation of feeding-related
peptide/protein signals by the blood-brain barrier. J. Neurochem. 90: 455 - 461, 2004
807.
Pan W, A.J. Kastin. Why study transport of peptides and proteins at the neurovascular
interface. Brain Res. Rev. 46: 32 - 43, 2004
808.
Pan, W., A.J. Kastin, T.C. Zankel, P. van Kerhof, T. Terasaki, and G. Bu. Efficient
transfer of receptor-associated protein (RAP) across the blood-brain barrier. J. Cell Sci.
117: 5071-5078, 2004.
76
809.
Yu, Y., A. Jawa, W. Pan, and A.J. Kastin. Effects of peptides, with emphasis on feeding,
pain, and behavior: A 5-year (1999-2003) review of publications in Peptides. Peptides 25:
2257-2289, 2004.
810.
Kastin, A.J. and W. Pan. Targeting neurite growth inhibitors to induce CNS regeneration.
Curr. Pharm. Des. 11: 1247-1253, 2005.
811.
Xiang, S., W. Pan, and A.J. Kastin. Strategies to create a regenerating environment for
the injured spinal cord. Curr. Pharm. Des. 11: 1267-1277, 2005.
812.
Ding, Y., A.J. Kastin and W. Pan. Neural plasticity after spinal cord injury. Curr. Pharm.
Des. 11: 1441-1450, 2005.
813.
Pan, W., Y. Yu, C.M. Cain, F. Nyberg, P.O. Couraud, and A.J. Kastin. Permeation of
growth hormone across the blood-brain barrier. Endocrinology 146: 4898-4904, 2005.
814.
Pan, W., A.J. Kastin, Y. Yu, C.M. Cain, T. Fairburn, A.M. Stütz, C. Morrison, and G.
Argyropoulos. Selective tissue uptake of AgRP (82-131) and its modulation by fasting.
Endocrinology 146: 5533-5539, 2005.
815.
Pan, W., Y. Yu, F. Nyberg, and A.J. Kastin. Growth hormone, insulin, and insulin-like
growth factor-1: Do they interact at the blood-brain barrier? In: The Somatotropic Axis in
Brain Function, edited by Fred Nyberg, San Diego, California: Elsevier, 2006, pp 75-79.
816.
Pan, W., Y. Ding, Y. Yu, H. Ohtaki, T. Nakamachi, and A.J. Kastin. Stroke upregulates
TNFα transport across the blood-brain barrier. Exp. Neurol. 198: 222–233, 2006.
817.
Pan, W., H. Tu, and A.J. Kastin. Differential BBB interactions of three ingestive
peptides: obestatin, ghrelin, and adiponectin. Peptides 27: 911-916, 2006.
818.
Kastin, A.J. & W. Pan. Editorial: Intranasal leptin: blood-brain barrier bypass (BBBB)
for obesity? Endocrinology 147: 2086-2087, 2006.
819.
Pan, W, X. Xiang, H. Tu, and A.J. Kastin. Cytokines interact with the blood-brain barrier.
Chapter 11, in: The Blood-brain Barriers: From Ontogeny to Artificial Interfaces.
Volume I, Dermietzel R, Spray DC and Nedergaard M ed., Winheim, Germany: WileyVCH, 2006, pp 247-264.
820.
Yu, Y., A.J. Kastin, and W. Pan. Reciprocal interactions of insulin and IGF-I in receptormediated transport across the blood-brain barrier. Endocrinology 147: 2611-2615, 2006.
77
821.
Pan W., C. Cain, Y. Yu, and A.J. Kastin. Receptor-mediated transport of LIF across
blood-spinal cord barrier is upregulated after spinal cord injury. J. Neuroimmunol. 174:
119-125, 2006.
822.
Pan, W, Y. Yu, R. Yemane, C. Cain, C. Yu, and A.J. Kastin. Permeation of hepatocyte
growth factor across the blood-brain barrier. Exp Neurol 201:99-104, 2006.
823.
Yu, C., A.J. Kastin, Y. Ding, and W. Pan. Gamma glutamyl transpeptidase is a dynamic
indicator of endothelial response to stroke. Exp Neurol 203:116-122, 2007.
824.
Tu, H., A.J. Kastin, and W. Pan. CRH-R1 and CRH-R2 are both trafficking and signaling
receptors for urocortin. Mol Endocrinol 21:700-711, 2007.
825.
Pan, W. and A.J. Kastin. Mahogany, blood-brain barrier, and fat mass surge in AVY mice.
Int J Obes 31:1030-1032, 2007.
826.
Tu, H., W. Pan, L. Feucht, and A.J. Kastin. Convergent trafficking pattern of leptin after
endocytosis mediated by ObRa – ObRd. J Cell Physiol. 212:215-222, 2007.
827.
Pan W, A.J. Kastin, J. Daniel, C. Yu, L.M. Baryshnikova, and C.S. von Bartheld. TNF
trafficking in cerebral vascular endothelial cells. J Neuroimmunol 185:47-56, 2007.
828.
Yu, C., A.J. Kastin, H. Tu, and W. Pan. Opposing effects of proteasomes and lysosomes
on LIFR: modulation by TNF. J Mol Neurosci 31:80-89, 2007.
829.
Pan, W., M. Barron, H. Hsuchou, H. Tu, and A.J. Kastin. Increased leptin permeation
across the blood-brain barrier after chronic alcohol ingestion.
Neuropsychopharmacology 33:859-866, 2008.
830.
Tu, H., A.J. Kastin, C. Bjørbæk, and W. Pan. Urocortin trafficking in cerebral
microvessel endothelial cells. J Mol Neurosci. 31:171-182, 2007.
831.
Pan, W. and A.J. Kastin. Adipokines and the blood-brain barrier. Peptides 28:1317-1330,
2007.
832.
Yu, C., A.J. Kastin, and W. Pan. TNF reduces LIF endocytosis despite increasing
NFkappaB-mediated gp130 expression. J Cell Physiol. 213: 161-166, 2007.
833.
Pan, W. and A.J. Kastin. Peptide/polypeptide transport in the central nervous system. In:
Handbook of Neurochemistry and Molecular Neurobiology: Neural Membranes and
Transport. Lajtha, A. and Reith, E.A., eds, New York: Springer, 2007, pp 406-422.
834.
Pan, W., H. Tu, C. Yu, H. Hsuchou, Y. Yang, and A.J. Kastin. Differential role of TNF
receptors in cellular trafficking of intact TNF. Cell Physiol Biochem 20:559-568, 2007.
78
835.
Yu, C., W. Pan, H. Tu, S. Waters, and A.J. Kastin. TNF activates p-glycoprotein in
cerebral microvascular endothelial cells. Cell Physiol Biochem 20:853-858, 2007.
836.
Pan, W., H. Hsuchou, and A.J. Kastin. Nesfatin-1 crosses the blood–brain barrier without
saturation. Peptides 28:2223-2228, 2007.
837.
Hsuchou, H., Pan, W., and A.J. Kastin. The fasting polypeptide FGF21 can enter brain
from blood. Peptides 28:2382-2386, 2007.
838.
Pan, W. and A.J. Kastin. From MIF-1 to endomorphin: the TYR-MIF-1 family of
peptides. Peptides 28:2411-2434, 2007.
839.
Pan, W. and A.J. Kastin. Tumor necrosis factor and stroke: role of the blood-brain
barrier. Prog Neurobiol 83:363-374, 2007.
840.
Pan W., H. Hsuchou, H. Tu, and A.J. Kastin. Developmental changes of leptin receptors
in cerebral microvessels: unexpected relation to leptin transport. Endocrinology 149:877885, 2008.
841.
Pan, W. and A.J. Kastin. In vivo techniques quantifying blood-brain barrier permeability
to small proteins in mice. In: Neuropeptide Techniques. Gozes, I., ed, Totowa, NJ:
Humana Press, 2007, pp 97-113.
842.
Tu H., A.J. Kastin, H. Hsuchou, W. Pan. Soluble receptor inhibits leptin transport. J Cell
Physiol 214:301-305, 2008.
843.
Pan, W. and A.J. Kastin. Urocortin and the brain. Prog Neurobiol 84:148-56, 2008.
844.
Pan W., H. Tu, H. Hsuchou, J. Daniel, A.J. Kastin. Unexpected amplification of leptininduced Stat3 signaling by urocortin: implications for obesity. J Mol Neurosci 33:232238, 2007.
845.
Wang, Q-P., J-L Guan, W. Pan, A.J. Kastin, S. Shioda. A diffusion barrier between the
area postrema and nucleus tractus solitarius. Neurochem Res 33:2035-43, 2008.
846.
Pan, W., H. Hsuchou, C. Yu, and A.J. Kastin. Permeation of blood-borne IL15 across the
blood-brain barrier and the effect of LPS. J Neurochem 106:313-319, 2008.
847.
Pan, W., H. Hsuchou, Y. He, A. Sakharkar, C. Cain, C. Yu, and A.J. Kastin. Astrocyte
leptin receptor (ObR) and leptin transport in adult-onset obese mice. Endocrinology
149:2798-806, 2008.
848.
Kastin, A.J. and W. Pan. Peptides and Hormesis. Crit Rev Toxicol 38:1-3, 2008.
79
849.
Pan W., C. Yu, H. Hsuchou, Y. Zhang, and A.J. Kastin. Neuroinflammation facilitates
LIF entry into brain: role of TNF. Am J Physiol Cell Physiol 294: C1436-42, 2008.
850.
Kastin A.J. and W. Pan. Blood-brain barrier and feeding: regulatory roles of saturable
transport systems for ingestive peptides. Curr Pharm Des 14:1615-19, 2008.
851.
Pan, W., and A.J. Kastin. Cytokine transport across the injured blood-spinal cord barrier.
Curr Pharm Des 14:1620-4, 2008.
852.
Yu, C., G. Argyropoulos, Y. Zhang, A.J. Kastin, H. Hsuchou, and W. Pan.
Neuroinflammation activates Mdr1b efflux transport through NFκB: promoter analysis in
BBB endothelia. Cell Physiol Biochem 22:745-56, 2008.
853.
Kheterpal, I., A.J. Kastin, C.Yu, S. Mollah, and W. Pan. Mass spectrometric
quantification of MIF-1 in mouse brain by multiple reaction monitoring. Peptides
30:1276-81, 2009.
854.
He, Y., A.J. Kastin, H. Hsuchou, and W. Pan. The Cdk5/p35 kinases modulate leptininduced STAT3 signaling. J Mol Neurosci 39:49-58, 2009.
855.
Hsuchou H., Y. He, A.J. Kastin, H. Tu, E.N. Markadakis, R.C. Rogers, P.B. Fossier and
W. Pan. Obesity induces functional astrocytic leptin receptors in hypothalamus. Brain
132:889-902, 2009.
856.
Pan, W. and A.J. Kastin. Evolution of neuropeptide concepts illustrated by MIF-1 and
MSH. In: Transmitters and Modulators in Health and Disease. New Frontiers in
Neuroscience. Shioda S, I. Homma and N. Kato, eds, Tokyo: Springer, 2009, pp 3-17.
857.
Hsuchou H, Pan W, Wu X, Kastin AJ. Cessation of blood-to-brain influx of interleukin15 during development of EAE. J Cereb Blood Flow Metab 29:1568-78, 2009.
858.
Zhang Y, Wu X, He Y, Kastin AJ, Hsuchou H, Rosenblum CI, Pan W. Melanocortin
potentiates leptin-induced STAT3 signaling via MAPK pathway. J Neurochem 110:3909, 2009.
859.
Pan W, Yu C, Hsuchou H, Khan RS, Kastin AJ. Cerebral microvascular IL15 is a novel
mediator of TNF action. J Neurochem 111:819-27, 2009.
860.
Hsuchou H, Pan W, Barnes MJ, Kastin AJ. Leptin receptor mRNA in rat brain astrocytes.
Peptides 30:2275-80, 2009.
861.
Kastin AJ. Peptide conservation: From Erspamer’s amphibians to rodents. In: In Memory
of Vittorio Erspamer. Negri L et al, eds. Rome: University of Rome 2009, pp 79-83.
80
862.
Hsuchou H, Kastin AJ, Wu X, Tu H, Pan W. Corticotropin-releasing hormone receptor-1
in cerebral microvessels changes during development and influences urocortin transport
across the blood-brain barrier. Endocrinology 151:1221-7, 2010.
863.
He Y, Wu X, Khan RS, Kastin AJ, Cornelissen-Guillaume GG, Hsuchou H, Robert B,
Halberg F, Pan W. IL-15 receptor deletion results in circadian changes of locomotor and
metabolic activity. J Mol Neurosci 41:315-21, 2010.
864.
Tu H, Hsuchou H, Kastin AJ, Wu X, Pan W. Unique leptin trafficking by a tailless
receptor. FASEB J24:2281-91, 2010.
865.
Pan W, Yu C, Hsuchou H, Kastin AJ. The role of cerebral vascular NFκB in LPSinduced inflammation: differential regulation of efflux transporter and transporting
cytokine receptors. Cell Physiol Biochem 25:623-30, 2010.
866.
Khan RS, Yu C, Kastin AJ, He Y, Ehrensing RH, Hsuchou H, Stone KP, Pan W. Brain
activation by peptide Pro-Leu-Gly-NH2 (MIF-1). Int J Peptides 2010.
867.
He Y, Wu X, Hsuchou H, Kastin AJ, Khan RS, Pistell P, Wang W-H, Feng J, Li Z, Guo
X, Pan W. Interleukin-15 receptor is essential to facilitate GABA transmission and
hippocampal dependent memory. J Neurosci 30:4725-34, 2010.
868.
Wu X, Pan W, Stone KP, Zhang Y, Hsuchou H, Kastin AJ. Expression and signaling of
novel IL15Rα splicing variants in cerebral endothelial cells of the blood-brain barrier. J
Neurochem 114:122-9, 2010
869.
Wu X, Pan W, He Y, Hsuchou H, Kastin AJ. Cerebral interleukin-15 shows upregulation
and beneficial effects in experimental autoimmune encephalomyelitis. J Neuroimmunol
223: 65-72, 2010.
870.
Wu X, Kastin AJ, Hsuchou H, Pan W. The effects of IL2Rγ knockout on depression and
contextual memory. Behav Brain Res 213: 319-22, 2010.
871.
Wu X, He Y, Hsuchou H, Kastin, AJ, Rood JC, Pan W. Essential role of interleukin-15
receptor in normal anxiety behavior. Brain Behav Immun 24: 1340-6, 2010.
872.
Kastin AJ, Pan W. Concepts of biologically active peptides. Current Pharmaceutical
Design, 16: 3390-3400, 2010.
873.
Hsuchou H, Kastin AJ, Tu H, Abbott NJ, Couraud PO, Pan W. Role of astrocytic leptin
receptor subtypes on leptin permeation across hCMEC/D3 human brain endothelial cells.
Journal of Neurochemistry, 115: 1288-98, 2010.
874.
Wu X, Hsuchou H, Kastin AJ, He Y, Khan RS, Stone KP, Cash MS, Pan W. Interleukin81
15 affects serotonin system and exerts antidepressive effects through IL15Rα receptor.
Psychoneuroendocrinology, 36: 266-78, 2011
875.
Pan W, Wu X, Kastin AJ, Zhang Y, Hsuchou H, Halberg F, Chatu F, Khan RS, Robert B,
Cornelissen-Guillaume. Potential protective role of IL15Ralpha in homeostasis during
inflammation. Journal of Molecular Neuroscience, 43: 412-23, 2011
876.
Pan W, Hsuchou H, Xu C, Wu X, Bouret SG, Kastin AJ. Astrocytes modulate
distribution and neuronal signaling of leptin in the hypothalamus of obese Avy mice.
Journal of Molecular Neuroscience, 43: 478-84, 2011
877.
Stone KP, Kastin AJ, Hsuchou H, Yu C, Pan W. Rapid endocytosis of interleukin-15 by
cerebral endothelia. Journal of Neurochemistry, 116: 544-53, 2011
82